[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"_public_publisher_all{\"sortAscending\":false,\"sortField\":\"updateTime\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"\"}":3,"_public_publisher_byId_6814e24d-1b39-4468-8092-9712509bfcc2":656,"_public_publication_all{\"sortAscending\":false,\"sortField\":\"totalCitation\",\"page\":0,\"size\":10,\"facet\":true,\"searchKey\":\"publisherId:6814e24d-1b39-4468-8092-9712509bfcc2,\"}":755},{"meta":4,"data":6},{"total":5},"117",[7,60,176,207,299,413,445,480,543,572],{"id":8,"createTime":9,"updateTime":10,"relativeEntities":11,"slug":12,"properties":13,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":29,"subjectFields":30,"manageAffiliations":31,"indexDatabases":32,"url":33,"thumbnailPath":34,"statistic":35,"gsStatistic":26,"type":26,"analyzePriority":26},"5a09599f-54d1-44c3-8f16-3847ac552024","2023-08-17T04:28:50.832+00:00","2025-10-13T23:58:52.517+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Truy%E1%BB%81n-nhi%E1%BB%85m-Vi%E1%BB%87t-Nam",{"country":14,"issn":16,"introduce":18,"title":21},{"VOID":15},"VN",{"VOID":17},"08667829",{"EN":19,"VI":20},"{\"ops\":[{\"insert\":\"Vietnam Journal of Infectious Diseases is a social - professional forum of the Vietnam Society for Infectious Diseases, whose responsibility is to introduce the researches, the scientific advances in Vietnam and from the world; to contribute to the improvement of knowledges for health care staffs about clinic, treatment, guideline, prevention, epidemiology for infectious diseases, HIV\u002FAIDS and community health care; to provide, exchange and publish scientific information to the public accurately and promptly.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Vietnam Journal of Infectious Diseases publishes in the whole country; serves the professional work for researchers, clinical staffs, administrators, undergraduate and postgraduate students who are working and studying in the infections, tropical diseases and HIV\u002FAIDS from central to local levels, also organizations and individuals in the world who are interested in infectious and tropical diseases and prevention for HIV\u002FAIDS.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Editor in Chief:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Kinh. - Chairman of Editorial Board\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Prof. Dr. Nguyen Van Mui.\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Headquarter:\"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Address:\"},{\"insert\":\" Level 6, National Hospital for Tropical Diseases, No. 78 Giai Phong Street, Dong Da District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tel:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913552672\"},\"insert\":\"0913552672\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"insert\":\".\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Bank account:\"},{\"insert\":\" 0021000275119, Vietcombank Hanoi Branch. Transaction office No. 7, 402 Tran Khat Chan, Hai Ba Trung District, Hanoi city, Vietnam.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Tạp chí Truyền nhiễm Việt Nam là cơ quan ngôn luận của Hội Truyền nhiễm Việt Nam, chịu sự lãnh đạo, chỉ đạo trực tiếp của Thường vụ Ban Chấp hành Hội Truyền nhiễm Việt Nam; sự kiểm tra, giám sát về nghiệp vụ báo chí của các cơ quan chức năng quản lý báo chí thuộc Bộ Thông tin và Truyền thông và Ban Tuyên giáo Trung ương Đảng.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí có trách nhiệm giới thiệu các công trình nghiên cứu khoa học, những tiến bộ khoa học trên thế giới và trong nước, góp phần nâng cao kiến thức khoa học cho cán bộ y tế về lâm sàng, điều trị, hướng dẫn, dự phòng, dịch tễ học các bệnh truyền nhiễm, HIV\u002FAIDS và chăm sóc sức khỏe cộng đồng; cung cấp, trao đổi, phổ biến các thông tin khoa học tới công chúng chính xác và kịp thời.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Tạp chí xuất bản 03 tháng\u002F01 kỳ và được phát hành qua Bưu điện và tự phát hành trong phạm vi toàn quốc.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Lãnh đạo Tạp chí: \"},{\"attributes\":{\"header\":4},\"insert\":\"\\n\"},{\"insert\":\"Tổng Biên tập: ThS.BSCKII Nguyễn Trung Cấp\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"Phó Tổng Biên tập:\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"insert\":\"            TS.BSCKII Phạm Ngọc Thạch\"},{\"attributes\":{\"align\":\"justify\",\"blockquote\":true},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Trụ sở tòa soạn:\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Địa chỉ: Tầng 6, Bệnh viện Bệnh Nhiệt đới Trung ương, 78 đường Giải Phóng, phường Phương Mai, quận Đống Đa, thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Điện thoại:\"},{\"insert\":\" \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:02435765464\"},\"insert\":\"02435765464\"},{\"insert\":\" - \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Ftel:0913228072\"},\"insert\":\"0913228072\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Email\"},{\"insert\":\": \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Findex\u002Fadmin\u002Fcontexts\u002Fmailto:tungphamvan52@gmail.com\"},\"insert\":\"tungphamvan52@gmail.com\"},{\"insert\":\"; \"},{\"attributes\":{\"color\":\"#008d45\",\"background\":\"transparent\",\"link\":\"https:\u002F\u002Fbvnd.vojs.vn\u002Findex.php\u002Fvjid\u002Fmanagement\u002Fsettings\u002Fcontext\u002Fmailto:tapchitruyennhiem@gmail.com\"},\"insert\":\"tapchitruyennhiem@gmail.com\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Tài khoản:\"},{\"insert\":\" Số 0021000275119 Ngân hàng Ngoại thương Việt Nam, chi nhánh Hà Nội (Vietcombank Hà Nội). Phòng giao dịch số 7, 402 Trần Khát Chân, quận Hai Bà Trưng, Thành phố Hà Nội.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":22,"VI":23},"Vietnam Journal of Infectious Diseases","Tạp chí Truyền nhiễm Việt Nam","PUBLISHER","VERIFIED",null,"Admin update database","PENDING",51,[],[],[],"https:\u002F\u002Ftruyennhiemvietnam.vn\u002Findex.php\u002Fvjid","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F5a09599f-54d1-44c3-8f16-3847ac552024\u002Fadb0e52bf25e0de580fd4289519cb8bf.jpg",{"impactFactor":36,"impactFactorByYear":37,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":41,"totalPublicationByYear":42,"totalCitation":48,"totalCitationByYear":49,"totalCitationPerPublication":54,"totalCitationPerPublicationByYear":55,"hindexLast5Year":59,"hindex":59},0,{"2022":38,"2023":39,"2024":40},0.01,0.03,0.13,315,{"2020":43,"2021":44,"2022":45,"2023":46,"2024":47},63,58,57,65,72,43,{"2020":50,"2021":51,"2022":52,"2023":53},8,15,9,11,0.14,{"2020":40,"2021":56,"2022":57,"2023":58},0.26,0.16,0.17,3,{"id":61,"createTime":62,"updateTime":63,"relativeEntities":64,"slug":65,"properties":66,"entityType":24,"verifyStatus":25,"verifyTime":78,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":79,"subjectFields":80,"manageAffiliations":81,"indexDatabases":136,"url":137,"thumbnailPath":26,"statistic":138,"gsStatistic":155,"type":175,"analyzePriority":26},"25b6bd10-676c-40c0-8dc3-356d1679a284","2023-05-19T02:22:33.430+00:00","2026-06-18T23:33:57.141+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Y-D%C6%B0%E1%BB%A3c-h%E1%BB%8Dc-C%E1%BA%A7n-Th%C6%A1",{"country":67,"issn":68,"introduce":70,"title":73,"gsId":76},{"VOID":15},{"VOID":69},"23541210",{"EN":71,"VI":72},"\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">04\u002F10\u002F2015 Ministry of Information and Communications allowed Can Tho journal of medicine and pharmacy to operate (102 \u002FGP-BTTTT)\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">07\u002F16\u002F2015 Can Tho journal of medicine and pharmacy is internationally recognized: ISSN 2354-1210\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">In 2016, The journal has been included in the list of medical science journals by The State Council for professorship which is awarded a work score of 0-0.5 points for a published article.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Can Tho Journal of Medicine and Pharmacy welcome original works that haven’t been submitted or published in other medical journals. Posts must contain content related to one of the journal’s categories.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The content published\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The journal is divided into 3 categories:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Scientific research article: are valuable scientific works, which have been researched and accepted.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Overview of medicine, biology and pharmacy: serving the objective of continuing training in the fields of medicine, biology and pharmacy; to systematize classical and modern knowledge.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Update information on new knowledge about medicine, biology, pharmacy in the country and in the world.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Scope\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Publication and introduction of scientific research in the fields:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Medicine (internal medicine, surgery, pediatrics, obstetrics and gynecology, odonto-stomatology, laboratory, oncology, traditional medicine, nursing).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Biology (genetics, biotechnology).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">+ Pharmacology (pharmaceutics, drug quality analysis-control, synthetic pharmaceutical chemistry, biochemistry, pharmacognosy, botany, clinical pharmacy).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- To enhance the quality of undergraduate, postgraduate education, scientifically researching and meet the necessary treatment in hospital.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Introducing the updated domestic and oversea information about science technology to promote scientific research and exchanging technology in local, other universities.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">- Exchanging pharmaceutical and medical information for social health developing in the Mekong Delta and Vietnam.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">The object\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Postgraduate students, student of Can Tho University of Medicine and Pharmacy, scientists from schools, research institutes, hospitals, health centers, pharmaceutical companies of the Mekong Delta; other provinces and regions in Vietnam and other country.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Address\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Headquarters of Can Tho Journal of Medicine and Pharmacy, located Scientific Research and International Cooperation Office: 179 Nguyen Van Cu Street, An Khanh Ward, Ninh Kieu District, Can Tho City, Vietnam.\u003C\u002Fspan>\u003C\u002Fp>","\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Ngày 16\u002F7\u002F2015, Tạp chí Y Dược học Cần Thơ được cấp chỉ số quốc tế: ISSN 2354-1210.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 4\u002F2016, Tạp chí đã được Hội đồng Giáo sư ngành Y đưa vào danh sách các tạp chí khoa học Y học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Năm 2020 Tạp chí Y Dược học Cần Thơ đã được phê duyệt vào danh mục của các Hội đồng Giáo sư ngành Dược học được tính điểm công trình 0-0,5 điểm cho một bài báo đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ ra 12 số\u002Fnăm, 180-200 trang\u002Fsố.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Từ tháng 12\u002F2022 Tạp chí Y Dược học Cần Thơ là thành viên của hệ thống Crossref và từ tháng 01\u002F2023 tạp chí thực hiện bình duyệt online kín 2 chiều nhằm tăng tính minh bạch, tin cậy của các công trình nghiên cứu khoa học và đảm bảo tốt nhất chất lượng khoa học của bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ, mục đích và phạm vi của tạp chí\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tôn chỉ và mục đích hoạt động của tạp chí: xuất bản nhằm mục đích phổ biến kết quả từ các đề tài nghiên cứu khoa học; giao lưu trao đổi khoa học, chia sẻ kinh nghiệm, học tập, đồng thời cập nhật thông tin khoa học mới trong các lĩnh vực y, sinh, dược học trong và ngoài nước.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phạm vi của tạp chí: Tạp chí xuất bản được chia thành 3 chuyên mục: (i) Bài báo nghiên cứu khoa học là kết quả công trình nghiên cứu khoa học có giá trị đã được triển khai nghiên cứu, (ii) Bài tổng quan y, sinh, dược học: phục vụ mục tiêu đào tạo liên tục trong lĩnh vực y, sinh, dược học; nhằm hệ thống hóa những kiến thức kinh điển và hiện đại; (iii) Thông tin cập nhật kiến thức mới về y, sinh, dược học trong nước và trên thế giới.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Chính sách truy cập mở\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ áp dụng chính sách truy cập mở đối với các bài báo đã xuất bản đến với độc giả, nhằm mở rộng cơ hội tiếp cận các kết quả nghiên cứu chất lượng cao và tăng cường trao đổi kiến thức. Tạp chí đăng tải trực tuyến (miễn phí) toàn văn các bài báo được công bố trên website của Tạp chí (https:\u002F\u002Ftapchi.ctump.edu.vn).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đạo đức xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ cam kết tuân thủ đạo đức xuất bản phù hợp với các hướng dẫn và tiêu chuẩn của the Committee on Publication Ethics (COPE), tuân thủ các nguyên tắc của COPE’s Core Practices, Best Practices Guidelines for Journal Editors và Guidelines on Good Publication Practices.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Bản thảo bài báo chỉ được chấp nhận khi được tác giả chịu trách nhiệm chính cam kết các nội dung sau: Các nội dung của bản thảo chưa được đăng tải toàn bộ hoặc một phần ở các tạp chí khác; Tất cả các tác giả đều có đóng góp một cách đáng kể vào quá trình nghiên cứu hoặc chuẩn bị bản thảo và cùng chịu trách nhiệm về các nội dung của bản thảo; Tuân thủ các biện pháp đảm bảo đạo đức nghiên cứu (ví dụ thỏa thuận đồng ý tham gia nghiên cứu).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Cam kết bảo mật\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí cam kết thực hiện và tuân thủ các quy định của luật và các văn bản hướng dẫn liên quan đến bảo mật thông tin cá nhân trên không gian mạng. Các thông tin mà người dùng (tác giả, độc giả, biên tập viên, người phản biện) nhập vào các biểu mẫu trên Hệ thống Quản lý xuất bản trực tuyến của tạp chí chỉ được sử dụng vào các mục đích đã được tuyên bố rõ ràng và sẽ không được cung cấp cho bất kỳ bên thứ ba nào khác, hay dùng vào bất kỳ mục đích nào khác.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Phí gửi bài\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng bài: 1.000.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Lệ phí gửi đăng nhanh: 1.500.000đ\u002Fbài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với tác giả là cán bộ viên chức thuộc Trường Đại học Y Dược Cần Thơ thì được hỗ trợ 50% lệ phí gửi đăng bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Đối với sinh viên thực hiện đề tài nghiên cứu khoa học cấp trường được hỗ trợ 100% lệ phí đăng bài ( Tác giả gửi đính kèm “ Quyết định về việc giao tổ chức thực hiện đề tài nghiên cứu khoa học cấp Trường của sinh viên”).\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Hình thức nộp lệ phí:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Tiền mặt:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Nộp trực tiếp tại Phòng Tài chính - Kế toán, Trường Đại học Y Dược Cần Thơ, số 179 Nguyễn Văn Cừ, P. An Khánh, Q. Ninh Kiều, thành phố Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Chuyển khoản:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tên Tài khoản: Trường ĐHYD Cần Thơ, Số TK: 0111000115668, tại ngân hàng Vietcombank chi nhánh Cần Thơ.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Thời gian: Áp dụng từ ngày 01\u002F02\u002F2023.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">* Phí gửi bài không được hoàn trả khi bài viết bị từ chối hoặc tác giả xin rút bài viết.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Quy trình phản biện bài báo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tạp chí Y Dược học Cần Thơ thực hiện quy trình phản biện kín hai chiều nghiêm ngặt. Danh tính của những người phản biện không được tiết lộ cho các tác giả và ngược lại. Quy trình thẩm định bài báo đăng gồm các bước sau:\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tiếp nhận bản thảo\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Tác giả liên hệ gửi bản thảo đến Tạp chí qua hệ thống trực tuyến tại website: https:\u002F\u002Ftapchi.ctump.edu.vn. Hướng dẫn về cách đăng ký, gửi bài và chuẩn bị bản thảo được cung cấp trên website của Tạp chí.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sàng lọc sơ bộ\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Sau khi Tòa soạn nhận được bài báo của tác giả, Ban Thư ký sẽ tiến hành kiểm tra sơ bộ bài báo (các yêu cầu về nội dung và hình thức). Những bài báo không đúng quy cách hoặc có nội dung không phù hợp hoặc vi phạm bản quyền sẽ bị từ chối (Ban Thư ký thông báo phản hồi đến tác giả trong vòng 1 tuần). Những bài báo đủ điều kiện, được Ban Thư ký tòa soạn chuyển đến Ban Biên tập có cùng chuyên môn với nội dung bài báo để đề xuất người phản biện. Thời gian kể từ khi Ban Biên tập nhận bài báo đến khi đề xuất người phản biện bài báo chậm nhất là 5 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Vòng phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký gửi bài và yêu cầu phản biện đến 02 phản biện độc lập.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Các phản biện gởi nhận xét cho Ban Thư ký. Thời gian từ khi gửi bài cho phản biện đến khi nhận ý kiến của phản biện tối đa là 20 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xử ký kết quả phản biện\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Nếu ý kiến đồng ý cho đăng và không cần chỉnh sửa, Ban Thư ký tiếp tục đăng bài theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Nếu ý kiến đồng ý đăng và cần chỉnh sửa, Ban Thư ký sẽ thông tin đến tác giả chỉnh sửa theo yêu cầu của người phản biện. Thời gian chỉnh sửa và gửi lại kéo dài không quá 2 tuần, từ khi tác giả bài báo nhận được thông tin (Quá trình này có thể lặp lại tối đa 2 lần\u002F1 bài báo). Khi có sự thống nhất, đồng ý của người phản biện; bài báo được tiếp tục đăng theo qui trình.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Những bài báo có chất lượng không đạt yêu cầu, cả 2 phản biện không đồng ý cho đăng sẽ bị Tòa soạn từ chối đăng.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">Xuất bản\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">1. Ban Thư ký tổng hợp các bản thảo đã được tác giả hoàn thiện sau thẩm định trình Ban Biên tập xem xét, Tổng Biên tập phê duyệt, quyết định bài đăng theo các tiêu chí: sự phù hợp nội dung với tôn chỉ và mục đích, thể loại bài viết (ưu tiên các bài có bài có nghiên cứu chuyên sâu, hàm lượng khoa học cao), đóng góp mới bài báo, bài báo được ưu tiên đăng trong số gần nhất của Tạp chí theo thứ tự: tính thời sự, chất lượng bài báo và thời gian gửi bài.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">2. Ban Biên tập và Ban Thư ký biên tập bản thảo, chế bản, đọc rà soát lỗi. Thời gian hoàn thành từ 10-15 ngày.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">3. Ban Thư ký có trách nhiệm thông báo cho tác giả bài báo (bằng e-mail) về tình hình phê duyệt bài báo, thời gian, số kỳ, tập xuất bản bài báo theo qui định.\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>\u003Cp>\u003Cspan style=\"color: rgb(0, 0, 0);\">4. Danh sách bài báo theo số Tạp chí được in ấn và phát hành trong năm định kỳ được công bố chính thức trên website: https:\u002F\u002Ftapchi.ctump.edu.vn\u003C\u002Fspan>\u003C\u002Fp>\u003Cp>\u003Cbr>\u003C\u002Fp>",{"EN":74,"VI":75},"Cantho Journal of Medicine and Pharmacy","Tạp chí Y Dược học Cần Thơ",{"VOID":77},"wcQ1uqwAAAAJ","2023-05-30T08:17:21.868+00:00",32,[],[82],{"id":83,"createTime":84,"updateTime":85,"relativeEntities":86,"slug":87,"properties":88,"entityType":98,"verifyStatus":25,"verifyTime":99,"verifyNote":26,"syncStatus":28,"languages":100,"translateLanguages":26,"viewCount":103,"url":104,"parentIds":105,"statistic":106},"6413896b-eca9-442b-a73f-182a58a0ce40","2023-06-12T14:59:13.446+00:00","2026-06-19T02:29:32.871+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Y-D%C6%B0%E1%BB%A3c-C%E1%BA%A7n-Th%C6%A1",{"country":89,"title":90,"address":93,"abbreviation":96},{"VOID":15},{"EN":91,"VI":92},"Can Tho University of Medicine and Pharmacy","Trường Đại học Y Dược Cần Thơ",{"VI":94,"EN":95},"Số 179, đường Nguyễn Văn Cừ, phường An Khánh, quận Ninh Kiều, thành phố Cần Thơ, Việt Nam","No 179, Nguyen Van Cu street, An Khanh ward, Ninh Kieu district, Can Tho city, Vietnam",{"VOID":97},"ctump","AFFILIATION","2023-08-01T14:07:27.977+00:00",[101,102],"VI","EN",12,"http:\u002F\u002Fwww.ctump.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":107,"i10Index":111,"i10IndexLast5Year":59,"totalPublication":112,"totalPublicationByYear":113,"totalCitation":122,"totalCitationByYear":123,"totalCitationPerPublication":128,"totalCitationPerPublicationByYear":129,"hindexLast5Year":135,"hindex":135},{"2022":108,"2023":109,"2024":110,"2025":38},0.1,0.05,0.07,4,1489,{"2013":114,"2014":115,"2015":115,"2016":111,"2017":115,"2018":59,"2019":114,"2020":116,"2021":117,"2022":118,"2023":119,"2024":120,"2025":121,"2026":111},2,1,10,84,281,680,260,156,313,{"2013":59,"2014":114,"2018":124,"2021":125,"2022":126,"2023":127},17,36,123,132,0.21,{"2013":130,"2014":114,"2018":131,"2021":132,"2022":133,"2023":134},1.5,5.67,0.43,0.44,0.19,6,[],"https:\u002F\u002Ftapchi.ctump.edu.vn\u002Findex.php\u002Fctump",{"impactFactor":36,"impactFactorByYear":139,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":140,"totalPublicationByYear":141,"totalCitation":147,"totalCitationByYear":148,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":152,"hindexLast5Year":135,"hindex":135},{"2022":38,"2023":36,"2024":39,"2025":38},1956,{"0":114,"2019":114,"2020":50,"2021":142,"2022":143,"2023":144,"2024":145,"2025":146},76,403,789,305,371,524,{"0":114,"2019":135,"2021":124,"2022":149,"2023":150,"2024":111,"2025":114},287,206,0.27,{"0":115,"2019":59,"2021":153,"2022":154,"2023":56,"2024":38,"2025":38},0.22,0.71,{"impactFactor":26,"impactFactorByYear":26,"i10Index":114,"i10IndexLast5Year":114,"totalPublication":156,"totalPublicationByYear":157,"totalCitation":163,"totalCitationByYear":164,"totalCitationPerPublication":169,"totalCitationPerPublicationByYear":170,"hindexLast5Year":135,"hindex":135},461,{"0":158,"2019":114,"2021":159,"2022":160,"2023":161,"2024":158,"2025":162},7,37,296,107,5,419,{"2021":59,"2022":59,"2023":165,"2024":166,"2025":167,"2026":168},71,126,171,41,0.91,{"2021":171,"2022":38,"2023":172,"2024":173,"2025":174},0.08,0.66,18,34.2,"JOURNAL",{"id":177,"createTime":178,"updateTime":179,"relativeEntities":180,"slug":181,"properties":182,"entityType":24,"verifyStatus":25,"verifyTime":193,"verifyNote":26,"syncStatus":28,"languages":194,"translateLanguages":26,"viewCount":36,"subjectFields":195,"manageAffiliations":196,"indexDatabases":197,"url":198,"thumbnailPath":26,"statistic":26,"gsStatistic":199,"type":175,"analyzePriority":26},"f8d0bf97-8d89-482e-b58c-2fc481a0b79b","2025-10-27T06:27:08.591+00:00","2026-06-18T23:33:41.667+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-v%C3%A0-C%C3%B4ng-ngh%E1%BB%87-nhi%E1%BB%87t-%C4%91%E1%BB%9Bi",{"country":183,"introduce":184,"gsId":186,"title":188,"issn":191},{"VOID":15},{"EN":185},"\u003Cp style=\"text-align:justify;\">     Journal of Tropical Science and Engineering (JTSE) is a multidisciplinary scientific journal, licensed to operate as a print journal in 2012 and an electronic journal in 2024 (License No.1479\u002FGP-BTTTT dated August 20, 2012 and No.91\u002FGP-BTTTT dated April 9, 2024 issued by the Ministry of Information and Communications of Vietnam). The JTSE is headquartered in Hanoi.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">        The JTSE is published every 3 months (4 issues\u002Fyear), publishing research results and overview articles in 3 groups of fields: Tropical Ecology and Environment; Chemistry and Material Sciences; Biomedicine and Pharmacy. In 2022, the JTSE registered the international identifier Digital Object Identifier (DOI): 10.58334\u002Fvrtc.jtst and assigned DOI codes to all articles of the journal. The members of the Editorial Board of the JTSE are prestigious scientists and leading scientists from Vietnam and many countries in the world. The JTSE has been recognized by the Vietnam State Council for Professorship to score scientific articles in Chemistry, Medicine and Biology with scores ranging from 0-0.75 points.\u003C\u002Fp>\u003Cp style=\"text-align:justify;\">      Currently, the JTSE is building and perfecting a set of criteria and making efforts to join the List of prestigious  international journals with a roadmap to enter Scopus and SCIE in the coming time.\u003C\u002Fp>",{"VOID":187},"MS2_GJQAAAAJ",{"VI":189,"EN":190},"Tạp chí Khoa học và Công nghệ nhiệt đới","Journal of Tropical Science and Engineering",{"VOID":192},"08667535","2025-10-27T06:27:25.058+00:00",[101,102],[],[],[],"https:\u002F\u002Ftapchikhcnnd.com.vn",{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":200,"totalPublicationByYear":201,"totalCitation":161,"totalCitationByYear":203,"totalCitationPerPublication":153,"totalCitationPerPublicationByYear":205,"hindexLast5Year":114,"hindex":114},481,{"0":115,"2020":115,"2021":115,"2022":114,"2024":115,"2025":202,"2026":115},474,{"2017":114,"2018":115,"2019":111,"2020":162,"2021":162,"2022":116,"2023":50,"2024":162,"2025":204,"2026":52},52,{"2020":162,"2021":162,"2022":162,"2024":162,"2025":206,"2026":52},0.11,{"id":208,"createTime":209,"updateTime":210,"relativeEntities":211,"slug":212,"properties":213,"entityType":24,"verifyStatus":25,"verifyTime":221,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"subjectFields":223,"manageAffiliations":224,"indexDatabases":225,"url":226,"thumbnailPath":26,"statistic":227,"gsStatistic":276,"type":175,"analyzePriority":26},"a3d1e82a-57e2-40f9-940e-f5fa8b9ef64a","2023-06-01T07:11:26.039+00:00","2026-06-18T23:33:28.573+00:00",[],"VNU-Journal-of-Science-Earth-and-Environmental-Sciences",{"issn":214,"title":216,"country":218,"gsId":219},{"VOID":215},"26159279",{"EN":217},"VNU Journal of Science: Earth and Environmental Sciences",{"VOID":15},{"VOID":220},"UmXD8vEAAAAJ","2023-06-01T07:17:59.210+00:00",27,[],[],[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FEES",{"impactFactor":36,"impactFactorByYear":228,"i10Index":234,"i10IndexLast5Year":36,"totalPublication":235,"totalPublicationByYear":236,"totalCitation":246,"totalCitationByYear":247,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":262,"hindexLast5Year":103,"hindex":103},{"2010":229,"2012":40,"2013":230,"2014":230,"2015":231,"2016":54,"2017":171,"2018":109,"2019":110,"2020":57,"2021":232,"2022":233,"2023":151,"2024":58},0.02,0.04,0.09,0.31,0.4,19,656,{"2008":237,"2009":238,"2010":239,"2011":238,"2012":240,"2013":241,"2014":239,"2015":242,"2016":243,"2017":244,"2018":245,"2019":165,"2020":125,"2021":168,"2022":125,"2023":222,"2024":111},23,24,22,28,25,20,146,29,78,1038,{"2008":248,"2009":249,"2010":250,"2011":251,"2012":252,"2013":253,"2014":254,"2015":255,"2016":256,"2017":257,"2018":161,"2019":258,"2020":259,"2021":29,"2022":260},119,64,66,86,38,73,59,31,129,39,97,53,26,1.58,{"2008":263,"2009":264,"2010":59,"2011":265,"2012":266,"2013":267,"2014":268,"2015":269,"2016":270,"2017":271,"2018":272,"2019":272,"2020":273,"2021":274,"2022":275},5.17,2.67,3.58,1.36,2.92,2.68,1.55,0.88,1.34,1.37,1.47,1.24,0.72,{"impactFactor":26,"impactFactorByYear":26,"i10Index":173,"i10IndexLast5Year":135,"totalPublication":277,"totalPublicationByYear":278,"totalCitation":279,"totalCitationByYear":280,"totalCitationPerPublication":288,"totalCitationPerPublicationByYear":289,"hindexLast5Year":158,"hindex":298},113,{"2007":114,"2008":103,"2009":173,"2010":116,"2011":51,"2012":239,"2013":103,"2014":162,"2015":53,"2016":135},616,{"2009":162,"2010":114,"2011":52,"2012":124,"2013":222,"2014":255,"2015":48,"2016":44,"2017":281,"2018":282,"2019":259,"2020":283,"2021":284,"2022":285,"2023":286,"2024":257,"2025":287,"2026":59},54,60,49,47,34,44,33,5.45,{"2009":290,"2010":291,"2011":292,"2012":293,"2013":294,"2014":295,"2015":296,"2016":297},0.28,0.2,0.6,0.77,2.25,6.2,3.91,9.67,14,{"id":300,"createTime":301,"updateTime":302,"relativeEntities":303,"slug":304,"properties":305,"entityType":24,"verifyStatus":25,"verifyTime":316,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":234,"subjectFields":317,"manageAffiliations":318,"indexDatabases":388,"url":389,"thumbnailPath":390,"statistic":391,"gsStatistic":409,"type":175,"analyzePriority":26},"a7166325-6c9e-4db3-8a59-7c879701a372","2023-07-31T04:28:49.231+00:00","2026-06-18T23:33:22.428+00:00",[],"VNU-Journal-of-Science-Policy-and-Management-Studies",{"country":306,"issn":307,"eissn":309,"title":311,"gsId":314},{"VOID":15},{"VOID":308},"26159295",{"VOID":310},"25881116",{"EN":312,"VI":313},"VNU Journal of Science: Policy and Management Studies","Tạp chí Nghiên cứu Chính sách và Quản lý",{"VOID":315},"xKW2E_cAAAAJ","2023-08-01T03:23:46.688+00:00",[],[319],{"id":320,"createTime":321,"updateTime":322,"relativeEntities":323,"slug":324,"properties":325,"entityType":98,"verifyStatus":25,"verifyTime":335,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":336,"url":337,"parentIds":338,"statistic":339},"12466116-8f60-4b01-8faf-2411483a0977","2023-05-30T09:37:38.472+00:00","2026-06-19T02:14:28.352+00:00",[],"Vietnam-National-University",{"country":326,"title":327,"abbreviation":330,"address":332},{"VOID":15},{"EN":328,"VI":329},"Vietnam National University, Hanoi","Đại học Quốc gia Hà Nội",{"VOID":331},"VNU",{"VI":333,"EN":334},"Số 144 Xuân Thủy, Phường Dịch Vọng Hậu, Quận Cầu Giấy, Hà Nội, Việt Nam","No. 144 Xuan Thuy Street, Dich Vong Hau Ward, Cau Giay District, Hanoi, Vietnam","2023-08-02T13:58:17.029+00:00",16,"http:\u002F\u002Fwww.vnu.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":340,"i10Index":285,"i10IndexLast5Year":162,"totalPublication":344,"totalPublicationByYear":345,"totalCitation":354,"totalCitationByYear":355,"totalCitationPerPublication":368,"totalCitationPerPublicationByYear":369,"hindexLast5Year":336,"hindex":336},{"2014":109,"2015":231,"2016":231,"2017":206,"2018":341,"2019":110,"2020":342,"2021":343,"2022":171,"2023":231,"2024":110,"2025":39},0.06,0.18,0.35,1247,{"2003":115,"2004":115,"2005":114,"2006":59,"2007":111,"2008":162,"2009":59,"2010":50,"2011":124,"2012":336,"2013":260,"2014":244,"2015":250,"2016":281,"2017":346,"2018":347,"2019":348,"2020":349,"2021":350,"2022":351,"2023":352,"2024":353,"2025":255,"2026":50},94,88,83,67,176,185,187,93,1644,{"2004":111,"2005":115,"2006":52,"2007":298,"2008":356,"2009":298,"2010":286,"2011":357,"2012":244,"2013":358,"2014":359,"2015":360,"2016":361,"2017":362,"2018":363,"2019":364,"2020":365,"2021":366,"2022":367,"2023":367,"2024":162},13,81,48,70,151,115,109,259,174,181,121,101,1.32,{"2004":111,"2005":370,"2006":59,"2007":371,"2008":372,"2009":373,"2010":374,"2011":375,"2012":376,"2013":377,"2014":378,"2015":379,"2016":380,"2017":381,"2018":382,"2019":383,"2020":384,"2021":385,"2022":386,"2023":387,"2024":109},0.5,3.5,2.6,4.67,5.5,4.76,1.81,1.85,2.41,2.29,2.13,1.16,2.94,2.1,2.7,0.69,0.55,0.54,[],"https:\u002F\u002Fjs.vnu.edu.vn\u002FPaM","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002Fa7166325-6c9e-4db3-8a59-7c879701a372\u002Fecfe83f4bcc60c7023ae04d8900fe0ac.jpg",{"impactFactor":36,"impactFactorByYear":392,"i10Index":111,"i10IndexLast5Year":36,"totalPublication":394,"totalPublicationByYear":395,"totalCitation":399,"totalCitationByYear":400,"totalCitationPerPublication":293,"totalCitationPerPublicationByYear":403,"hindexLast5Year":158,"hindex":158},{"2018":109,"2019":171,"2020":393,"2021":108,"2022":54,"2023":206,"2024":54},0.23,320,{"2015":50,"2016":239,"2017":286,"2018":396,"2019":397,"2020":159,"2021":398,"2022":168,"2023":79,"2024":255},30,35,40,247,{"2015":115,"2016":242,"2017":401,"2018":222,"2019":402,"2020":79,"2021":239,"2022":50,"2023":116},77,50,{"2015":404,"2016":169,"2017":405,"2018":406,"2019":407,"2020":408,"2021":386,"2022":291,"2023":232},0.12,1.75,0.9,1.43,0.86,{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":103,"totalPublicationByYear":410,"totalCitation":234,"totalCitationByYear":411,"totalCitationPerPublication":261,"totalCitationPerPublicationByYear":412,"hindexLast5Year":114,"hindex":59},{"2015":114,"2016":116},{"2016":115,"2017":114,"2018":114,"2019":59,"2020":114,"2021":59,"2022":114,"2023":114,"2024":115,"2026":115},{"2016":108},{"id":414,"createTime":415,"updateTime":416,"relativeEntities":417,"slug":418,"properties":419,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":238,"subjectFields":428,"manageAffiliations":429,"indexDatabases":430,"url":431,"thumbnailPath":26,"statistic":432,"gsStatistic":438,"type":175,"analyzePriority":26},"16e65a3f-d274-47dd-8691-56d76eb58c3d","2023-05-30T09:10:06.062+00:00","2026-06-18T23:33:17.679+00:00",[],"Vietnam-Journal-of-Otorhinolaryngology-Head-and-Neck-Surgery",{"country":420,"issn":421,"title":423,"gsId":426},{"VOID":15},{"VOID":422},"18593704",{"EN":424,"VI":425},"Vietnam Journal of Otorhinolaryngology - Head and Neck Surgery","Tạp chí Tai Mũi Họng Việt Nam",{"VOID":427},"L78B_eIAAAAJ",[],[],[],"https:\u002F\u002Ftapchitaimuihong.vn\u002Findex.php\u002Ftmh",{"impactFactor":36,"impactFactorByYear":433,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":434,"totalPublicationByYear":435,"totalCitation":111,"totalCitationByYear":436,"totalCitationPerPublication":230,"totalCitationPerPublicationByYear":437,"hindexLast5Year":115,"hindex":115},{"2024":229},95,{"2022":52,"2023":286,"2024":255,"2025":53},{"2023":111},{"2023":231},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":240,"totalPublicationByYear":439,"totalCitation":234,"totalCitationByYear":440,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":442,"hindexLast5Year":114,"hindex":114},{"2023":53,"2024":116,"2025":135,"2026":115},{"2024":59,"2025":298,"2026":114},0.68,{"2024":443,"2025":444,"2026":114},0.3,2.33,{"id":446,"createTime":447,"updateTime":448,"relativeEntities":449,"slug":450,"properties":451,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":396,"subjectFields":460,"manageAffiliations":461,"indexDatabases":462,"url":463,"thumbnailPath":464,"statistic":465,"gsStatistic":472,"type":175,"analyzePriority":26},"25988add-c322-4eda-afda-63b1559bb824","2023-04-07T03:49:55.817+00:00","2026-06-18T23:32:23.776+00:00",[],"T%E1%BA%A1p%20ch%C3%AD%20Y%20-%20D%C6%B0%E1%BB%A3c%20h%E1%BB%8Dc%20qu%C3%A2n%20s%E1%BB%B1",{"country":452,"issn":453,"title":455,"gsId":458},{"VOID":15},{"VOID":454},"18590748",{"EN":456,"VI":457},"Journal of Military Pharmaco-medicine","Tạp chí Y - Dược học quân sự",{"VOID":459},"_pmQ8IEAAAAJ",[],[],[],"https:\u002F\u002Fjmpm.vn\u002Findex.php\u002Fjmpm","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F25988add-c322-4eda-afda-63b1559bb824\u002F09c6bc42157cf5ece95edc971ccddb52.jpg",{"impactFactor":36,"impactFactorByYear":466,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":467,"totalPublicationByYear":468,"totalCitation":135,"totalCitationByYear":470,"totalCitationPerPublication":38,"totalCitationPerPublicationByYear":471,"hindexLast5Year":115,"hindex":115},{"2023":229,"2024":38},475,{"2022":168,"2023":365,"2024":469,"2025":124},236,{"2022":114,"2023":111},{"2022":109,"2023":229},{"impactFactor":26,"impactFactorByYear":26,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":277,"totalPublicationByYear":473,"totalCitation":401,"totalCitationByYear":474,"totalCitationPerPublication":441,"totalCitationPerPublicationByYear":475,"hindexLast5Year":59,"hindex":59},{"2015":115,"2018":114,"2019":115,"2020":115,"2021":59,"2022":103,"2023":159,"2024":287,"2025":237},{"2020":115,"2021":115,"2022":115,"2023":52,"2024":237,"2025":79,"2026":116},{"2020":115,"2021":476,"2022":171,"2023":477,"2024":478,"2025":479},0.33,0.24,0.7,1.39,{"id":481,"createTime":482,"updateTime":483,"relativeEntities":484,"slug":485,"properties":486,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":496,"translateLanguages":26,"viewCount":45,"subjectFields":497,"manageAffiliations":498,"indexDatabases":525,"url":526,"thumbnailPath":527,"statistic":528,"gsStatistic":26,"type":26,"analyzePriority":26},"2b8d7b12-2d20-4777-be98-077f44f03c69","2023-09-07T07:40:58.286+00:00","2025-07-13T21:21:00.542+00:00",[],"VNU-Journal-of-Social-Sciences-and-Humanities",{"country":487,"issn":488,"introduce":490,"title":493},{"VOID":15},{"VOID":489},"23541172",{"EN":491,"VI":492},"{\"ops\":[{\"insert\":\"VNU Journal of Social Sciences and Humanities (ISSN 2354-1172) is a double-blind peer-reviewed journal published by University of Social Sciences and Humanities, Vietnam National University, Hanoi, Vietnam, under the publication permit no. 155\u002FGP-BTTTT, issued on 11\"},{\"attributes\":{\"script\":\"super\"},\"insert\":\"th \"},{\"insert\":\"May, 2015 by Ministry of Information and Communications. The journal publishes four Vietnamese issues and two English issues per year.\\nCurrently, there are 35 reputable professors in the editorial board. The main objectives of the journal include: providing an intellectual platform for Vietnamese and international scholars; promoting interdisciplinary studies in social sciences and humanities; becoming the leading journal in social sciences and humanities in Vietnam; being indexed by worldwide databases and having academic recognition internationally in the near future.\\nThe journal is currently indexed by Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services and Vietnam National University’s digital archive.\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Journal of Social Sciences and Humanities-Vietnam\"},{\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"ISSN 2354-1172, email: tapchikhxhnv@gmail.com, tckhxhnv@vnu.edu.vn\"},{\"insert\":\"\\n\"}]}","{\"ops\":[{\"insert\":\"Được thành lập ngày 31\u002F8\u002F2015 (giấy phép hoạt động số 155\u002FGP-BVHTT ngày 11 tháng 5 năm 2015 của Bộ Thông tin và Truyền thông, mã số tiêu chuẩn quốc tế ISSN 2354-1172), Tạp chí Khoa học Xã hội và Nhân văn (Journal of Social Sciences and Humanities) là ấn phẩm khoa học chính thức, duy nhất của Trường Đại học Khoa học Xã hội và Nhân văn, ĐHQG Hà Nội, phát triển và kế thừa Chuyên san Khoa học Xã hội và Nhân văn, Tạp chí Khoa học, ĐHQG Hà Nội.\\nTạp chí xuất bản định kỳ (04 số tiếng Việt\u002Fnăm và 02 số tiếng Anh\u002Fnăm), có nhiệm vụ \"},{\"attributes\":{\"italic\":true},\"insert\":\"công bố, giới thiệu các công trình nghiên cứu khoa học khoa học xã hội và nhân văn của các tác giả là các nhà khoa học trong và ngoài nước, phục vụ giảng dạy, học tập và nghiên cứu khoa học\"},{\"insert\":\". Hội đồng biên tập của Tạp chí hiện bao gồm 33 nhà khoa học có uy tín trong nước và quốc tế. Tạp chí tập trung và ưu tiên đăng tải những bài báo theo định hướng của tinh thần cởi mở, sáng tạo, nhanh chóng vươn lên để tiếp cận và sánh ngang với các tạp chí có uy tín hàng đầu của khu vực và trên thế giới. Nội dung chính của Tạp chí bao gồm các Bài nghiên cứu (khoảng 6000 đến 15000 từ), các bài điểm sách, thông tin khoa học (khoảng 300 đến 1500 từ) được trình bày theo đúng cấu trúc và chuẩn mực của một tạp chí khoa học.\\nCác bài viết của Tạp chí hiện đang được trích dẫn bởi Google Scholar, WorldCat, Open Archives, Cosmos Impact Factor, Advanced Sciences Index, Scientific Indexing Services, CrossRef, EBSCO Information Services.\\nMọi thông tin xin liên hệ: \"},{\"attributes\":{\"italic\":true},\"insert\":\"Phòng Tạp chí, 701 - E, Trường Đại học Khoa học Xã hội và Nhân văn, 336 Nguyễn Trãi, Thanh Xuân, Hà Nội. ĐT: 024.35581984; email: tckhxhnv@vnu.edu.vn \"},{\"insert\":\"hoặc \"},{\"attributes\":{\"italic\":true},\"insert\":\"tapchikhxhnv@gmail.com \"},{\"insert\":\"\\n\"}]}",{"EN":494,"VI":495},"VNU Journal of Social Sciences and Humanities","Tạp chí Khoa học Xã hội và Nhân văn",[101,102],[],[499],{"id":500,"createTime":501,"updateTime":502,"relativeEntities":503,"slug":504,"properties":505,"entityType":98,"verifyStatus":25,"verifyTime":509,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":222,"url":26,"parentIds":510,"statistic":511},"8b6e349b-0daf-4895-9c3f-85f30f1bfd42","2023-07-31T12:55:58.430+00:00","2026-06-19T02:30:07.899+00:00",[],"Tr%C6%B0%E1%BB%9Dng-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Khoa-h%E1%BB%8Dc-X%C3%A3-h%E1%BB%99i-v%C3%A0-Nh%C3%A2n-v%C4%83n-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-H%C3%A0-N%E1%BB%99i",{"title":506},{"EN":507,"VI":508},"VNU University of Social Sciences and Humanities","Trường Đại học Khoa học Xã hội và Nhân văn, Đại học Quốc gia Hà Nội","2023-08-02T15:28:49.057+00:00",[],{"impactFactor":36,"impactFactorByYear":512,"i10Index":59,"i10IndexLast5Year":115,"totalPublication":514,"totalPublicationByYear":515,"totalCitation":518,"totalCitationByYear":519,"totalCitationPerPublication":520,"totalCitationPerPublicationByYear":521,"hindexLast5Year":162,"hindex":162},{"2016":229,"2017":230,"2018":229,"2021":230,"2022":58,"2023":513,"2024":38},0.15,365,{"2013":115,"2014":158,"2015":125,"2016":252,"2017":44,"2018":516,"2019":286,"2020":396,"2021":259,"2022":517,"2023":396,"2024":115,"2025":59,"2026":115},21,42,169,{"2015":283,"2016":135,"2017":52,"2018":50,"2019":298,"2020":53,"2021":359,"2022":115,"2023":115},0.46,{"2015":266,"2016":57,"2017":57,"2018":522,"2019":523,"2020":524,"2021":368,"2022":229,"2023":39},0.38,0.32,0.37,[],"http:\u002F\u002Fjournal.ussh.vnu.edu.vn\u002Findex.php\u002Fvjossh","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F2b8d7b12-2d20-4777-be98-077f44f03c69\u002F0bd0751202944a4b4165b482e6e623e4.png",{"impactFactor":36,"impactFactorByYear":529,"i10Index":162,"i10IndexLast5Year":115,"totalPublication":530,"totalPublicationByYear":531,"totalCitation":537,"totalCitationByYear":538,"totalCitationPerPublication":343,"totalCitationPerPublicationByYear":540,"hindexLast5Year":135,"hindex":135},{"2016":341,"2017":39,"2018":229,"2019":38,"2020":110,"2021":231,"2022":231,"2023":341,"2024":39},764,{"2015":255,"2016":245,"2017":532,"2018":259,"2019":533,"2020":534,"2021":535,"2022":536,"2023":534,"2024":254,"2025":50},111,106,68,92,89,265,{"2015":539,"2016":241,"2017":168,"2018":51,"2019":349,"2020":260,"2021":244,"2022":298,"2023":114},46,{"2015":541,"2016":523,"2017":524,"2018":290,"2019":542,"2020":522,"2021":523,"2022":57,"2023":39},1.48,0.63,{"id":544,"createTime":545,"updateTime":546,"relativeEntities":547,"slug":548,"properties":549,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":558,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":50,"subjectFields":559,"manageAffiliations":560,"indexDatabases":561,"url":562,"thumbnailPath":563,"statistic":564,"gsStatistic":26,"type":26,"analyzePriority":26},"6ec01bd0-15c0-469a-86ac-41339076ae0a","2023-08-10T07:08:33.153+00:00","2026-01-31T21:19:06.362+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Da-li%E1%BB%85u-h%E1%BB%8Dc-Vi%E1%BB%87t-Nam",{"country":550,"issn":551,"introduce":553,"title":555},{"VOID":15},{"VOID":552},"18594824",{"VI":554},"{\"ops\":[{\"insert\":\"Tạp chí “Da liễu học Việt Nam” (Tiếng Anh: Vietnamese Journal of Dermatology and Venereology) thuộc Hội Da liễu Việt Nam, xuất bản 4 số mỗi năm bằng tiếng Việt hoặc tiếng Anh.\\nTạp chí Da liễu học Việt Nam hoạt động với mục đích, tôn chỉ là phổ biến, trao đổi thông tin trong lĩnh vực chuyên ngành da liễu; đăng tải các công trình nghiên cứu khoa học; chuyển giao công nghệ - kinh tế và khoa học kỹ thuật liên quan đến lĩnh vực da liễu.\\nPhạm vi của tạp chí là tất cả các bài báo khoa học, bài tổng quan, giới thiệu ca lâm sàng, … có liên quan tới chuyên ngành da liễu trong và ngoài nước. Tạp chí công bố các công trình nghiên cứu liên quan đến mô hình bệnh tật, các phương pháp chẩn đoán, điều trị, dự phòng và phục hồi chức năng các bệnh thuộc chuyên ngành da liễu. Ngoài ra, tạp chí còn đăng tải các bài tổng quan, cập nhật thông tin, kiến thức, hướng dẫn chẩn đoán, điều trị trong chuyên ngành da liễu trong nước và quốc tế; đăng tải các bài ca lâm sàng đặc biệt trong chuyên ngành da liễu.\\nTạp chí Da liễu học Việt Nam được biết tới là một tạp chí chuyên ngành có uy tín trong lĩnh vực da liễu. Các bài báo về nghiên cứu khoa học đăng trong Tạp chí được bình duyệt một cách nghiêm ngặt bởi ít nhất 2 chuyên gia. Hội đồng biên tập tạp chí bao gồm các nhà khoa học có uy tín (Giáo sư, Phó Giáo sư, Tiến sĩ, Bác sĩ…) trong chuyên ngành da liễu nhằm đảm bảo chất lượng và tính khách quan, khoa học cho các bài viết đăng trên Tạp chí.\\n\"}]}",{"EN":556,"VI":557},"Vietnamese Journal of Dermatology and Venereology","Tạp chí Da liễu học Việt Nam","Admin Import",[],[],[],"https:\u002F\u002Fvjdv.vn\u002Findex.php\u002Fvjdv","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F6ec01bd0-15c0-469a-86ac-41339076ae0a\u002F3cbc81720e58429dc7b1c4d7ab1935ca.jpg",{"impactFactor":36,"impactFactorByYear":565,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":566,"totalPublicationByYear":567,"totalCitation":116,"totalCitationByYear":570,"totalCitationPerPublication":109,"totalCitationPerPublicationByYear":571,"hindexLast5Year":115,"hindex":115},{"2023":38,"2024":230},182,{"2022":568,"2023":45,"2024":569},69,56,{"2022":52,"2023":115},{"2022":40,"2023":229},{"id":573,"createTime":574,"updateTime":575,"relativeEntities":576,"slug":577,"properties":578,"entityType":24,"verifyStatus":25,"verifyTime":26,"verifyNote":27,"syncStatus":28,"languages":587,"translateLanguages":26,"viewCount":283,"subjectFields":588,"manageAffiliations":589,"indexDatabases":647,"url":648,"thumbnailPath":649,"statistic":650,"gsStatistic":26,"type":26,"analyzePriority":26},"19221551-7519-47ff-a892-331d1139c64b","2023-09-12T07:03:05.744+00:00","2026-01-24T20:54:40.144+00:00",[],"T%E1%BA%A1p-ch%C3%AD-Khoa-h%E1%BB%8Dc-S%E1%BB%A9c-kho%E1%BA%BB-%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":579,"issn":580,"introduce":582,"title":584},{"VOID":15},{"VOID":581},"27349446",{"EN":583},"{\"ops\":[{\"attributes\":{\"bold\":true},\"insert\":\"1. History\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"Science and Technology Development Journal\"},{\"insert\":\" (STDJ) (ISSN 2734-9446), Vietnam National University - Ho Chi Minh City (VNU-HCM) was established in 1997. And the first issue was published in January 1998 with ISSN 1859-0128. Since then, STDJ has become the most important scientific forum of scientists from VNU-HCM as well as other universities. The magazine has undergone 20 years of development and has become a bridge for scientific exchanges, as well as enriching reference materials for the faculty, doctoral students, students of VNU-HCM in particular and other universities, institutes...\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Science and Technology Development Journal - Health Sciences (STDJ-HS) is a subjournal of Science and Technology Development Journal since 2020.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\" \"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"attributes\":{\"bold\":true},\"insert\":\"2. Focus and Scope\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Publishing articles with contents on healthcare, research projects in the field of health, advanced directions in health education and management. Therefore, STDJ-HS will accept articles from doctors, administrators, teachers, researchers, graduate students and fellows. The authors will be responsible for the accuracy of the data, opinions, opinions and material cited in the article.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"Facilitating the exchange of scientific and technological information and act as a bridge between theory and practice in the community of educators, scientists, managers, policy makers and enterprises in and out of the country.\"},{\"attributes\":{\"align\":\"justify\"},\"insert\":\"\\n\"},{\"insert\":\"\\n\"}]}",{"EN":585,"VI":586},"VNUHCM JOURNAL OF HEALTH SCIENCES","Tạp chí Khoa học Sức khoẻ Đại học Quốc gia Thành phố Hồ Chí Minh",[101,102],[],[590],{"id":591,"createTime":592,"updateTime":593,"relativeEntities":594,"slug":595,"properties":596,"entityType":98,"verifyStatus":25,"verifyTime":606,"verifyNote":26,"syncStatus":28,"languages":607,"translateLanguages":26,"viewCount":608,"url":609,"parentIds":610,"statistic":611},"fc4c2560-868c-4677-acb1-8686bef88727","2023-06-26T04:48:23.774+00:00","2026-06-19T01:46:17.248+00:00",[],"%C4%90%E1%BA%A1i-h%E1%BB%8Dc-Qu%E1%BB%91c-gia-Th%C3%A0nh-ph%E1%BB%91-H%E1%BB%93-Ch%C3%AD-Minh",{"country":597,"title":598,"abbreviation":601,"address":603},{"VOID":15},{"EN":599,"VI":600},"Vietnam National University Ho Chi Minh City","Đại học Quốc gia Thành phố Hồ Chí Minh",{"VOID":602},"VNUHCM",{"VI":604,"EN":605},"khu phố 6, Phường Linh Trung, Thành phố Thủ Đức, Thành phố Hồ Chí Minh, Việt Nam","Quarter 6, Linh Trung Ward, Thu Duc City, Ho Chi Minh City, Vietnam","2023-08-16T14:13:07.134+00:00",[101,102],45,"https:\u002F\u002Fvnuhcm.edu.vn\u002F",[],{"impactFactor":36,"impactFactorByYear":612,"i10Index":285,"i10IndexLast5Year":51,"totalPublication":613,"totalPublicationByYear":614,"totalCitation":624,"totalCitationByYear":625,"totalCitationPerPublication":634,"totalCitationPerPublicationByYear":635,"hindexLast5Year":124,"hindex":124},{"2014":36,"2015":38,"2016":109,"2017":39,"2018":229,"2019":38,"2020":110,"2021":171,"2022":110,"2023":110,"2024":171,"2025":229},3708,{"2005":115,"2006":115,"2007":115,"2008":135,"2009":111,"2010":53,"2011":52,"2012":568,"2013":615,"2014":351,"2015":616,"2016":469,"2017":617,"2018":127,"2019":618,"2020":619,"2021":620,"2022":621,"2023":622,"2024":623,"2025":159,"2026":50},164,266,177,226,603,931,314,246,74,2399,{"2006":115,"2008":50,"2010":162,"2011":242,"2012":222,"2013":43,"2014":626,"2015":627,"2016":628,"2017":629,"2018":258,"2019":630,"2020":631,"2021":632,"2022":633,"2023":353,"2024":115},250,124,157,162,152,385,559,128,0.65,{"2006":115,"2008":636,"2010":637,"2011":638,"2012":639,"2013":522,"2014":640,"2015":641,"2016":642,"2017":643,"2018":644,"2019":642,"2020":645,"2021":292,"2022":646,"2023":522,"2024":38},1.33,0.45,2.22,0.39,1.35,0.47,0.67,0.92,0.73,0.64,0.41,[],"http:\u002F\u002Fstdjhs.scienceandtechnology.com.vn\u002Findex.php\u002Fstdjhs","\u002Fapi\u002Fpublic\u002Ffile\u002Fpublisher\u002F19221551-7519-47ff-a892-331d1139c64b\u002F2e10768b7d1e380c36a25ed0c714dd7e.png",{"impactFactor":36,"impactFactorByYear":651,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":652,"totalPublicationByYear":653,"totalCitation":516,"totalCitationByYear":654,"totalCitationPerPublication":151,"totalCitationPerPublicationByYear":655,"hindexLast5Year":59,"hindex":59},{"2022":57,"2023":108,"2024":39},79,{"2020":116,"2021":240,"2022":239,"2023":52,"2024":162,"2025":162},{"2020":59,"2021":51,"2022":59},{"2020":443,"2021":387,"2022":54},{"code":657,"data":658,"meta":26},"SUCCESS",{"id":659,"createTime":660,"updateTime":661,"relativeEntities":662,"slug":663,"properties":664,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":671,"manageAffiliations":688,"indexDatabases":708,"url":26,"thumbnailPath":26,"statistic":748,"gsStatistic":26,"type":175,"analyzePriority":26},"6814e24d-1b39-4468-8092-9712509bfcc2","2024-04-09T01:18:13.861+00:00","2025-11-21T09:55:14.224+00:00",[],"BMC-Endocrine-Disorders",{"issn":665,"title":667,"url":669},{"VOID":666},"14726823",{"EN":668},"BMC Endocrine Disorders",{"VOID":670},"https:\u002F\u002Flink.springer.com\u002Fjournal\u002F12902",[672,680],{"id":673,"createTime":674,"updateTime":675,"relativeEntities":676,"label":677,"description":679,"parentId":26,"standard":26,"scholarHubFieldId":26},"1af9c91a-59a8-48f8-b117-f75b9207cb09","2023-05-29T10:24:13.173+00:00","2023-11-21T07:47:43.788+00:00",[],{"EN":678},"Endocrinology, Diabetes and Metabolism",{},{"id":681,"createTime":682,"updateTime":683,"relativeEntities":684,"label":685,"description":687,"parentId":26,"standard":26,"scholarHubFieldId":26},"0254e3e5-c28d-4a33-83da-81bc94d29ffd","2023-05-29T10:24:00.931+00:00","2023-11-21T07:56:41.438+00:00",[],{"EN":686},"Medicine (miscellaneous)",{},[689,698],{"id":690,"createTime":691,"updateTime":692,"relativeEntities":693,"slug":694,"properties":695,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":52,"url":26,"parentIds":697,"statistic":26},"67883518-0c98-470e-b6b0-160ab49bb03d","2023-05-29T12:06:59.969+00:00","2024-02-19T18:45:45.100+00:00",[],"BMC",{"title":696},{"EN":694},[],{"id":699,"createTime":700,"updateTime":701,"relativeEntities":702,"slug":703,"properties":704,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":116,"url":26,"parentIds":707,"statistic":26},"c5894808-4e99-4047-bbce-594f58821845","2023-05-29T10:24:08.212+00:00","2025-11-21T10:07:05.787+00:00",[],"BioMed-Central-Ltd-",{"title":705},{"EN":706},"BioMed Central Ltd.",[],[709,729],{"id":710,"indexDatabase":711,"url":723,"indexYears":724,"academicFieldIds":725,"indexDatabaseRanking":728},"5c1df476-dc4a-4b17-b831-108667b40901",{"id":712,"createTime":713,"updateTime":714,"relativeEntities":715,"label":716,"description":718,"key":720,"publicationTags":721,"standard":26},"3c7051d4-eb7d-4c57-a56b-36fc74c5d1e9","2023-05-22T09:57:18.509+00:00","2025-11-21T10:07:52.274+00:00",[],{"EN":717,"VI":717},"Scopus - Elsevier",{"EN":717,"VI":719},"Cơ sở dữ liệu Scopus thuộc Elsevier","scopus",[722],"SCOPUS","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002F25411","2001-2025",[726,727],"e89cebf4-fecf-4b74-8ab4-88fca891e4c2","5b134d7d-51cf-4eea-aade-eaec47ba2837","SCOPUS__Q2",{"id":730,"indexDatabase":731,"url":745,"indexYears":26,"academicFieldIds":746,"indexDatabaseRanking":26},"ce127ecd-b54c-4ae0-ae9a-0647abdaff33",{"id":732,"createTime":733,"updateTime":734,"relativeEntities":735,"label":736,"description":738,"key":741,"publicationTags":742,"standard":26},"a4921856-b128-4d9f-8f1f-e80813d3bbd4","2023-05-22T09:59:31.026+00:00","2025-11-21T10:07:52.153+00:00",[],{"EN":737,"VI":737},"ISI\u002FSCIE - Science Citation Index Expanded",{"VI":739,"EN":740},"Cơ sở dữ liệu SCIE","SCIE database","scie",[743,744],"SCIE","ISI","https:\u002F\u002Fwww.scopus.com\u002Fsourceid\u002Fnull",[747],"7fc7f180-3918-45ab-8bea-b2226f5d88f6",{"impactFactor":36,"impactFactorByYear":749,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":751,"totalCitation":36,"totalCitationByYear":753,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":754,"hindexLast5Year":36,"hindex":36},{},988,{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},142,{},{},{"meta":756,"data":758},{"total":757},"1256",[759,997,1287,1503,1866,2117,2276,2529,2920,3318],{"id":760,"createTime":761,"updateTime":761,"relativeEntities":762,"slug":763,"properties":764,"entityType":779,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":780,"translateLanguages":26,"viewCount":36,"primaryUrl":781,"fullTextUrl":26,"authors":782,"publicationType":858,"publisherRelationship":859,"citationCount":893,"citationInfo":894,"publishDate":896,"publishYear":897,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":898,"isForceReanalyzing":996},"55f4777a-ce5f-4fb8-bfa7-cb5018cb0de7","2024-04-19T20:29:53.977+00:00",[],"Validation-of-ICD-9-CM-coding-algorithm-for-improved-identification-of-hypoglycemia-visits",{"mag":765,"keywords":767,"pmc":768,"openalex":770,"abstract":772,"title":773,"pm":775,"doi":777},{"VOID":766},"2048981123",{},{"VOID":769},"2323001",{"VOID":771},"W2048981123",{},{"EN":774},"Validation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits",{"VOID":776},"18380903",{"VOID":778},"10.1186\u002F1472-6823-8-4","PUBLICATION",[102],"https:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002F1472-6823-8-4",[783,802,822,839],{"id":784,"sortIndex":115,"researcher":26,"roles":785,"affiliations":786,"properties":797},"4a1a3783-ab53-4332-a69c-2bb2d08415bd",[],[787],{"id":788,"sortIndex":36,"affiliation":789,"properties":26},"fe15f425-6a3d-497a-8537-6a15d5893bbf",{"id":790,"createTime":791,"updateTime":791,"relativeEntities":792,"slug":793,"properties":794,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a81df8d7-0189-4403-8149-32ac968170a8","2024-04-19T20:29:54.034+00:00",[],"Division-of-Emergency-Medicine-Massachusetts-General-Hospital-Boston-MA-USA",{"title":795},{"EN":796},"Division of Emergency Medicine, Massachusetts General Hospital, Boston, MA, USA",{"openalex":798,"title":800},{"VOID":799},"A5007497734",{"EN":801},"Phillip G. Blanc",{"id":803,"sortIndex":36,"researcher":26,"roles":804,"affiliations":805,"properties":815},"13ce9129-c834-4758-aafe-0438970e01da",[],[806],{"id":807,"sortIndex":36,"affiliation":808,"properties":26},"e6d82809-9669-461f-ac73-71f6c86e17b3",{"id":809,"createTime":810,"updateTime":810,"relativeEntities":811,"slug":26,"properties":812,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"631fa581-bce4-4995-9f45-fd187825c22c","2024-01-04T15:30:01.448+00:00",[],{"title":813},{"VI":814},"Division of Emergency Medicine, University of Colorado, Denver School of Medicine, Aurora, CO, USA",{"openalex":816,"orcid":818,"title":820},{"VOID":817},"A5029459847",{"VOID":819},"https:\u002F\u002Forcid.org\u002F0000-0003-2325-206X",{"EN":821},"Adit A. Ginde",{"id":823,"sortIndex":59,"researcher":26,"roles":824,"affiliations":825,"properties":832},"33d59014-5590-42a6-980e-b5f49cde32c6",[],[826],{"id":827,"sortIndex":36,"affiliation":828,"properties":26},"5449a7dc-51bb-4a41-aa59-5e5a6a133563",{"id":790,"createTime":791,"updateTime":791,"relativeEntities":829,"slug":793,"properties":830,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":831},{"EN":796},{"openalex":833,"orcid":835,"title":837},{"VOID":834},"A5062152763",{"VOID":836},"https:\u002F\u002Forcid.org\u002F0000-0002-5071-7654",{"EN":838},"Carlos A. Camargo",{"id":840,"sortIndex":114,"researcher":26,"roles":841,"affiliations":842,"properties":853},"50580ce0-e924-4733-b808-5a51b85289b4",[],[843],{"id":844,"sortIndex":36,"affiliation":845,"properties":26},"a26b6caa-4300-468a-90e1-d435df261289",{"id":846,"createTime":847,"updateTime":847,"relativeEntities":848,"slug":849,"properties":850,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b7b42510-dbfc-4234-b4d7-71a7f3e6f714","2024-04-19T20:29:54.019+00:00",[],"Division-of-Emergency-Medicine-Beth-Israel-Deaconess-Medical-Center-Boston-MA-USA",{"title":851},{"EN":852},"Division of Emergency Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA",{"openalex":854,"title":856},{"VOID":855},"A5010851440",{"EN":857},"Rebecca M. Lieberman","ARTICLE",{"url":26,"publisher":860,"properties":888},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":861,"slug":663,"properties":862,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":866,"manageAffiliations":867,"indexDatabases":868,"url":26,"thumbnailPath":26,"statistic":883,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":863,"title":864,"url":865},{"VOID":666},{"EN":668},{"VOID":670},[],[],[869,876],{"id":730,"indexDatabase":870,"url":745,"indexYears":26,"academicFieldIds":875,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":871,"label":872,"description":873,"key":741,"publicationTags":874,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":877,"url":723,"indexYears":724,"academicFieldIds":882,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":878,"label":879,"description":880,"key":720,"publicationTags":881,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":884,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":885,"totalCitation":36,"totalCitationByYear":886,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":887,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"volume":889,"issue":891},{"VOID":890},"8",{"VOID":892},"1",221,{"total":893,"publishYear":26,"statisticByYear":895},{"2012":59,"2013":53,"2014":242,"2015":336,"2016":242,"2017":239,"2018":237,"2019":238,"2020":239,"2021":516,"2022":356,"2023":53,"2024":115},"2008-12-01",2008,[899,903,907,911,915,919,923,927,931,934,938,942,946,950,954,957,961,965,968,972,976,980,984,988,992],{"id":26,"text":900,"url":26,"identifiers":901},"The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993, 329: 977-986. 10.1056\u002FNEJM199309303291401.",{"doi":902},"10.1056\u002FNEJM199309303291401",{"id":26,"text":904,"url":26,"identifiers":905},"The United Kingdom Prospective Diabetes Study Research Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998, 352: 837-853. 10.1016\u002FS0140-6736(05)61359-1.",{"doi":906},"10.1016\u002FS0140-6736(98)07019-6",{"id":26,"text":908,"url":26,"identifiers":909},"The United Kingdom Prospective Diabetes Study Research Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet. 1998, 352: 854-865. 10.1016\u002FS0140-6736(05)61359-1.",{"doi":910},"10.1016\u002FS0140-6736(98)07037-8",{"id":26,"text":912,"url":26,"identifiers":913},"Cryer PE: Hypoglycemia: The limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia. 2002, 45: 937-948. 10.1007\u002Fs00125-002-0822-9.",{"doi":914},"10.1007\u002Fs00125-002-0822-9",{"id":26,"text":916,"url":26,"identifiers":917},"MacLeod KM, Hepburn DA, Frier BM: Frequency and morbidity of severe hypoglycemia in insulin-treated diabetic patients. Diabet Med. 1993, 10: 238-245.",{"doi":918},"10.1111\u002Fj.1464-5491.1993.tb00051.x",{"id":26,"text":920,"url":26,"identifiers":921},"Laing SP, Swerdlow AJ, Slater SD, Botha JL, Burden AC, Waugh NR, Smith AW, Hill RD, Bingley PJ, Patterson CC, Qiao Z, Keen H: The British Diabetic Association Cohort Study II. Cause-specific mortality inpatients with insulin-treated diabetes mellitus. Diabet Med. 1999, 16: 466-471. 10.1046\u002Fj.1464-5491.1999.00076.x.",{"doi":922},"10.1046\u002Fj.1464-5491.1999.00076.x",{"id":26,"text":924,"url":26,"identifiers":925},"DCCT Research Group: Hypoglycemia in the diabetes control and complications trial. Diabetes. 1997, 46: 271-286. 10.2337\u002Fdiabetes.46.2.271.",{"doi":926},"10.2337\u002Fdiab.46.2.271",{"id":26,"text":928,"url":26,"identifiers":929},"Holstein A, Plaschke A, Egberts EH: Incidence and costs of severe hypoglycemia. Diabetes Care. 2002, 25: 2109-10.2337\u002Fdiacare.25.11.2109.",{"doi":930},"10.2337\u002Fdiacare.25.11.2109",{"id":26,"text":932,"url":26,"identifiers":933},"The International Classification of Diseases, 9th revision. Clinical Modification. 1997, Salt Lake City, UT, Medicode Publications, 5",{},{"id":26,"text":935,"url":26,"identifiers":936},"Johnson ES, Koepsell TD, Reiber G, Stergachis A, Platt R: Increasing incidence of serious hypoglycemia in insulin users. J Clin Epidemiol. 2002, 55: 253-259. 10.1016\u002FS0895-4356(01)00479-6.",{"doi":937},"10.1016\u002FS0895-4356(01)00479-6",{"id":26,"text":939,"url":26,"identifiers":940},"Shorr RI, Ray WA, Daugherty JR, Griffin MR: Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med. 1997, 15: 1681-1687. 10.1001\u002Farchinte.157.15.1681.",{"doi":941},"10.1001\u002Farchinte.1997.00440360095010",{"id":26,"text":943,"url":26,"identifiers":944},"Herings RMC, de Boer A, Stricker BHCh, Leufkens HGM, Porsuis A: Hypoglycemia associated with use of inhibitors of angiotensin converting enzyme. Lancet. 1995, 345: 1195-1198. 10.1016\u002FS0140-6736(95)91988-0.",{"doi":945},"10.1016\u002FS0140-6736(95)91988-0",{"id":26,"text":947,"url":26,"identifiers":948},"Morris AD, Boyle DIR, McMahon AD, Pearce H, Evans JM, Newton RW, Jung RT, MacDonald TM: ACE inhibitor use is associated with hospitalization for severe hypoglycemia in patients with diabetes. Diabetes Care. 1997, 20: 1363-1367. 10.2337\u002Fdiacare.20.9.1363.",{"doi":949},"10.2337\u002Fdiacare.20.9.1363",{"id":26,"text":951,"url":26,"identifiers":952},"Shorr RI, Ray WA, Daugherty JR, Griffin MR: Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas. JAMA. 1997, 278: 40-43. 10.1001\u002Fjama.278.1.40.",{"doi":953},"10.1001\u002Fjama.1997.03550010054039",{"id":26,"text":955,"url":26,"identifiers":956},"The Emergency Medicine Network. [\n                    http:\u002F\u002Fwww.emnet-usa.org\u002F\n                    \n                  ]",{},{"id":26,"text":958,"url":26,"identifiers":959},"American Diabetes Association Workgroup on Hypoglycemia: Defining and reporting hypoglycemia in diabetes. Diabetes Care. 2005, 28: 1245-1249. 10.2337\u002Fdiacare.28.5.1245.",{"doi":960},"10.2337\u002Fdiacare.28.5.1245",{"id":26,"text":962,"url":26,"identifiers":963},"Cryer PE, Davis SN, Shamoon H: Hypoglycemia in diabetes. Diabetes Care. 2003, 26: 1902-1912. 10.2337\u002Fdiacare.26.6.1902.",{"doi":964},"10.2337\u002Fdiacare.26.6.1902",{"id":26,"text":966,"url":26,"identifiers":967},"O'Malley KJ, Cook KF, Price MD, Wildes KR, Hurdle JF, Ashton CM: Measuring diagnoses: ICD code accuracy. HSR. 2005, 40: 1620-1639.",{},{"id":26,"text":969,"url":26,"identifiers":970},"Lopushinsky SR, Covarrubia KA, Rabeneck L, Austin PC, Urbach DR: Accuracy of administrative health data for the diagnosis of upper gastrointestinal diseases. Surg Endo. 2007, 21 (10): 1733-1737. 10.1007\u002Fs00464-006-9136-1.",{"doi":971},"10.1007\u002Fs00464-006-9136-1",{"id":26,"text":973,"url":26,"identifiers":974},"Scheurer DB, Hicks LS, Cood EF, Schnipper JL: Accuracy of ICD-9 coding for Clostridium difficile infections: a retrospective cohort. Epidemiol Infect. 2007, 135: 1010-1013. 10.1017\u002FS0950268806007655.",{"doi":975},"10.1017\u002FS0950268806007655",{"id":26,"text":977,"url":26,"identifiers":978},"Goldstein JB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke. 1998, 29: 1602-1604.",{"doi":979},"10.1161\u002F01.STR.29.8.1602",{"id":26,"text":981,"url":26,"identifiers":982},"Buchbinder R, Goel V, Bombardier C: Lack of concordance between the ICD-9 classification of soft tissue disorders of the neck and upper limbs and chart review diagnosis: One steel mill's experience. Am J Ind Med. 1996, 29: 171-182. 10.1002\u002F(SICI)1097-0274(199602)29:2\u003C171::AID-AJIM7>3.0.CO;2-V.",{"doi":983},"10.1002\u002F(SICI)1097-0274(199602)29:2\u003C171::AID-AJIM7>3.0.CO;2-V",{"id":26,"text":985,"url":26,"identifiers":986},"Guevara RE, Butler JC, Marston BJ, Plouffe JF, File TM, Breiman RF: Accuracy of ICD-9-CM codes in detecting community-acquired pneumococcal pneumonia for incidence and vaccine efficacy studies. Am J Epidemiol. 1999, 149: 282-289.",{"doi":987},"10.1093\u002Foxfordjournals.aje.a009804",{"id":26,"text":989,"url":26,"identifiers":990},"Bazarian JJ, Veazie P, Mookerjee S, Lerner EB: Accuracy of Mild Traumatic Brain Injury Case Ascertainment Using ICD-9-CM Codes. Acad Emerg Med. 2006, 13: 31-38. 10.1111\u002Fj.1553-2712.2006.tb00981.x.",{"doi":991},"10.1111\u002Fj.1553-2712.2006.tb00981.x",{"id":26,"text":993,"url":26,"identifiers":994},"White RH, Brickner LA, Scannell KA: ICD-9-CM codes poorly identified venous thromboembolism during pregnancy. J Clin Epidemiol. 2004, 57: 985-988. 10.1016\u002Fj.jclinepi.2004.02.003.",{"doi":995},"10.1016\u002Fj.jclinepi.2004.02.003",false,{"id":998,"createTime":999,"updateTime":1000,"relativeEntities":1001,"slug":1002,"properties":1003,"entityType":779,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":1018,"translateLanguages":26,"viewCount":36,"primaryUrl":1019,"fullTextUrl":26,"authors":1020,"publicationType":858,"publisherRelationship":1109,"citationCount":1138,"citationInfo":1139,"publishDate":1141,"publishYear":1142,"citationAnalyzeStatus":1143,"lastCitationAnalyze":1000,"indexDatabases":26,"openAccess":26,"references":1144,"isForceReanalyzing":996},"6a4cd647-d291-4c83-b788-e140cb09c727","2024-04-13T15:11:33.812+00:00","2024-04-14T00:32:35.368+00:00",[],"Mortality-in-patients-with-diabetic-foot-ulcer-a-retrospective-study-of-513-cases-from-a-single-Centre-in-the-Northern-Territory-of-Australia",{"mag":1004,"keywords":1006,"pmc":1007,"openalex":1009,"abstract":1011,"title":1012,"pm":1014,"doi":1016},{"VOID":1005},"2909122645",{},{"VOID":1008},"6318899",{"VOID":1010},"W2909122645",{},{"EN":1013},"Mortality in patients with diabetic foot ulcer: a retrospective study of 513 cases from a single Centre in the Northern Territory of Australia",{"VOID":1015},"30606164",{"VOID":1017},"10.1186\u002Fs12902-018-0327-2",[102],"https:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002Fs12902-018-0327-2",[1021,1039,1059,1079,1093],{"id":1022,"sortIndex":115,"researcher":26,"roles":1023,"affiliations":1024,"properties":1034},"293a74ca-c613-446f-9c42-04da71de788a",[],[1025],{"id":26,"sortIndex":36,"affiliation":1026,"properties":26},{"id":1027,"createTime":1028,"updateTime":1028,"relativeEntities":1029,"slug":1030,"properties":1031,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3072118e-a3dd-4d95-9576-0b8a46425c63","2024-04-13T15:11:33.835+00:00",[],"Department-of-Prosthetics-and-Orthotics-Royal-Darwin-Hospital-Darwin-Northern-Territory-Australia",{"title":1032},{"EN":1033},"Department of Prosthetics and Orthotics, Royal Darwin Hospital, Darwin, Northern Territory, Australia",{"openalex":1035,"title":1037},{"VOID":1036},"A5051232498",{"EN":1038},"Thomas Berhane",{"id":1040,"sortIndex":114,"researcher":26,"roles":1041,"affiliations":1042,"properties":1052},"a1ef0d2f-0654-4b64-ac26-1c56279e1e63",[],[1043],{"id":26,"sortIndex":36,"affiliation":1044,"properties":26},{"id":1045,"createTime":1046,"updateTime":1046,"relativeEntities":1047,"slug":1048,"properties":1049,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"bb58496e-581b-452f-a0ad-2865ba264678","2024-04-13T15:11:33.860+00:00",[],"Department-of-Vascular-Surgery-Royal-Darwin-Hospital-Darwin-Northern-Territory-Australia",{"title":1050},{"EN":1051},"Department of Vascular Surgery, Royal Darwin Hospital, Darwin, Northern Territory, Australia",{"openalex":1053,"orcid":1055,"title":1057},{"VOID":1054},"A5048912952",{"VOID":1056},"https:\u002F\u002Forcid.org\u002F0000-0001-9020-352X",{"EN":1058},"Mark Hamilton",{"id":1060,"sortIndex":111,"researcher":26,"roles":1061,"affiliations":1062,"properties":1072},"e659a8a2-65f1-4eb6-8a9b-e4e433bd7cb0",[],[1063],{"id":26,"sortIndex":36,"affiliation":1064,"properties":26},{"id":1065,"createTime":1066,"updateTime":1066,"relativeEntities":1067,"slug":1068,"properties":1069,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"a8ad81b5-90fa-443d-91ce-0dcf2c229d09","2024-04-13T15:11:33.822+00:00",[],"Department-of-Endocrinology-Royal-Darwin-Hospital-Darwin-Northern-Territory-Australia",{"title":1070},{"EN":1071},"Department of Endocrinology, Royal Darwin Hospital, Darwin, Northern Territory, Australia",{"openalex":1073,"orcid":1075,"title":1077},{"VOID":1074},"A5061952775",{"VOID":1076},"https:\u002F\u002Forcid.org\u002F0000-0002-5622-6987",{"EN":1078},"Henrik Falhammar",{"id":1080,"sortIndex":59,"researcher":26,"roles":1081,"affiliations":1082,"properties":1088},"db994890-625e-4b12-adf3-4d223cb0126c",[],[1083],{"id":26,"sortIndex":36,"affiliation":1084,"properties":26},{"id":1045,"createTime":1046,"updateTime":1046,"relativeEntities":1085,"slug":1048,"properties":1086,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1087},{"EN":1051},{"openalex":1089,"title":1091},{"VOID":1090},"A5029088324",{"EN":1092},"Abhilash P. Chandra",{"id":1094,"sortIndex":36,"researcher":26,"roles":1095,"affiliations":1096,"properties":1102},"b1661b23-f526-4dbb-a89b-c290e9bfa0c7",[],[1097],{"id":26,"sortIndex":36,"affiliation":1098,"properties":26},{"id":1065,"createTime":1066,"updateTime":1066,"relativeEntities":1099,"slug":1068,"properties":1100,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1101},{"EN":1071},{"openalex":1103,"orcid":1105,"title":1107},{"VOID":1104},"A5042300645",{"VOID":1106},"https:\u002F\u002Forcid.org\u002F0000-0002-8220-1302",{"EN":1108},"Kanakamani Jeyaraman",{"url":26,"publisher":1110,"properties":26},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1111,"slug":663,"properties":1112,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1116,"manageAffiliations":1117,"indexDatabases":1118,"url":26,"thumbnailPath":26,"statistic":1133,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":1113,"title":1114,"url":1115},{"VOID":666},{"EN":668},{"VOID":670},[],[],[1119,1126],{"id":730,"indexDatabase":1120,"url":745,"indexYears":26,"academicFieldIds":1125,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":1121,"label":1122,"description":1123,"key":741,"publicationTags":1124,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":1127,"url":723,"indexYears":724,"academicFieldIds":1132,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":1128,"label":1129,"description":1130,"key":720,"publicationTags":1131,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":1134,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":1135,"totalCitation":36,"totalCitationByYear":1136,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":1137,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},91,{"total":1138,"publishYear":26,"statisticByYear":1140},{"2019":162,"2020":237,"2021":124,"2022":234,"2023":173,"2024":158},"2019-12-01",2019,"ERROR_IN_ANALYZE_CITATION",[1145,1149,1153,1157,1161,1165,1169,1173,1177,1181,1185,1188,1192,1196,1200,1204,1208,1212,1215,1218,1222,1226,1230,1234,1238,1242,1246,1250,1254,1258,1261,1264,1268,1272,1276,1279,1283],{"id":26,"text":1146,"url":26,"identifiers":1147},"Brownrigg JRW, Griffin M, Hughes CO, Jones KG, Patel N, Thompson MM, Hinchliffe RJ. Influence of foot ulceration on cause-specific mortality in patients with diabetes mellitus. J Vasc Surg. 2014;60(4):982–6.",{"doi":1148},"10.1016\u002Fj.jvs.2014.04.052",{"id":26,"text":1150,"url":26,"identifiers":1151},"Chammas NK, Hill RLR, Edmonds ME. Increased mortality in diabetic foot ulcer patients: the significance of ulcer type. J Diabetes Res. 2016;2016:2879809.",{"doi":1152},"10.1155\u002F2016\u002F2879809",{"id":26,"text":1154,"url":26,"identifiers":1155},"Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet. 2005;366(9498):1719–24.",{"doi":1156},"10.1016\u002FS0140-6736(05)67698-2",{"id":26,"text":1158,"url":26,"identifiers":1159},"Martins-Mendes D, Monteiro-Soares M, Boyko EJ, Ribeiro M, Barata P, Lima J, Soares R. The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. J Diabetes Complicat. 2014;28:632–8.",{"doi":1160},"10.1016\u002Fj.jdiacomp.2014.04.011",{"id":26,"text":1162,"url":26,"identifiers":1163},"Walsh JW, Hoffstad OJ, Sullivan MO, Margolis DJ. Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom. Diabet Med. 2016;33(11):1493–8.",{"doi":1164},"10.1111\u002Fdme.13054",{"id":26,"text":1166,"url":26,"identifiers":1167},"Jupiter DC, Thorud JC, Buckley CJ, Shibuya N. The impact of foot ulceration and amputation on mortality in diabetic patients. I: from ulceration to death, a systematic review. Int Wound J. 2016;13(5):892–903.",{"doi":1168},"10.1111\u002Fiwj.12404",{"id":26,"text":1170,"url":26,"identifiers":1171},"Dietrich I, Braga GA, de Melo FG, da Costa Silva ACC. The diabetic foot as a proxy for cardiovascular events and mortality review. Curr Atheroscler Rep. 2017;19(11):44.",{"doi":1172},"10.1007\u002Fs11883-017-0680-z",{"id":26,"text":1174,"url":26,"identifiers":1175},"Bergin SM, Alford JB, Allard BP, Gurr JM, Holland EL, Horsley MW, Kamp MC, Lazzarini PA, Nube VL, Sinha AK. A limb lost every 3 hours: can Australia reduce amputations in people with diabetes? Med J Aust. 2012;197(4):197–8.",{"doi":1176},"10.5694\u002Fmja10.10837",{"id":26,"text":1178,"url":26,"identifiers":1179},"O’rourke I, Heard S, Treacy J, Gruen R, Whitbread C. Risks to feet in the top end: outcomes of diabetic foot complications. ANZ J Surg. 2002;72(4):282–6.",{"doi":1180},"10.1046\u002Fj.1445-2197.2002.02367.x",{"id":26,"text":1182,"url":26,"identifiers":1183},"Zhao Y, Guthridge S, Falhammar H, Flavell H, Cadilhac DA. Cost-effectiveness of stroke care in aboriginal and non-aboriginal patients: an observational cohort study in the Northern Territory of Australia. BMJ Open. 2017;7(10):e015033.",{"doi":1184},"10.1136\u002Fbmjopen-2016-015033",{"id":26,"text":1186,"url":26,"identifiers":1187},"Charles J. An investigation into the foot health of Aboriginal and Torres Strait Islander peoples: A literature review. Aust Indigenous HealthBulletin. 2015;15(3):8.",{},{"id":26,"text":1189,"url":26,"identifiers":1190},"Naqshbandi M, Harris SB, Esler JG, Antwi-Nsiah F. Review: global complication rates of type 2 diabetes in indigenous peoples: a comprehensive review. Diabetes Res Clin Pract. 2008;82:1–17.",{"doi":1191},"10.1016\u002Fj.diabres.2008.07.017",{"id":26,"text":1193,"url":26,"identifiers":1194},"Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–100.",{"doi":1195},"10.1111\u002Fj.1523-1755.2005.00365.x",{"id":26,"text":1197,"url":26,"identifiers":1198},"Morbach S, Furchert H, Gröblinghoff U, Hoffmeier H, Kersten K, Klauke G-T, Klemp U, Roden T, Icks A, Haastert B. Long-term prognosis of diabetic foot patients and their limbs. Diabetes Care. 2012;35(10):2021–7.",{"doi":1199},"10.2337\u002Fdc12-0200",{"id":26,"text":1201,"url":26,"identifiers":1202},"Ghanassia E, Villon L, J-FT DD, Boegner C, Avignon A, Sultan A. Long-term outcome and disability of diabetic patients hospitalized for diabetic foot ulcers. Diabetes Care. 2008;31(7):1288–92.",{"doi":1203},"10.2337\u002Fdc07-2145",{"id":26,"text":1205,"url":26,"identifiers":1206},"Brennan MB, Hess TM, Bartle B, Cooper JM, Kang J, Huang ES, Smith M, Sohn M-W, Crnich C. Diabetic foot ulcer severity predicts mortality among veterans with type 2 diabetes. J Diabetes Complicat. 2017;31(3):556–61.",{"doi":1207},"10.1016\u002Fj.jdiacomp.2016.11.020",{"id":26,"text":1209,"url":26,"identifiers":1210},"Moulik PK, Mtonga R, Gill GV. Amputation and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care. 2003;26(2):491–4.",{"doi":1211},"10.2337\u002Fdiacare.26.2.491",{"id":26,"text":1213,"url":26,"identifiers":1214},"Deaths Report. \n                    https:\u002F\u002Fwww.aihw.gov.au\u002Freports\u002Flife-expectancy-death\u002Fdeaths-in-australia\u002Fcontents\u002Flife-expectancy\n                    \n                  . Accessed 15 Nov 2018.",{},{"id":26,"text":1216,"url":26,"identifiers":1217},"Young BA, Katon W, Von Korff M, Lin EHB, Simon G, Ciechanowski P, Ludman E, Kinder L, Boyko EJ. Diabetes Complications Severity Index and Risk of Mortality, Hospitalization and Health Care Utilization. Diabetes. 2006;55:A549.",{},{"id":26,"text":1219,"url":26,"identifiers":1220},"Pinto A, Tuttolomondo A, Di Raimondo D, Fernandez P, La Placa S, Di Gati M, Licata G. Cardiovascular risk profile and morbidity in subjects affected by type 2 diabetes mellitus with and without diabetic foot. Metabolism. 2008;57(5):676–82.",{"doi":1221},"10.1016\u002Fj.metabol.2008.01.004",{"id":26,"text":1223,"url":26,"identifiers":1224},"Iversen MM, Tell GS, Riise T, Hanestad BR, Østbye T, Graue M, Midthjell K. History of foot ulcer increases mortality among individuals with diabetes. Diabetes Care. 2009;32(12):2193–9.",{"doi":1225},"10.2337\u002Fdc09-0651",{"id":26,"text":1227,"url":26,"identifiers":1228},"Patrova J, Kjellman M, Wahrenberg H, Falhammar H. Increased mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: a 13-year retrospective study from one center. Endocrine. 2017;58(2):267–75.",{"doi":1229},"10.1007\u002Fs12020-017-1400-8",{"id":26,"text":1231,"url":26,"identifiers":1232},"Jose Antonio Robio SJ, Alvarez J. Clinical characteristics and mortality in patients treated in a multidisciplinary diabetic foot unit. Endocrinol Diabetes Nutr. 2017;64(5):241–9.",{"doi":1233},"10.1016\u002Fj.endinu.2017.02.012",{"id":26,"text":1235,"url":26,"identifiers":1236},"Gershater MA, ML PN, Larson J, Thome J, Apelqvist J. Complexity of factors related to outcome of neuropathic and neuroiscaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52:398–407.",{"doi":1237},"10.1007\u002Fs00125-008-1226-2",{"id":26,"text":1239,"url":26,"identifiers":1240},"Margolis DJ, Hofstad O, Feldman HI. Association between renal failure and foot ulcer or lower-extremity amputation in patients with diabetes. Diabetes Care. 2008;31(7):1331–6.",{"doi":1241},"10.2337\u002Fdc07-2244",{"id":26,"text":1243,"url":26,"identifiers":1244},"Wolf G, Müller N, Busch M, Eidner G, Kloos C, Hunger-Battefeld W, Müller UA. Diabetic foot syndrome and renal function in type 1 and 2 diabetes mellitus show close association. Nephrol Dial Transplant. 2009;24(6):1896–901.",{"doi":1245},"10.1093\u002Fndt\u002Fgfn724",{"id":26,"text":1247,"url":26,"identifiers":1248},"Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol. 1997;50(6):693–703.",{"doi":1249},"10.1016\u002FS0895-4356(97)00015-2",{"id":26,"text":1251,"url":26,"identifiers":1252},"Herselman M, Esau N, Kruger J-M, Labadarios D, Moosa MR. Relationship between serum protein and mortality in adults on long-term hemodialysis: exhaustive review and meta-analysis. Nutrition. 2010;26(1):10–32.",{"doi":1253},"10.1016\u002Fj.nut.2009.07.009",{"id":26,"text":1255,"url":26,"identifiers":1256},"de Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW, Netherlands Cooperative Study on the Adequacy of Dialysis IISG. Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Renal Nutr. 2009;19(2):127–35.",{"doi":1257},"10.1053\u002Fj.jrn.2008.08.003",{"id":26,"text":1259,"url":26,"identifiers":1260},"Bramley D, Hebert P, Jackson RT, Chassin M. Indigenous disparities in disease-specific mortality, a cross-country comparison: New Zealand, Australia, Canada, and the United States; 2004.",{},{"id":26,"text":1262,"url":26,"identifiers":1263},"Dinh T, Veves A. The influence of gender as a risk factor in diabetic foot ulceration. Wounds. 2008;20(5):127–31.",{},{"id":26,"text":1265,"url":26,"identifiers":1266},"Faglia E, Favales F, Morabito A. New ulceration, new major amputation, and survival rates in diabetic subjects hospitalized for foot ulceration from 1990 to 1993. Diabetes Care. 2001;24(1):78–83.",{"doi":1267},"10.2337\u002Fdiacare.24.1.78",{"id":26,"text":1269,"url":26,"identifiers":1270},"Sohn M-W, Lee TA, Stuck RM, Frykberg RG, Budiman-Mak E. Mortality risk of Charcot arthropathy compared with that of diabetic foot ulcer and diabetes alone. Diabetes Care. 2009;32(5):816–21.",{"doi":1271},"10.2337\u002Fdc08-1695",{"id":26,"text":1273,"url":26,"identifiers":1274},"Winkley K, Stahl D, Chalder T, Edmonds ME, Ismail K. Original article: risk factors associated with adverse outcomes in a population-based prospective cohort study of people with their first diabetic foot ulcer. J Diabetes Complicat. 2007;21:341–9.",{"doi":1275},"10.1016\u002Fj.jdiacomp.2007.09.004",{"id":26,"text":1277,"url":26,"identifiers":1278},"Chalapati Roa TA, Bain C, Suhail AR. Mortality from diabetic renal disease: a hidden epidemic. Eur J Pub Health. 2011;22(2):280–4.",{},{"id":26,"text":1280,"url":26,"identifiers":1281},"Thorud JC, Plemmons B, Buckley CJ, Shibuya N, Jupiter DC. Mortality after nontraumatic major amputation among patients with diabetes and peripheral vascular disease: a systematic review. J Foot Ankle Surg. 2016;55(3):591–9.",{"doi":1282},"10.1053\u002Fj.jfas.2016.01.012",{"id":26,"text":1284,"url":26,"identifiers":1285},"Apelqvist J, Larsson J, Agardh CD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233(6):485–91.",{"doi":1286},"10.1111\u002Fj.1365-2796.1993.tb01003.x",{"id":1288,"createTime":1289,"updateTime":1289,"relativeEntities":1290,"slug":1291,"properties":1292,"entityType":779,"verifyStatus":25,"verifyTime":1289,"verifyNote":1307,"syncStatus":28,"languages":1308,"translateLanguages":26,"viewCount":36,"primaryUrl":1309,"fullTextUrl":26,"authors":1310,"publicationType":858,"publisherRelationship":1382,"citationCount":1138,"citationInfo":1415,"publishDate":1141,"publishYear":1142,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1417,"isForceReanalyzing":996},"2f9b2048-20fd-403d-a756-0c6157206ea5","2024-09-26T12:51:45.008+00:00",[],"Total-adiponectin-in-overweight-and-obese-subjects-and-its-response-to-visceral-fat-loss",{"mag":1293,"keywords":1295,"pmc":1296,"openalex":1298,"abstract":1300,"title":1301,"pm":1303,"doi":1305},{"VOID":1294},"2948468029",{},{"VOID":1297},"6545728",{"VOID":1299},"W2948468029",{},{"EN":1302},"Total adiponectin in overweight and obese subjects and its response to visceral fat loss",{"VOID":1304},"31159801",{"VOID":1306},"10.1186\u002Fs12902-019-0386-z","Auto Verify",[102],"https:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002Fs12902-019-0386-z",[1311,1333,1348,1365],{"id":1312,"sortIndex":114,"researcher":26,"roles":1313,"affiliations":1314,"properties":1326},"b036d339-0888-4f2e-b658-3d073eb23e31",[],[1315],{"id":1316,"sortIndex":36,"affiliation":1317,"properties":26},"cd17f2f3-12bc-4675-9b22-5fba1ae713bc",{"id":1318,"createTime":1319,"updateTime":1320,"relativeEntities":1321,"slug":1322,"properties":1323,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"b653c978-20eb-4c0b-a80e-beb6877d24d2","2024-01-12T04:33:22.173+00:00","2024-12-30T03:08:59.896+00:00",[],"Department-of-Internal-Medicine-College-of-Medicine-and-Health-Sciences-United-Arab-Emirates-University-Al-Ain-United-Arab-Emirates",{"title":1324},{"VI":1325},"Department of Internal Medicine, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates",{"openalex":1327,"orcid":1329,"title":1331},{"VOID":1328},"A5001515790",{"VOID":1330},"https:\u002F\u002Forcid.org\u002F0000-0002-5867-2833",{"EN":1332},"Javed Yasin",{"id":1334,"sortIndex":59,"researcher":26,"roles":1335,"affiliations":1336,"properties":1343},"ca62878d-dcea-451c-8bb5-113da9e1d729",[],[1337],{"id":1338,"sortIndex":36,"affiliation":1339,"properties":26},"8ed159d6-ec6a-45f5-b79c-f19414f2680e",{"id":1318,"createTime":1319,"updateTime":1320,"relativeEntities":1340,"slug":1322,"properties":1341,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1342},{"VI":1325},{"openalex":1344,"title":1346},{"VOID":1345},"A5051045549",{"EN":1347},"Awad Al Essa",{"id":1349,"sortIndex":115,"researcher":26,"roles":1350,"affiliations":1351,"properties":1358},"6e664e14-5fa1-4dfb-867d-5abdbda75fee",[],[1352],{"id":1353,"sortIndex":36,"affiliation":1354,"properties":26},"cf9ca601-3955-494b-accf-fb48606c9b79",{"id":1318,"createTime":1319,"updateTime":1320,"relativeEntities":1355,"slug":1322,"properties":1356,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1357},{"VI":1325},{"openalex":1359,"orcid":1361,"title":1363},{"VOID":1360},"A5069604882",{"VOID":1362},"https:\u002F\u002Forcid.org\u002F0000-0003-2477-0408",{"EN":1364},"Juma Alkaabi",{"id":1366,"sortIndex":36,"researcher":26,"roles":1367,"affiliations":1368,"properties":1375},"d28507b0-cdad-4441-9c1e-561e5d4e1345",[],[1369],{"id":1370,"sortIndex":36,"affiliation":1371,"properties":26},"38c85340-e6c9-4259-9531-1fb6b29466d5",{"id":1318,"createTime":1319,"updateTime":1320,"relativeEntities":1372,"slug":1322,"properties":1373,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1374},{"VI":1325},{"openalex":1376,"orcid":1378,"title":1380},{"VOID":1377},"A5065018778",{"VOID":1379},"https:\u002F\u002Forcid.org\u002F0000-0002-0069-6322",{"EN":1381},"Salah Gariballa",{"url":26,"publisher":1383,"properties":1411},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1384,"slug":663,"properties":1385,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1389,"manageAffiliations":1390,"indexDatabases":1391,"url":26,"thumbnailPath":26,"statistic":1406,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":1386,"title":1387,"url":1388},{"VOID":666},{"EN":668},{"VOID":670},[],[],[1392,1399],{"id":730,"indexDatabase":1393,"url":745,"indexYears":26,"academicFieldIds":1398,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":1394,"label":1395,"description":1396,"key":741,"publicationTags":1397,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":1400,"url":723,"indexYears":724,"academicFieldIds":1405,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":1401,"label":1402,"description":1403,"key":720,"publicationTags":1404,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":1407,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":1408,"totalCitation":36,"totalCitationByYear":1409,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":1410,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"volume":1412,"issue":1414},{"VOID":1413},"19",{"VOID":892},{"total":1138,"publishYear":26,"statisticByYear":1416},{"2019":115,"2020":158,"2021":239,"2022":240,"2023":234,"2024":356},[1418,1421,1424,1428,1432,1436,1440,1444,1448,1452,1456,1460,1464,1468,1472,1476,1480,1484,1488,1492,1496,1499],{"id":26,"text":1419,"url":26,"identifiers":1420},"Obesity: preventing and managing the global epidemic. Report of a WHO consultation, World Health Organ Tech Rep Ser 894 (2000), pp. I–xii 1–253.",{},{"id":26,"text":1422,"url":26,"identifiers":1423},"The Report of a British Nutrition Foundation Task Force. Cardiovascular disease, Diet, Nutrition and Emerging Risk Factors. Oxford: Balckwell Publishing Ltd; 2005.",{},{"id":26,"text":1425,"url":26,"identifiers":1426},"Malik A, Babir A, Abi Saab B, Roglic G, King H. Glucose intolerance and associated factors in the UAE. Diabetes Res Clin Pract. 2005;69:188–95.",{"doi":1427},"10.1016\u002Fj.diabres.2004.12.005",{"id":26,"text":1429,"url":26,"identifiers":1430},"Gariballa S, Kosanovic M, Yasin J, Essa AE. Oxidative damage and inflammation in obese diabetic emirati subjects. Nutrients. 2014;6(11):4872–80.",{"doi":1431},"10.3390\u002Fnu6114872",{"id":26,"text":1433,"url":26,"identifiers":1434},"Gariballa S, Alkaabi J, Yasin J, Al Essa A. Oxidative damage and associated inflammatory risk factors in obese Emirati women. Body mass index versus waist circumference. Saudi Med J. 2017;38(9):960–4.",{"doi":1435},"10.15537\u002Fsmj.2017.9.19629",{"id":26,"text":1437,"url":26,"identifiers":1438},"Expert Consultation WHO. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.",{"doi":1439},"10.1016\u002FS0140-6736(03)15268-3",{"id":26,"text":1441,"url":26,"identifiers":1442},"Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.",{"doi":1443},"10.1016\u002FS0140-6736(04)17018-9",{"id":26,"text":1445,"url":26,"identifiers":1446},"Wang ZV, Scherer PE. Adiponectin, the past 2 decades. J Mol Cell Biol. 2016;8(2):93–100.",{"doi":1447},"10.1093\u002Fjmcb\u002Fmjw011",{"id":26,"text":1449,"url":26,"identifiers":1450},"Woodward L, Akoumianakis I, Antoniades C. Unravelling the adiponectin paradox: novel roles of adiponectin in the regulation of cardiovascular disease. Br J Pharmacol. 2017;174(22):4007–20.",{"doi":1451},"10.1111\u002Fbph.13619",{"id":26,"text":1453,"url":26,"identifiers":1454},"Sulistyoningrum DC, Gasevic D, Lear SA, Ho J, Mente A, Devlin AM. Total and high molecular weight adiponectin and ethnic-specific differences in adiposity and insulin resistance: a cross-sectional study. Cardiovasc Diabetol. 2013;12:170.",{"doi":1455},"10.1186\u002F1475-2840-12-170",{"id":26,"text":1457,"url":26,"identifiers":1458},"Lopez-Jaramillo P. The Role of Adiponectin in Cardiometabolic Diseases: Effects of Nutritional Interventions. J Nutr. 2016;146(2):422S–6S.",{"doi":1459},"10.3945\u002Fjn.114.202432",{"id":26,"text":1461,"url":26,"identifiers":1462},"Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, Hoddy KK, Calvo Y. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013;12:146.",{"doi":1463},"10.1186\u002F1475-2891-12-146",{"id":26,"text":1465,"url":26,"identifiers":1466},"Hosseinzadeh-Attar MJ, Golpaie A, Janani L, Derakhshanian H. Effect of Weight Reduction Following Bariatric Surgery on Serum Visfatin and Adiponectin Levels in Morbidly Obese Subjects. Obes Facts. 2013;6(2):193–202.",{"doi":1467},"10.1159\u002F000351162",{"id":26,"text":1469,"url":26,"identifiers":1470},"Ferris WF, Naran NH, Crowther NJ, Rheeder P, van der Merwe L, Chetty N. The relationship between insulin sensitivity and serum adiponectin levels in three population groups. Horm Metab Res. 2005;37(11):695–701.",{"doi":1471},"10.1055\u002Fs-2005-870580",{"id":26,"text":1473,"url":26,"identifiers":1474},"Shah A, Hernandez A, Mathur D, Budoff MJ, Kanaya AM. Adipokines and body fat composition in South Asians: results of the Metabolic Syndrome and Atherosclerosis in South Asians Living in America (MASALA) study. Int J Obes. 2012;36(6):810–6.",{"doi":1475},"10.1038\u002Fijo.2011.167",{"id":26,"text":1477,"url":26,"identifiers":1478},"Al-Badri MR, Zantout MS, Azar ST. The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab. 2015;6(3):103–8.",{"doi":1479},"10.1177\u002F2042018815577039",{"id":26,"text":1481,"url":26,"identifiers":1482},"Liu C, Feng X, Li Q, Wang Y, Li Q, Hua M. Adiponectin, TNF-α and inflammatory cytokines and risk of type 2 diabetes: A systematic review and meta-analysis. Cytokine. 2016;86:100–9.",{"doi":1483},"10.1016\u002Fj.cyto.2016.06.028",{"id":26,"text":1485,"url":26,"identifiers":1486},"Altinova AE, Toruner F, Bukan N, Yasar DG, Akturk M, Cakir N, Arslan M. Decreased plasma adiponectin is associated with insulin resistance and HDL cholesterol in overweight subjects. Endocr J. 2007;54(2):221–6.",{"doi":1487},"10.1507\u002Fendocrj.K06-021",{"id":26,"text":1489,"url":26,"identifiers":1490},"Barter P. High density lipoprotein: a therapeutic target in type 2 diabetes. Endocrinol Metab. 2013;28:169–77.",{"doi":1491},"10.3803\u002FEnM.2013.28.3.169",{"id":26,"text":1493,"url":26,"identifiers":1494},"Hawkes N. Small falls in weight can improve health provided they are long term, says NICE. BMJ. 2014;348:g3576.",{"doi":1495},"10.1136\u002Fbmj.g3576",{"id":26,"text":1497,"url":26,"identifiers":1498},"National Institute for Health and Care Excellence. Managing overweight and obesity in adults—lifestyle weight management services. 2014. \n                    http:\u002F\u002Fguidance.nice.org.uk\u002FPH53",{},{"id":26,"text":1500,"url":26,"identifiers":1501},"Ma W, Huang T, Zheng Y, Wang M, Bray GA, Sacks FM, Qi L. Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial. J Clin Endocrinol Metab. 2016;101(6):2415–22.",{"doi":1502},"10.1210\u002Fjc.2016-1207",{"id":1504,"createTime":1505,"updateTime":1505,"relativeEntities":1506,"slug":1507,"properties":1508,"entityType":779,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":1523,"translateLanguages":26,"viewCount":36,"primaryUrl":1524,"fullTextUrl":26,"authors":1525,"publicationType":858,"publisherRelationship":1658,"citationCount":117,"citationInfo":1691,"publishDate":1693,"publishYear":1694,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":1695,"isForceReanalyzing":996},"a76a3ce5-89a0-4afc-b5f2-1bc13b01681e","2024-04-18T22:54:51.238+00:00",[],"Plasma-salivary-and-urinary-cortisol-levels-following-physiological-and-stress-doses-of-hydrocortisone-in-normal-volunteers",{"mag":1509,"keywords":1511,"pmc":1512,"openalex":1514,"abstract":1516,"title":1517,"pm":1519,"doi":1521},{"VOID":1510},"2104596388",{},{"VOID":1513},"4280712",{"VOID":1515},"W2104596388",{},{"EN":1518},"Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers",{"VOID":1520},"25425285",{"VOID":1522},"10.1186\u002F1472-6823-14-91",[102],"https:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002F1472-6823-14-91",[1526,1544,1565,1584,1605,1626,1643],{"id":1527,"sortIndex":111,"researcher":26,"roles":1528,"affiliations":1529,"properties":1539},"3dd91ecc-8fc7-40e1-b4c4-5bc2b68e05eb",[],[1530],{"id":1531,"sortIndex":36,"affiliation":1532,"properties":26},"8e4bbd71-ad97-4a82-b8c5-855c39ce4389",{"id":1533,"createTime":1534,"updateTime":1534,"relativeEntities":1535,"slug":26,"properties":1536,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e91ba1e0-3557-4045-9d81-e37336940788","2024-02-10T20:01:50.060+00:00",[],{"title":1537},{"VI":1538},"Steroid & Immunobiochemistry Laboratory, Canterbury Health Laboratories, Christchurch, New Zealand",{"openalex":1540,"title":1542},{"VOID":1541},"A5006695630",{"EN":1543},"John G. Lewis",{"id":1545,"sortIndex":162,"researcher":26,"roles":1546,"affiliations":1547,"properties":1558},"580a2ec2-7853-4754-b1d6-104a183eb37f",[],[1548],{"id":1549,"sortIndex":36,"affiliation":1550,"properties":26},"9fd536b2-7e1b-4218-9983-c17a01e763fb",{"id":1551,"createTime":1552,"updateTime":1552,"relativeEntities":1553,"slug":1554,"properties":1555,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"3917eb94-2d5a-435b-afa8-501ad9537e2f","2024-04-18T22:54:51.297+00:00",[],"Endocrine-and-Metabolic-Unit-Royal-Adelaide-Hospital-Adelaide-South-Australia-Australia",{"title":1556},{"EN":1557},"Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, South Australia, Australia",{"openalex":1559,"orcid":1561,"title":1563},{"VOID":1560},"A5024911159",{"VOID":1562},"https:\u002F\u002Forcid.org\u002F0000-0002-5069-0981",{"EN":1564},"David J. Torpy",{"id":1566,"sortIndex":115,"researcher":26,"roles":1567,"affiliations":1568,"properties":1579},"6adeab4e-0edf-4199-af66-e4a1b14823fb",[],[1569],{"id":1570,"sortIndex":36,"affiliation":1571,"properties":26},"9886ea98-da61-4f14-9262-fb3bb287ad46",{"id":1572,"createTime":1573,"updateTime":1573,"relativeEntities":1574,"slug":1575,"properties":1576,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"f38cbac6-c98a-4fa9-81ca-62b80f89f18f","2024-04-18T22:54:51.284+00:00",[],"Department-of-Biochemistry-Melbourne-Pathology-Melbourne-VIC-Australia",{"title":1577},{"EN":1578},"Department of Biochemistry, Melbourne Pathology, Melbourne, VIC, Australia",{"openalex":1580,"title":1582},{"VOID":1581},"A5058795639",{"EN":1583},"Santo Greco",{"id":1585,"sortIndex":135,"researcher":26,"roles":1586,"affiliations":1587,"properties":1598},"9ae68a8a-7074-4205-8686-626662ceb017",[],[1588],{"id":1589,"sortIndex":36,"affiliation":1590,"properties":26},"0c09f6c9-d2f3-4553-98de-607e15259398",{"id":1591,"createTime":1592,"updateTime":1592,"relativeEntities":1593,"slug":1594,"properties":1595,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"62223574-8de9-404b-84aa-35058eeb0734","2024-04-18T22:54:51.338+00:00",[],"Department-of-Diabetes-and-Endocrinology-Princess-Alexandra-Hospital-Brisbane-QLD-Australia",{"title":1596},{"EN":1597},"Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane, QLD, Australia",{"openalex":1599,"orcid":1601,"title":1603},{"VOID":1600},"A5063527776",{"VOID":1602},"https:\u002F\u002Forcid.org\u002F0000-0001-5078-4980",{"EN":1604},"Warrick J. Inder",{"id":1606,"sortIndex":36,"researcher":26,"roles":1607,"affiliations":1608,"properties":1619},"9a031ec1-0c74-41f8-aa05-146d6a34ea01",[],[1609],{"id":1610,"sortIndex":36,"affiliation":1611,"properties":26},"aeab4ebf-ee32-4234-9b62-4fd1fbdb55b2",{"id":1612,"createTime":1613,"updateTime":1613,"relativeEntities":1614,"slug":1615,"properties":1616,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"af5a9cd1-5be0-4bda-bb79-d1d9fd5efe07","2024-04-18T22:54:51.259+00:00",[],"Department-of-Endocrinology-and-Diabetes-St-Vincent-s-Hospital-Melbourne-VIC-Australia",{"title":1617},{"EN":1618},"Department of Endocrinology and Diabetes, St Vincent’s Hospital, Melbourne, VIC, Australia",{"openalex":1620,"orcid":1622,"title":1624},{"VOID":1621},"A5007968465",{"VOID":1623},"https:\u002F\u002Forcid.org\u002F0000-0003-1934-4551",{"EN":1625},"Caroline Jung",{"id":1627,"sortIndex":114,"researcher":26,"roles":1628,"affiliations":1629,"properties":1636},"a6a61971-bce0-4efd-ae5d-7389c771c710",[],[1630],{"id":1631,"sortIndex":36,"affiliation":1632,"properties":26},"a82db878-3a9f-4263-8041-acaf1345bd09",{"id":1572,"createTime":1573,"updateTime":1573,"relativeEntities":1633,"slug":1575,"properties":1634,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1635},{"EN":1578},{"openalex":1637,"orcid":1639,"title":1641},{"VOID":1638},"A5047261135",{"VOID":1640},"https:\u002F\u002Forcid.org\u002F0000-0002-8846-6168",{"EN":1642},"Hanh H. Nguyen",{"id":1644,"sortIndex":59,"researcher":26,"roles":1645,"affiliations":1646,"properties":1653},"9a2d6f35-4ce7-4f66-8ac5-ec9523c077c4",[],[1647],{"id":1648,"sortIndex":36,"affiliation":1649,"properties":26},"e3263439-e047-4c9d-afc9-8d0936bfbac6",{"id":1551,"createTime":1552,"updateTime":1552,"relativeEntities":1650,"slug":1554,"properties":1651,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1652},{"EN":1557},{"openalex":1654,"title":1656},{"VOID":1655},"A5000650184",{"EN":1657},"J. T. Ho",{"url":26,"publisher":1659,"properties":1687},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1660,"slug":663,"properties":1661,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":1665,"manageAffiliations":1666,"indexDatabases":1667,"url":26,"thumbnailPath":26,"statistic":1682,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":1662,"title":1663,"url":1664},{"VOID":666},{"EN":668},{"VOID":670},[],[],[1668,1675],{"id":730,"indexDatabase":1669,"url":745,"indexYears":26,"academicFieldIds":1674,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":1670,"label":1671,"description":1672,"key":741,"publicationTags":1673,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":1676,"url":723,"indexYears":724,"academicFieldIds":1681,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":1677,"label":1678,"description":1679,"key":720,"publicationTags":1680,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":1683,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":1684,"totalCitation":36,"totalCitationByYear":1685,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":1686,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"volume":1688,"issue":1690},{"VOID":1689},"14",{"VOID":892},{"total":117,"publishYear":26,"statisticByYear":1692},{"2016":116,"2017":298,"2018":135,"2019":52,"2020":53,"2021":116,"2022":103,"2023":52,"2024":114},"2014-12-01",2014,[1696,1700,1704,1707,1711,1714,1717,1721,1725,1729,1732,1736,1740,1744,1748,1752,1756,1760,1764,1768,1772,1776,1780,1784,1788,1792,1796,1800,1804,1808,1812,1816,1820,1824,1827,1831,1835,1839,1843,1847,1851,1854,1858,1862],{"id":26,"text":1697,"url":26,"identifiers":1698},"Thomson AH, Devers MC, Wallace AM, Grant D, Campbell K, Freel M, Connell JM: Variability in hydrocortisone plasma and saliva pharmacokinetics following intravenous and oral administration to patients with adrenal insufficiency. Clin Endocrinol (Oxf). 2007, 66: 789-796. 10.1111\u002Fj.1365-2265.2007.02812.x.",{"doi":1699},"10.1111\u002Fj.1365-2265.2007.02812.x",{"id":26,"text":1701,"url":26,"identifiers":1702},"Besser GM, Jeffcoate WJ: Endocrine and metabolic diseases: Adrenal diseases. Br Med J. 1976, 1: 448-451. 10.1136\u002Fbmj.1.6007.448.",{"doi":1703},"10.1136\u002Fbmj.1.6007.448",{"id":26,"text":1705,"url":26,"identifiers":1706},"Kenny FM, Preeyasombat C, Migeon CJ: Cortisol production rate II Normal infants, children, and adults. Pediatrics. 1966, 37: 34-42.",{},{"id":26,"text":1708,"url":26,"identifiers":1709},"Esteban NV, Loughlin T, Yergey AL, Zawadzki JK, Booth JD, Winterer JC, Loriaux DL: Daily cortisol production rate in man determined by stable isotope dilution\u002Fmass spectrometry. J Clin Endocrinol Metab. 1991, 72: 39-45. 10.1210\u002Fjcem-72-1-39.",{"doi":1710},"10.1210\u002Fjcem-72-1-39",{"id":26,"text":1712,"url":26,"identifiers":1713},"Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD: Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab. 1993, 76: 1505-1510.",{},{"id":26,"text":1715,"url":26,"identifiers":1716},"Kraan GP, Dullaart RP, Pratt JJ, Wolthers BG, Drayer NM, De Bruin R: The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different. J Clin Endocrinol Metab. 1998, 83: 1247-1252.",{},{"id":26,"text":1718,"url":26,"identifiers":1719},"Crown A, Lightman S: Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf). 2005, 63: 483-492. 10.1111\u002Fj.1365-2265.2005.02320.x.",{"doi":1720},"10.1111\u002Fj.1365-2265.2005.02320.x",{"id":26,"text":1722,"url":26,"identifiers":1723},"Howlett TA: An assessment of optimal hydrocortisone replacement therapy. Clin Endocrinol (Oxf). 1997, 46: 263-268. 10.1046\u002Fj.1365-2265.1997.1340955.x.",{"doi":1724},"10.1046\u002Fj.1365-2265.1997.1340955.x",{"id":26,"text":1726,"url":26,"identifiers":1727},"Sherlock M, Reulen RC, Alonso AA, Ayuk J, Clayton RN, Sheppard MC, Hawkins MM, Bates AS, Stewart PM: ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab. 2009, 94: 4216-4223. 10.1210\u002Fjc.2009-1097.",{"doi":1728},"10.1210\u002Fjc.2009-1097",{"id":26,"text":1730,"url":26,"identifiers":1731},"Arlt W, Rosenthal C, Hahner S, Allolio B: Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf). 2006, 64: 384-389.",{},{"id":26,"text":1733,"url":26,"identifiers":1734},"Zueger T, Kirchner P, Herren C, Fischli S, Zwahlen M, Christ E, Stettler C: Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J Clin Endocrinol Metab. 2012, 97: E1938-E1942. 10.1210\u002Fjc.2012-2432.",{"doi":1735},"10.1210\u002Fjc.2012-2432",{"id":26,"text":1737,"url":26,"identifiers":1738},"Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ: Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Clin Endocrinol (Oxf). 2006, 65: 45-50. 10.1111\u002Fj.1365-2265.2006.02544.x.",{"doi":1739},"10.1111\u002Fj.1365-2265.2006.02544.x",{"id":26,"text":1741,"url":26,"identifiers":1742},"Lovas K, Husebye ES: Continuous subcutaneous hydrocortisone infusion in Addison’s disease. Eur J Endocrinol. 2007, 157: 109-112. 10.1530\u002FEJE-07-0052.",{"doi":1743},"10.1530\u002FEJE-07-0052",{"id":26,"text":1745,"url":26,"identifiers":1746},"Newell-Price J, Whiteman M, Rostami-Hodjegan A, Darzy K, Shalet S, Tucker GT, Ross RJ: Modified-release hydrocortisone for circadian therapy: a proof-of-principle study in dexamethasone-suppressed normal volunteers. Clin Endocrinol (Oxf). 2008, 68: 130-135. 10.1111\u002Fj.1365-2265.2007.03011.x.",{"doi":1747},"10.1111\u002Fj.1365-2265.2007.03011.x",{"id":26,"text":1749,"url":26,"identifiers":1750},"Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, Darzy K, Merke DP, Arlt W, Ross RJ: Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009, 94: 1548-1554. 10.1210\u002Fjc.2008-2380.",{"doi":1751},"10.1210\u002Fjc.2008-2380",{"id":26,"text":1753,"url":26,"identifiers":1754},"Johannsson G, Bergthorsdottir R, Nilsson AG, Lennernas H, Hedner T, Skrtic S: Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur J Endocrinol. 2009, 161: 119-130. 10.1530\u002FEJE-09-0170.",{"doi":1755},"10.1530\u002FEJE-09-0170",{"id":26,"text":1757,"url":26,"identifiers":1758},"Russell GM, Durant C, Ataya A, Papastathi C, Bhake R, Woltersdorf W, Lightman S: Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf). 2014, 81: 289-293. 10.1111\u002Fcen.12470.",{"doi":1759},"10.1111\u002Fcen.12470",{"id":26,"text":1761,"url":26,"identifiers":1762},"Wong V, Yan T, Donald A, McLean M: Saliva and bloodspot cortisol: novel sampling methods to assess hydrocortisone replacement therapy in hypoadrenal patients. Clin Endocrinol (Oxf). 2004, 61: 131-137. 10.1111\u002Fj.1365-2265.2004.02062.x.",{"doi":1763},"10.1111\u002Fj.1365-2265.2004.02062.x",{"id":26,"text":1765,"url":26,"identifiers":1766},"Ekman B, Fitts D, Marelli C, Murray RD, Quinkler M, Zelissen PM: European Adrenal Insufficiency Registry (EU-AIR): a comparative observational study of glucocorticoid replacement therapy. BMC Endocr Disord. 2014, 14: 40-10.1186\u002F1472-6823-14-40.",{"doi":1767},"10.1186\u002F1472-6823-14-40",{"id":26,"text":1769,"url":26,"identifiers":1770},"Aanderud S, Myking OL: Plasma cortisol concentrations after oral substitution of cortisone in the fasting and non-fasting state. Acta Med Scand. 1981, 210: 157-161.",{"doi":1771},"10.1111\u002Fj.0954-6820.1981.tb09794.x",{"id":26,"text":1773,"url":26,"identifiers":1774},"Mah PM, Jenkins RC, Rostami-Hodjegan A, Newell-Price J, Doane A, Ibbotson V, Tucker GT, Ross RJ: Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency. Clin Endocrinol (Oxf). 2004, 61: 367-375. 10.1111\u002Fj.1365-2265.2004.02106.x.",{"doi":1775},"10.1111\u002Fj.1365-2265.2004.02106.x",{"id":26,"text":1777,"url":26,"identifiers":1778},"Oelkers W: Adrenal insufficiency. N Engl J Med. 1996, 335: 1206-1212. 10.1056\u002FNEJM199610173351607.",{"doi":1779},"10.1056\u002FNEJM199610173351607",{"id":26,"text":1781,"url":26,"identifiers":1782},"Kehlet H, Binder C, Blichert-Toft M: Glucocorticoid maintenance therapy following adrenalectomy: assessment of dosage and preparation. Clin Endocrinol (Oxf). 1976, 5: 37-41. 10.1111\u002Fj.1365-2265.1976.tb03801.x.",{"doi":1783},"10.1111\u002Fj.1365-2265.1976.tb03801.x",{"id":26,"text":1785,"url":26,"identifiers":1786},"Feek CM, Ratcliffe JG, Seth J, Gray CE, Toft AD, Irvine WJ: Patterns of plasma cortisol and ACTH concentrations in patients with Addison’s disease treated with conventional corticosteroid replacement. Clin Endocrinol (Oxf). 1981, 14: 451-458. 10.1111\u002Fj.1365-2265.1981.tb00634.x.",{"doi":1787},"10.1111\u002Fj.1365-2265.1981.tb00634.x",{"id":26,"text":1789,"url":26,"identifiers":1790},"Coolens JL, Van Baelen H, Heyns W: Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid-binding globulin. J Steroid Biochem. 1987, 26: 197-202. 10.1016\u002F0022-4731(87)90071-9.",{"doi":1791},"10.1016\u002F0022-4731(87)90071-9",{"id":26,"text":1793,"url":26,"identifiers":1794},"Maguire AM, Ambler GR, Moore B, Waite K, McLean M, Cowell CT: The clinical utility of alternative, less invasive sampling techniques in the assessment of oral hydrocortisone therapy in children and adolescents with hypopituitarism. Eur J Endocrinol. 2007, 156: 471-476. 10.1530\u002FEJE-06-0700.",{"doi":1795},"10.1530\u002FEJE-06-0700",{"id":26,"text":1797,"url":26,"identifiers":1798},"Lovas K, Thorsen TE, Husebye ES: Saliva cortisol measurement: simple and reliable assessment of the glucocorticoid replacement therapy in Addison’s disease. J Endocrinol Invest. 2006, 29: 727-731. 10.1007\u002FBF03344183.",{"doi":1799},"10.1007\u002FBF03344183",{"id":26,"text":1801,"url":26,"identifiers":1802},"Burch WM: Urine free-cortisol determination. A useful tool in the management of chronic hypoadrenal states. JAMA. 1982, 247: 2002-2004. 10.1001\u002Fjama.1982.03320390064047.",{"doi":1803},"10.1001\u002Fjama.1982.03320390064047",{"id":26,"text":1805,"url":26,"identifiers":1806},"Peacey SR, Guo CY, Robinson AM, Price A, Giles MA, Eastell R, Weetman AP: Glucocorticoid replacement therapy: are patients over treated and does it matter?. Clin Endocrinol (Oxf). 1997, 46: 255-261. 10.1046\u002Fj.1365-2265.1997.780907.x.",{"doi":1807},"10.1046\u002Fj.1365-2265.1997.780907.x",{"id":26,"text":1809,"url":26,"identifiers":1810},"Jung C, Inder WJ: Management of adrenal insufficiency during the stress of medical illness and surgery. Med J Aust. 2008, 188: 409-413.",{"doi":1811},"10.5694\u002Fj.1326-5377.2008.tb01686.x",{"id":26,"text":1813,"url":26,"identifiers":1814},"Debono M, Ross RJ, Newell-Price J: Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol. 2009, 160: 719-729. 10.1530\u002FEJE-08-0874.",{"doi":1815},"10.1530\u002FEJE-08-0874",{"id":26,"text":1817,"url":26,"identifiers":1818},"Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM: The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008, 93: 1526-1540. 10.1210\u002Fjc.2008-0125.",{"doi":1819},"10.1210\u002Fjc.2008-0125",{"id":26,"text":1821,"url":26,"identifiers":1822},"Tunn S, Mollmann H, Barth J, Derendorf H, Krieg M: Simultaneous measurement of cortisol in serum and saliva after different forms of cortisol administration. Clin Chem. 1992, 38: 1491-1494.",{"doi":1823},"10.1093\u002Fclinchem\u002F38.8.1491",{"id":26,"text":1825,"url":26,"identifiers":1826},"Aardal E, Holm AC: Cortisol in saliva–reference ranges and relation to cortisol in serum. Eur J Clin Chem Clin Biochem. 1995, 33: 927-932.",{},{"id":26,"text":1828,"url":26,"identifiers":1829},"Morgan SA, McCabe EL, Gathercole LL, Hassan-Smith ZK, Larner DP, Bujalska IJ, Stewart PM, Tomlinson JW, Lavery GG: 11beta-HSD1 is the major regulator of the tissue-specific effects of circulating glucocorticoid excess. Proc Natl Acad Sci U S A. 2014, 111: E2482-E2491. 10.1073\u002Fpnas.1323681111.",{"doi":1830},"10.1073\u002Fpnas.1323681111",{"id":26,"text":1832,"url":26,"identifiers":1833},"Smans L, Lentjes E, Hermus A, Zelissen P: Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison’s disease. Hormones (Athens). 2013, 12: 93-100.",{"doi":1834},"10.1007\u002FBF03401290",{"id":26,"text":1836,"url":26,"identifiers":1837},"Ho JT, Al-Musalhi H, Chapman MJ, Quach T, Thomas PD, Bagley CJ, Lewis JG, Torpy DJ: Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab. 2006, 91: 105-114. 10.1210\u002Fjc.2005-0265.",{"doi":1838},"10.1210\u002Fjc.2005-0265",{"id":26,"text":1840,"url":26,"identifiers":1841},"Widmer IE, Puder JJ, Konig C, Pargger H, Zerkowski HR, Girard J, Muller B: Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab. 2005, 90: 4579-4586. 10.1210\u002Fjc.2005-0354.",{"doi":1842},"10.1210\u002Fjc.2005-0354",{"id":26,"text":1844,"url":26,"identifiers":1845},"Arafah BM: Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab. 2006, 91: 3725-3745. 10.1210\u002Fjc.2006-0674.",{"doi":1846},"10.1210\u002Fjc.2006-0674",{"id":26,"text":1848,"url":26,"identifiers":1849},"Wood PJ, Barth JH, Freedman DB, Perry L, Sheridan B: Evidence for the low dose dexamethasone suppression test to screen for Cushing’s syndrome–recommendations for a protocol for biochemistry laboratories. Ann Clin Biochem. 1997, 34: 222-229. 10.1177\u002F000456329703400302.",{"doi":1850},"10.1177\u002F000456329703400302",{"id":26,"text":1852,"url":26,"identifiers":1853},"Taylor AE, Karavitaki N, Foster M, Meier S, O’Neil DM, Komninos J, Vassiliadi DM, Mowatt CJ, Lord JM, Wass JAH, Arlt W: Prevention of adrenal crisis in stress: serum cortisol during elective surgery, acute trauma surgery and during “stress dose cover” hydrocortisone replacement in adrenal insufficiency. ENDO. 2013, Poster abstract SAT-39",{},{"id":26,"text":1855,"url":26,"identifiers":1856},"Heazelwood VJ, Galligan JP, Cannell GR, Bochner F, Mortimer RH: Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability. Br J Clin Pharmacol. 1984, 17: 55-59. 10.1111\u002Fj.1365-2125.1984.tb04999.x.",{"doi":1857},"10.1111\u002Fj.1365-2125.1984.tb04999.x",{"id":26,"text":1859,"url":26,"identifiers":1860},"Behan LA, Rogers B, Hannon MJ, O’Kelly P, Tormey W, Smith D, Thompson CJ, Agha A: Optimizing glucocorticoid replacement therapy in severely adrenocorticotropin-deficient hypopituitary male patients. Clin Endocrinol (Oxf). 2011, 75: 505-513. 10.1111\u002Fj.1365-2265.2011.04074.x.",{"doi":1861},"10.1111\u002Fj.1365-2265.2011.04074.x",{"id":26,"text":1863,"url":26,"identifiers":1864},"Barlow NL, Holme J, Stockley RA, Clark PM: An evaluation of measured and calculated serum free cortisol in a group of patients with known adrenal suppression. Ann Clin Biochem. 2010, 47: 200-204. 10.1258\u002Facb.2010.009246.",{"doi":1865},"10.1258\u002Facb.2010.009246",{"id":1867,"createTime":1868,"updateTime":1869,"relativeEntities":1870,"slug":1871,"properties":1872,"entityType":779,"verifyStatus":25,"verifyTime":1869,"verifyNote":1307,"syncStatus":28,"languages":1887,"translateLanguages":26,"viewCount":36,"primaryUrl":1888,"fullTextUrl":26,"authors":1889,"publicationType":858,"publisherRelationship":1993,"citationCount":357,"citationInfo":2026,"publishDate":2028,"publishYear":2029,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":2030,"isForceReanalyzing":996},"82820776-7e8f-45bd-8f27-6dd66bd3d0c7","2024-04-17T13:48:49.660+00:00","2024-12-25T09:53:35.030+00:00",[],"Discordance-in-diagnosis-of-osteoporosis-using-spine-and-hip-bone-densitometry",{"mag":1873,"keywords":1875,"pmc":1876,"openalex":1878,"abstract":1880,"title":1881,"pm":1883,"doi":1885},{"VOID":1874},"1878155057",{},{"VOID":1877},"555556",{"VOID":1879},"W1878155057",{},{"EN":1882},"Discordance in diagnosis of osteoporosis using spine and hip bone densitometry",{"VOID":1884},"15762986",{"VOID":1886},"10.1186\u002F1472-6823-5-3",[102],"http:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002F1472-6823-5-3",[1890,1908,1923,1940,1957,1978],{"id":1891,"sortIndex":111,"researcher":26,"roles":1892,"affiliations":1893,"properties":1903},"dd0f106d-a79f-4e91-a63b-d83985d94513",[],[1894],{"id":1895,"sortIndex":36,"affiliation":1896,"properties":26},"96fcb464-9d63-47c2-943a-99f9886f61d8",{"id":1897,"createTime":1898,"updateTime":1898,"relativeEntities":1899,"slug":26,"properties":1900,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"e93cdb8a-6c80-406d-8e9b-b6a04d523bf3","2024-01-25T04:22:44.685+00:00",[],{"title":1901},{"VI":1902},"Endocrinology & Metabolism Research Centre, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran",{"openalex":1904,"title":1906},{"VOID":1905},"A5037092840",{"EN":1907},"Arash Hossein-neghad",{"id":1909,"sortIndex":36,"researcher":26,"roles":1910,"affiliations":1911,"properties":1918},"31484380-234f-483a-9bac-1cbef4707444",[],[1912],{"id":1913,"sortIndex":36,"affiliation":1914,"properties":26},"c59c9f38-6371-431e-a805-8817b705f1b9",{"id":1897,"createTime":1898,"updateTime":1898,"relativeEntities":1915,"slug":26,"properties":1916,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1917},{"VI":1902},{"openalex":1919,"title":1921},{"VOID":1920},"A5061938750",{"EN":1922},"Alireza Moayyeri",{"id":1924,"sortIndex":115,"researcher":26,"roles":1925,"affiliations":1926,"properties":1933},"8827a377-f1ba-458d-87d7-3967a4626264",[],[1927],{"id":1928,"sortIndex":36,"affiliation":1929,"properties":26},"ab21076e-ed53-491c-a9d9-a86f55c17345",{"id":1897,"createTime":1898,"updateTime":1898,"relativeEntities":1930,"slug":26,"properties":1931,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1932},{"VI":1902},{"openalex":1934,"orcid":1936,"title":1938},{"VOID":1935},"A5061318605",{"VOID":1937},"https:\u002F\u002Forcid.org\u002F0000-0003-3973-5744",{"EN":1939},"Akbar Soltani",{"id":1941,"sortIndex":162,"researcher":26,"roles":1942,"affiliations":1943,"properties":1950},"a9894e56-242a-4a6b-8ea0-485f0429d256",[],[1944],{"id":1945,"sortIndex":36,"affiliation":1946,"properties":26},"0626b09f-1f25-4fb8-af7b-15d76cb0a852",{"id":1897,"createTime":1898,"updateTime":1898,"relativeEntities":1947,"slug":26,"properties":1948,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1949},{"VI":1902},{"openalex":1951,"orcid":1953,"title":1955},{"VOID":1952},"A5007232361",{"VOID":1954},"https:\u002F\u002Forcid.org\u002F0000-0001-5386-7597",{"EN":1956},"Bagher Larijani",{"id":1958,"sortIndex":59,"researcher":26,"roles":1959,"affiliations":1960,"properties":1971},"e6880a6e-51d9-454c-9244-a668828b6154",[],[1961],{"id":1962,"sortIndex":36,"affiliation":1963,"properties":26},"1fc108ac-21b6-48d1-8329-cda136459657",{"id":1964,"createTime":1965,"updateTime":1965,"relativeEntities":1966,"slug":1967,"properties":1968,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"37554db8-e4b9-40e1-82e5-f74b28393a24","2024-04-17T13:48:49.729+00:00",[],"Research-Development-Center-Evidence-Based-Medicine-Working-Team-Shariati-hospital-Tehran-University-of-Medical-Sciences-Tehran-Iran",{"title":1969},{"EN":1970},"Research Development Center, Evidence Based Medicine Working Team, Shariati hospital, Tehran University of Medical Sciences, Tehran, Iran",{"openalex":1972,"orcid":1974,"title":1976},{"VOID":1973},"A5054105827",{"VOID":1975},"https:\u002F\u002Forcid.org\u002F0000-0002-0419-7862",{"EN":1977},"Mohsen Sadatsafavi",{"id":1979,"sortIndex":114,"researcher":26,"roles":1980,"affiliations":1981,"properties":1988},"18419006-ea24-46cd-9b81-73802141ff0c",[],[1982],{"id":1983,"sortIndex":36,"affiliation":1984,"properties":26},"72408cf4-ba7e-4e94-a394-cb486dd31c6a",{"id":1897,"createTime":1898,"updateTime":1898,"relativeEntities":1985,"slug":26,"properties":1986,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":1987},{"VI":1902},{"openalex":1989,"title":1991},{"VOID":1990},"A5054426866",{"EN":1992},"Nasibeh Khaleghnejad Tabari",{"url":26,"publisher":1994,"properties":2022},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":1995,"slug":663,"properties":1996,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2000,"manageAffiliations":2001,"indexDatabases":2002,"url":26,"thumbnailPath":26,"statistic":2017,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":1997,"title":1998,"url":1999},{"VOID":666},{"EN":668},{"VOID":670},[],[],[2003,2010],{"id":730,"indexDatabase":2004,"url":745,"indexYears":26,"academicFieldIds":2009,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":2005,"label":2006,"description":2007,"key":741,"publicationTags":2008,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":2011,"url":723,"indexYears":724,"academicFieldIds":2016,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":2012,"label":2013,"description":2014,"key":720,"publicationTags":2015,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":2018,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":2019,"totalCitation":36,"totalCitationByYear":2020,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":2021,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"volume":2023,"issue":2025},{"VOID":2024},"5",{"VOID":892},{"total":357,"publishYear":26,"statisticByYear":2027},{"2012":111,"2013":114,"2014":115,"2015":162,"2016":158,"2017":111,"2019":111,"2020":162,"2021":52,"2022":173,"2023":158},"2005-12-01",2005,[2031,2035,2039,2042,2046,2050,2054,2058,2062,2066,2070,2073,2077,2081,2085,2088,2092,2096,2100,2104,2108,2111,2114],{"id":26,"text":2032,"url":26,"identifiers":2033},"Consensus development conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1991, 90: 107-10. 10.1016\u002F0002-9343(91)90512-V.",{"doi":2034},"10.1016\u002F0002-9343(91)90512-V",{"id":26,"text":2036,"url":26,"identifiers":2037},"Consensus development conference: Diagnosis, prophylaxis and treatment of osteoporosis. Am J Med. 1993, 94: 646-50. 10.1016\u002F0002-9343(93)90218-E.",{"doi":2038},"10.1016\u002F0002-9343(93)90218-E",{"id":26,"text":2040,"url":26,"identifiers":2041},"World Health Organization: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Technical report series 843. 1994, Geneva: WHO",{},{"id":26,"text":2043,"url":26,"identifiers":2044},"Faulkner KG, von Stetten E, Miller P: Discordance in patient classification using T-scores. J Clin Densitom. 1999, 2: 343-50. 10.1385\u002FJCD:2:3:343.",{"doi":2045},"10.1385\u002FJCD:2:3:343",{"id":26,"text":2047,"url":26,"identifiers":2048},"Woodson G: Dual X-ray absorptiometry T-score concordance and discordance between the hip and spine measurement sites. J Clin Densitom. 2000, 3: 319-24. 10.1385\u002FJCD:3:4:319.",{"doi":2049},"10.1385\u002FJCD:3:4:319",{"id":26,"text":2051,"url":26,"identifiers":2052},"Mulder JE, Michaeli D, Flaster ER, Siris E: Comparison of bone mineral density of the phalanges, lumbar spine, hip, and forearm for the assessment of osteoporosis in postmenopausal women. J Clin Densitom. 2000, 3: 373-81. 10.1385\u002FJCD:3:4:373.",{"doi":2053},"10.1385\u002FJCD:3:4:373",{"id":26,"text":2055,"url":26,"identifiers":2056},"Abrahamsen B, Stilgren LS, Hermann AP, Tofteng CL, Barenholdt O, Vestergaard P, Brot C, Nielsen SP: Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women – implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study. J Bone Miner Res. 2001, 16: 1212-9.",{"doi":2057},"10.1359\u002Fjbmr.2001.16.7.1212",{"id":26,"text":2059,"url":26,"identifiers":2060},"Hans D, Rizzoli R, Thiebaud D, Lippuner K, Allaoua S, Genton L, Luzuy F, Krieg MA, Jaeger P, Slosman DO: Reference data in a Swiss population. Discordance in patient classification using T-scores among calcaneum, spine, and femur. J Clin Densitom. 2001, 4: 291-8. 10.1385\u002FJCD:4:4:291.",{"doi":2061},"10.1385\u002FJCD:4:4:291",{"id":26,"text":2063,"url":26,"identifiers":2064},"O'Gradaigh D, Debiram I, Love S, Richards HK, Compston JE: A prospective study of discordance in diagnosis of osteoporosis using spine and proximal femur bone densitometry. Osteoporos Int. 2003, 14: 13-8. 10.1007\u002Fs00198-002-1311-1.",{"doi":2065},"10.1007\u002Fs00198-002-1311-1",{"id":26,"text":2067,"url":26,"identifiers":2068},"Wells G, Tugwell P, Shea B, Guyatt G, Peterson J, Zytaruk N, Robinson V, Henry D, O'Connell D, Cranney A, Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group: Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev. 2002, 23: 529-39. 10.1210\u002Fer.2001-5002.",{"doi":2069},"10.1210\u002Fer.2001-5002",{"id":26,"text":2071,"url":26,"identifiers":2072},"Blumsohn A, Eastell R: Age-related factors. Osteoporosis Etiology, diagnosis, and management. Edited by: Riggs BL, Melton LJ III. 1995, Philadelphia: Lippincott-Raven Publishers, 161-182. Second",{},{"id":26,"text":2074,"url":26,"identifiers":2075},"Eastell R: Treatment of postmenopausal osteoporosis. N Engl J Med. 1998, 338: 736-46. 10.1056\u002FNEJM199803123381107.",{"doi":2076},"10.1056\u002FNEJM199803123381107",{"id":26,"text":2078,"url":26,"identifiers":2079},"Aaron JE, Johnson DR, Paxton S, Kanis JA: Secondary osteoporosis and the microanatomy of trabecular bone. Clin Rheumatol. 1989, 84-8. Suppl 2",{"doi":2080},"10.1007\u002FBF02207240",{"id":26,"text":2082,"url":26,"identifiers":2083},"Kohrt WM, Snead DB, Slatopolsky E, Birge SJ: Additive effects of weight-bearing exercise and estrogen on bone mineral density in older women. J Bone Miner Res. 1995, 10: 1303-11.",{"doi":2084},"10.1002\u002Fjbmr.5650100906",{"id":26,"text":2086,"url":26,"identifiers":2087},"Hashemipour S, Larijani B, Pajouhi M, Bastanhagh M, Soltani A, Javadi E, Adibi H, Shafaee A, Baradar Jalili R: Biochemical parameters of bone in different levels of vitamin D deficiency. Iranian South Medical Journal. 2002, 1: 25-17. (Article in Persian)",{},{"id":26,"text":2089,"url":26,"identifiers":2090},"Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, Soltani A, Shafaei AR, Hamidi Z, Fard AR, Hossein-Nezhad A, Booya F: Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health. 2004, 4: 38-10.1186\u002F1471-2458-4-38.",{"doi":2091},"10.1186\u002F1471-2458-4-38",{"id":26,"text":2093,"url":26,"identifiers":2094},"Bassir M, Laborie S, Lapillonne A, Claris O, Chappuis MC, Salle BL: Vitamin D deficiency in Iranian mothers and their neonates: a pilot study. Acta Paediatr. 2001, 90: 577-9. 10.1080\u002F080352501750197755.",{"doi":2095},"10.1111\u002Fj.1651-2227.2001.tb00802.x",{"id":26,"text":2097,"url":26,"identifiers":2098},"Lips P: Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001, 22: 477-501. 10.1210\u002Fer.22.4.477.",{"doi":2099},"10.1210\u002Fedrv.22.4.0437",{"id":26,"text":2101,"url":26,"identifiers":2102},"Rand T, Seidl G, Kainberger F, Resch A, Hittmair K, Schneider B, Gluer CC, Imhof H: Impact of spinal degenerative changes on the evaluation of bone mineral density with dual energy X-ray absorptiometry (DXA). Calcif Tissue Int. 1997, 60: 430-3. 10.1007\u002Fs002239900258.",{"doi":2103},"10.1007\u002Fs002239900258",{"id":26,"text":2105,"url":26,"identifiers":2106},"Reid IR, Evans MC, Ames R, Wattie DJ: The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women. J Clin Endocrinol Metab. 1991, 72: 1372-4.",{"doi":2107},"10.1210\u002Fjcem-72-6-1372",{"id":26,"text":2109,"url":26,"identifiers":2110},"Szklo M, Nieto FJ: Epidemiology. Beyond the Basics. 2000, Gaithersburg, Maryland: Aspen Publishers",{},{"id":26,"text":2112,"url":26,"identifiers":2113},"Larijani B, Soltani A, Pajouhi M, Bastanhagh M, Mirfezi SZ, Dashti R, Hossein-neghad A: Bone Mineral density variation in 20–69-years-old population of Tehran. Iranian South Medical Journal. 2002, 1: 49-41. (Article in Persian)",{},{"id":26,"text":2115,"url":26,"identifiers":2116},"Akbarian M, Davachi F, Salim Zadeh A, Shahram F, Gharib Doost F, Tajy A, Pajoohi M, Jamshidi AR: Bone mass density in normal Iranian population. The Journal of Tehran Faculty of Medicine. 2002, 4: 333-325. (Article in Persian)",{},{"id":2118,"createTime":2119,"updateTime":2120,"relativeEntities":2121,"slug":2122,"properties":2123,"entityType":779,"verifyStatus":25,"verifyTime":2120,"verifyNote":1307,"syncStatus":28,"languages":2138,"translateLanguages":26,"viewCount":36,"primaryUrl":2139,"fullTextUrl":26,"authors":2140,"publicationType":858,"publisherRelationship":2189,"citationCount":2218,"citationInfo":2219,"publishDate":2221,"publishYear":2222,"citationAnalyzeStatus":1143,"lastCitationAnalyze":2223,"indexDatabases":26,"openAccess":26,"references":2224,"isForceReanalyzing":996},"fdc9f98c-e403-4fb5-8893-1bdbdd2d47ac","2024-04-12T00:35:25.051+00:00","2024-12-14T10:38:23.540+00:00",[],"Glucagon-like-peptide-1-improved-glycemic-control-in-type-1-diabetes",{"mag":2124,"keywords":2126,"pmc":2127,"openalex":2129,"abstract":2131,"title":2132,"pm":2134,"doi":2136},{"VOID":2125},"1602119989",{},{"VOID":2128},"154101",{"VOID":2130},"W1602119989",{},{"EN":2133},"Glucagon-like peptide 1 improved glycemic control in type 1 diabetes",{"VOID":2135},"12697069",{"VOID":2137},"10.1186\u002F1472-6823-3-3",[102],"http:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002F1472-6823-3-3",[2141,2159,2173],{"id":2142,"sortIndex":115,"researcher":26,"roles":2143,"affiliations":2144,"properties":2154},"fac96224-9d12-4d90-b911-d167b9315b18",[],[2145],{"id":26,"sortIndex":36,"affiliation":2146,"properties":26},{"id":2147,"createTime":2148,"updateTime":2148,"relativeEntities":2149,"slug":2150,"properties":2151,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"23ce8798-e804-4917-a623-d084beea3f72","2024-04-12T00:35:27.422+00:00",[],"Department-of-Medicine-University-of-Western-Ontario-and-London-Health-Sciences-Centre-London-Ontario-N6A-5A5-Canada",{"title":2152},{"EN":2153},"Department of Medicine, University of Western Ontario and London Health Sciences Centre, London, Ontario, N6A 5A5, Canada",{"openalex":2155,"title":2157},{"VOID":2156},"A5030138213",{"EN":2158},"J. Dupré",{"id":2160,"sortIndex":36,"researcher":26,"roles":2161,"affiliations":2162,"properties":2168},"9b77facc-fd12-454c-a3f5-f3b2db7d8aa9",[],[2163],{"id":26,"sortIndex":36,"affiliation":2164,"properties":26},{"id":2147,"createTime":2148,"updateTime":2148,"relativeEntities":2165,"slug":2150,"properties":2166,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2167},{"EN":2153},{"openalex":2169,"title":2171},{"VOID":2170},"A5082821798",{"EN":2172},"Margaret T. Behme",{"id":2174,"sortIndex":114,"researcher":26,"roles":2175,"affiliations":2176,"properties":2182},"a59d5676-1f53-4324-89ec-aeb24e762e23",[],[2177],{"id":26,"sortIndex":36,"affiliation":2178,"properties":26},{"id":2147,"createTime":2148,"updateTime":2148,"relativeEntities":2179,"slug":2150,"properties":2180,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2181},{"EN":2153},{"openalex":2183,"orcid":2185,"title":2187},{"VOID":2184},"A5072646206",{"VOID":2186},"https:\u002F\u002Forcid.org\u002F0000-0003-0057-0997",{"EN":2188},"Thomas J. McDonald",{"url":26,"publisher":2190,"properties":26},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2191,"slug":663,"properties":2192,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2196,"manageAffiliations":2197,"indexDatabases":2198,"url":26,"thumbnailPath":26,"statistic":2213,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":2193,"title":2194,"url":2195},{"VOID":666},{"EN":668},{"VOID":670},[],[],[2199,2206],{"id":730,"indexDatabase":2200,"url":745,"indexYears":26,"academicFieldIds":2205,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":2201,"label":2202,"description":2203,"key":741,"publicationTags":2204,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":2207,"url":723,"indexYears":724,"academicFieldIds":2212,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":2208,"label":2209,"description":2210,"key":720,"publicationTags":2211,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":2214,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":2215,"totalCitation":36,"totalCitationByYear":2216,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":2217,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},80,{"total":2218,"publishYear":26,"statisticByYear":2220},{"2013":59,"2014":135,"2015":135,"2016":158,"2017":111,"2018":59,"2019":59,"2020":162,"2021":59,"2022":115,"2024":115},"2003-12-01",2003,"2024-04-13T06:48:26.569+00:00",[2225,2229,2233,2237,2241,2245,2249,2253,2257,2261,2265,2269,2272],{"id":26,"text":2226,"url":26,"identifiers":2227},"Holst JJ: Therapy of type 2 diabetes mellitus based on the actions of glucagon-like peptide-1. Diabetes Metab Res Rev. 2002, 18: 430-441. 10.1002\u002Fdmrr.328.",{"doi":2228},"10.1002\u002Fdmrr.328",{"id":26,"text":2230,"url":26,"identifiers":2231},"Todd JF, Wilding JPH, Edwards CMB, Khan FA, Ghatei MA, Bloom SR: Glucagon-like peptide-1 (GLP-1) – a trial of treatment in noninsulin-dependent diabetes mellitus. European J Clin Invest. 1997, 27: 533-536. 10.1046\u002Fj.1365-2362.1997.1490691.x.",{"doi":2232},"10.1046\u002Fj.1365-2362.1997.1490691.x",{"id":26,"text":2234,"url":26,"identifiers":2235},"Zander M, Madsbad S, Lysgaard J, Holst JJ: Effect of 6-week course of glucagon-like peptide 1 on glucose control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet. 2002, 359: 824-830. 10.1016\u002FS0140-6736(02)07952-7.",{"doi":2236},"10.1016\u002FS0140-6736(02)07952-7",{"id":26,"text":2238,"url":26,"identifiers":2239},"Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S: Antidiabetogenic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus. N Engl J Med. 1992, 326: 1316-1322.",{"doi":2240},"10.1056\u002FNEJM199205143262003",{"id":26,"text":2242,"url":26,"identifiers":2243},"Dupré J, Behme MT, Hramiak IM, McFarlane P, Williamson MP, Zabel P, McDonald TJ: Glucagon-like peptide 1 reduces post-prandial glucose excursions in IDDM. Diabetes. 1995, 44: 626-630.",{"doi":2244},"10.2337\u002Fdiab.44.6.626",{"id":26,"text":2246,"url":26,"identifiers":2247},"Creutzfeldt WO, Kleine N, Willms B, Orskov C, Holst JJ, Nauck MA: Glucagonostatic actions and reduction of fasting hyperglycaemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Diabetes Care. 1996, 19: 580-586.",{"doi":2248},"10.2337\u002Fdiacare.19.6.580",{"id":26,"text":2250,"url":26,"identifiers":2251},"Dupré J, Behme MT, Hramiak IM, McDonald TJ: Subcutaneous glucagon-like peptide-1 combined with insulin normalizes postprandial glycemia in IDDM. Diabetes Care. 1997, 20: 381-384.",{"doi":2252},"10.2337\u002Fdiacare.20.3.381",{"id":26,"text":2254,"url":26,"identifiers":2255},"Dupré J, Jenner M, Mahon JL, Purdon C, Rodger NW, Stiller CR: Endocrine-metabolic function in remission-phase insulin-dependent diabetes mellitus (IDDM) during administration of cyclosporin. Diabetes. 1991, 40: 598-604.",{"doi":2256},"10.2337\u002Fdiab.40.5.598",{"id":26,"text":2258,"url":26,"identifiers":2259},"Vella A, Shah P, Basu R, Basu A, Camilleri M, Schwenk FW, Holst JJ, Rizza RA: Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes. Diabetes. 2001, 50: 565-572.",{"doi":2260},"10.2337\u002Fdiabetes.50.3.565",{"id":26,"text":2262,"url":26,"identifiers":2263},"Kraegen EW, Chisholm DJ, McNamara ME: Timing of insulin delivery with meals. Horm Metab Res. 1981, 13: 365-367.",{"doi":2264},"10.1055\u002Fs-2007-1019271",{"id":26,"text":2266,"url":26,"identifiers":2267},"Ahren B, Simonsson E, Larsson H, Landin-Olsson M, Torgeirsson H, Jansson PA, Sandqvist M, Bavenholm P, Efendic S, Eriksson JW, Dickinson S, Holmes D: Inhibition of Dipeptidyl Peptidase IV improves metabolic control over a 4-week study period in type 2 diabetes. Diabetes Care. 2002, 25: 869-875.",{"doi":2268},"10.2337\u002Fdiacare.25.5.869",{"id":26,"text":2270,"url":26,"identifiers":2271},"Dupré J, Behme MT, McDonald TJ: Exendin-4 reduces glucose excursions after meals in insulin-treated diabetes. Abstract. Diabetes. 2002, 51 (Suppl 2): A84-",{},{"id":26,"text":2273,"url":26,"identifiers":2274},"Juhl CB, Hollingdal M, Sturis J, Jakobsen G, Agerso H, Veldhuis J, Porksen N, Schmitz O: Bedtime administration of NN2211 a long-acting GLP-1 derivative, substantially reduces fasting and postprandial glycemia in type 2 diabetes. Diabetes. 2002, 51: 424-429.",{"doi":2275},"10.2337\u002Fdiabetes.51.2.424",{"id":2277,"createTime":2278,"updateTime":2279,"relativeEntities":2280,"slug":2281,"properties":2282,"entityType":779,"verifyStatus":25,"verifyTime":2291,"verifyNote":1307,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"primaryUrl":2292,"fullTextUrl":26,"authors":2293,"publicationType":858,"publisherRelationship":2390,"citationCount":401,"citationInfo":2424,"publishDate":2427,"publishYear":2425,"citationAnalyzeStatus":28,"lastCitationAnalyze":2428,"indexDatabases":26,"openAccess":26,"references":2429,"isForceReanalyzing":996},"fcdb1be7-da69-4725-806a-a6e7b39b72a5","2024-01-17T18:02:26.790+00:00","2026-04-08T12:14:44.267+00:00",[],"The-effects-of-metformin-in-type-1-diabetes-mellitus",{"abstract":2283,"title":2285,"doi":2287,"gsPaper":2289},{"EN":2284},"This retrospective study investigated the effect of adding metformin to pharmacologic insulin dosing in type 1 diabetics on insulin therapy 1 year after treatment compared with patients on insulin therapy alone. Twenty-nine adults with type 1 diabetes who had metformin added to their insulin therapy for 12 months were compared with 29 adults with type 1 diabetes who remained on insulin-alone therapy. Fifty-eight patients with C peptide negative-type 1 diabetics (26 females, mean age: 29.01 ± 7.03 years, BMI: 24.18 ± 3.16 kg\u002Fm2) were analyzed. Age, sex, body weight, insulin dose requirement, plasma glucose (PG), blood pressure (BP), and lipids did not differ between groups before treatment (p > 0.05). Metabolic syndrome (44.8 vs 41.4%, p > 0.05) did not differ between the metformin-insulin and insulin alone groups before treatment. Metabolic syndrome was more decreased in the metformin-insulin group than in the insulin alone group after treatment (−8.9 ± 1.3 vs. 2.5 ± 0.6%, p = 0.028). Insulin dose requirement was lower in the metformin-insulin group than in the insulin alone group (−0.03 vs. 0.11 IU\u002Fkg\u002Fd, p = 0.006). Fasting PG (−26.9 ± 54.2 vs. 0.7 ± 29.5 mg\u002FdL, p = 0.022) and postprandial PG (−43.1 ± 61.8 mg\u002FdL vs. −3.1 ± 40.1 mg\u002FdL, p = 0.010) was more decreased in the metformin-insulin group than in the insulin alone group. Body weight, lipids, and HbA1c did not differ between the groups (p > 0.05). Metformin decreased glucose concentrations, reduced metabolic syndrome, as well as insulin dose requirement more than insulin therapy alone, 1 year after treatment. These results were independent of blood lipid improvement or weight loss, although on average weight remained decreased with metformin-insulin therapy, whereas the average weight increased with insulin therapy alone.",{"EN":2286},"The effects of metformin in type 1 diabetes mellitus",{"VOID":2288},"10.1186\u002Fs12902-017-0228-9",{"VOID":2290},"[\"2766050452282306870\"]","2024-05-04T13:28:00.884+00:00","https:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002Fs12902-017-0228-9",[2294,2310,2322,2348,2363,2378],{"id":2295,"sortIndex":111,"researcher":26,"roles":2296,"affiliations":2298,"properties":2307},"4e4504f9-5b4a-48ed-bcdb-9e3af29fa5c9",[2297],"AUTHOR",[2299],{"id":26,"sortIndex":36,"affiliation":2300,"properties":26},{"id":2301,"createTime":2302,"updateTime":2302,"relativeEntities":2303,"slug":26,"properties":2304,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1c8a8ebe-88be-4d24-8b41-f4bcc845f314","2024-01-17T18:02:26.947+00:00",[],{"title":2305},{"VI":2306},"Department of Endocrinology and Metabolism, Ankara Diskapi Teaching and Research Hospital, Ankara, Turkey",{"title":2308},{"VI":2309},"Bekir Ucan",{"id":2311,"sortIndex":162,"researcher":26,"roles":2312,"affiliations":2313,"properties":2319},"1b9048a4-90f7-4c72-96a9-644720272b8d",[2297],[2314],{"id":26,"sortIndex":36,"affiliation":2315,"properties":26},{"id":2301,"createTime":2302,"updateTime":2302,"relativeEntities":2316,"slug":26,"properties":2317,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2318},{"VI":2306},{"title":2320},{"VI":2321},"Erman Cakal",{"id":2323,"sortIndex":36,"researcher":26,"roles":2324,"affiliations":2325,"properties":2343},"1eda4a2e-c80a-4603-866c-214c588a88b0",[2297],[2326,2334],{"id":26,"sortIndex":36,"affiliation":2327,"properties":26},{"id":2328,"createTime":2329,"updateTime":2329,"relativeEntities":2330,"slug":26,"properties":2331,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"54e7877f-3e8e-4719-ad80-5dbf7cc3aaba","2024-01-17T18:02:26.821+00:00",[],{"title":2332},{"VI":2333},"Department of Endocrinology and Metabolism, Eskisehir State Hospital, Eskisehir, Turkey",{"id":2335,"sortIndex":115,"affiliation":2336,"properties":26},"17c0564d-b5da-4d50-8241-e185861254aa",{"id":2337,"createTime":2338,"updateTime":2338,"relativeEntities":2339,"slug":26,"properties":2340,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"75964b91-240d-4994-95bf-bbe1308b357e","2024-01-17T18:02:26.826+00:00",[],{"title":2341},{"VI":2342},"Department of Medical Biology, Baskent University, Ankara, Turkey",{"title":2344,"gsAuthor":2346},{"VI":2345},"Selvihan Beysel",{"VOID":2347},"[\"tHZ6maYAAAAJ\"]",{"id":2349,"sortIndex":59,"researcher":26,"roles":2350,"affiliations":2351,"properties":2360},"108d2930-b3c9-416d-8d7f-91b255013887",[2297],[2352],{"id":26,"sortIndex":36,"affiliation":2353,"properties":26},{"id":2354,"createTime":2355,"updateTime":2355,"relativeEntities":2356,"slug":26,"properties":2357,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"2ad92893-a902-49db-bfc8-c4955017e796","2024-01-17T18:02:26.883+00:00",[],{"title":2358},{"VI":2359},"Department of Endocrinology and Metabolism, Duzce Ataturk State Hospital, Duzce, Turkey",{"title":2361},{"VI":2362},"Mustafa Caliskan",{"id":2364,"sortIndex":114,"researcher":26,"roles":2365,"affiliations":2366,"properties":2375},"5ca67077-590e-44be-a568-b0ba2f19e8b6",[2297],[2367],{"id":26,"sortIndex":36,"affiliation":2368,"properties":26},{"id":2369,"createTime":2370,"updateTime":2370,"relativeEntities":2371,"slug":26,"properties":2372,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"7892f795-b71f-4a1a-b0f2-50b3d98bc69f","2024-01-17T18:02:26.858+00:00",[],{"title":2373},{"VI":2374},"Department of Endocrinology and Metabolism, Kilis State Hospital, Kilis, Turkey",{"title":2376},{"VI":2377},"Muhammed Kizilgul",{"id":2379,"sortIndex":115,"researcher":26,"roles":2380,"affiliations":2381,"properties":2387},"7fe0f5f1-db8d-46c1-bfd3-7919d3e174ff",[2297],[2382],{"id":26,"sortIndex":36,"affiliation":2383,"properties":26},{"id":2301,"createTime":2302,"updateTime":2302,"relativeEntities":2384,"slug":26,"properties":2385,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2386},{"VI":2306},{"title":2388},{"VI":2389},"Ilknur Ozturk Unsal",{"url":2292,"publisher":2391,"properties":2419},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2392,"slug":663,"properties":2393,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2397,"manageAffiliations":2398,"indexDatabases":2399,"url":26,"thumbnailPath":26,"statistic":2414,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":2394,"title":2395,"url":2396},{"VOID":666},{"EN":668},{"VOID":670},[],[],[2400,2407],{"id":730,"indexDatabase":2401,"url":745,"indexYears":26,"academicFieldIds":2406,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":2402,"label":2403,"description":2404,"key":741,"publicationTags":2405,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":2408,"url":723,"indexYears":724,"academicFieldIds":2413,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":2409,"label":2410,"description":2411,"key":720,"publicationTags":2412,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":2415,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":2416,"totalCitation":36,"totalCitationByYear":2417,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":2418,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"volume":2420,"pages":2422},{"VOID":2421},"18",{"VOID":2423},"1-6",{"total":401,"publishYear":2425,"statisticByYear":2426},2018,{"2018":59,"2019":50,"2020":50,"2021":53,"2022":116,"2023":103,"2024":356,"2025":103},"2018-01-16","2026-04-08T12:14:44.266+00:00",[2430,2433,2436,2439,2445,2448,2454,2457,2460,2463,2466,2472,2475,2478,2481,2484,2490,2493,2496,2499,2502,2505,2508,2511,2514,2517,2520,2523,2526],{"id":26,"text":2431,"url":26,"identifiers":2432},"Chiang JL, Kirkman MS, Laffel LMB, Peters AL, Type 1 Diabetes Sourcebook Authors. Type 1 diabetes through the life span: a position statement of the American Diabetes Association. Diabetes Care. 2014;37:2034–54.",{},{"id":26,"text":2434,"url":26,"identifiers":2435},"Purnell JQ, Hokanson JE, Marcovina SM, Steffes MW, Cleary PA, Brunzell JD. Effect of excessive weight gain with intensive therapy of type 1 diabetes on lipid levels and blood pressure: results from the DCCT. Diabetes control and complications trial. JAMA. 1998;280:140–6.",{},{"id":26,"text":2437,"url":26,"identifiers":2438},"Orchard TJ, Olson JC, Erbey JR, Williams K, Forrest KY-Z, Smithline Kinder L, Ellis D, Becker DJ. Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care. 2003;26:1374–9.",{},{"id":2440,"text":2441,"url":2442,"identifiers":2443},"4c68646b-0035-4279-8000-0006b275d4fa","Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, et al. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study. PLoS One. 2008;3:e3363.","https:\u002F\u002Flink.springer.com\u002F10.1007\u002Fs10440-022-00541-7",{"doi":2444},"10.1007\u002Fs10440-022-00541-7",{"id":2440,"text":2446,"url":2442,"identifiers":2447},"Pop A, Clenciu D, Anghel M, Radu S, Socea B, Mota E, Mota M, Panduru NM, RomDianeStudy Group. Insulin resistance is associated with all chronic complications in type 1 diabetes. J Diabetes. 2016;8(2):220–8.",{"doi":2444},{"id":2449,"text":2450,"url":2451,"identifiers":2452},"3d8586a0-d479-420e-919c-ff9ae096cda0","Krochik AG, Botto M, Bravo M, Hepner M, Frontroth JP, Miranda M, Mazza C. Association between insulin resistance and risk of complications in children and adolescents with type 1 diabetes. Diabetes Metab Syndr. 2015;9:14–8.","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS1871402114000903",{"doi":2453},"10.1016\u002Fj.dsx.2014.09.013",{"id":26,"text":2455,"url":26,"identifiers":2456},"Thorn LM, Forsblom C, Fagerudd J, Thomas MC, Pettersson-Fernholm K, Saraheimo M, Wadén J, Rönnback M, Rosengård-Bärlund M, Björkesten C-GA, et al. Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care. 2005;28:2019–24.",{},{"id":26,"text":2458,"url":26,"identifiers":2459},"Metascreen Writing Committee, Bonadonna RC, Cucinotta D, Fedele D, Riccardi G, Tiengo A. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey. Diabetes Care. 2006;29:2701–7.",{},{"id":26,"text":2461,"url":26,"identifiers":2462},"Kilpatrick ES, Rigby AS, Atkin SL. Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: “double diabetes” in the diabetes control and complications trial. Diabetes Care. 2007;30:707–12.",{},{"id":2440,"text":2464,"url":2442,"identifiers":2465},"Lauria A, Barker A, Schloot N, Hosszufalusi N, Ludvigsson J, Mathieu C, Mauricio D, Nordwall M, Van der Schueren B, Mandrup-Poulsen T, et al. BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children. Eur J Endocrinol Eur Fed Endocr Soc. 2015;172:107–13.",{"doi":2444},{"id":2467,"text":2468,"url":2469,"identifiers":2470},"c4f6d394-8908-4650-81db-fe77014b09f4","Yardley JE, Kenny GP, Perkins BA, Riddell MC, Goldfield GS, Donovan L, Hadjiyannakis S, Wells GA, Phillips P, Sigal RJ, et al. Resistance Exercise in Already-Active Diabetic Individuals (READI): study rationale, design and methods for a randomized controlled trial of resistance and aerobic exercise in type 1 diabetes. Contemp Clin Trials. 2015;41:129–38.","https:\u002F\u002Fwww.sciencedirect.com\u002Fscience\u002Farticle\u002Fpii\u002FS155171441400202X",{"doi":2471},"10.1016\u002Fj.cct.2014.12.017",{"id":26,"text":2473,"url":26,"identifiers":2474},"Sorensen JS, Birkebaek NH, Bjerre M, Pociot F, Kristensen K, Hoejberg AS, Frystyk J, Danish Society for Diabetes in Childhood and Adolescence. Residual β-cell function and the insulin-like growth factor system in Danish children and adolescents with type 1 diabetes. J Clin Endocrinol Metab. 2015;100:1053–61.",{},{"id":2440,"text":2476,"url":2442,"identifiers":2477},"Dejgaard TF, Knop FK, Tarnow L, Frandsen CS, Hansen TS, Almdal T, Holst JJ, Madsbad S, Andersen HU. Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes-a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study. BMJ Open. 2015;5:e007791.",{"doi":2444},{"id":2440,"text":2479,"url":2442,"identifiers":2480},"Inzucchi SE, Maggs DG, Spollett GR, Page SL, Rife FS, Walton V, Shulman GI. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus. N Engl J Med. 1998;338:867–72.",{"doi":2444},{"id":2440,"text":2482,"url":2442,"identifiers":2483},"George P, McCrimmon RJ. Potential role of non-insulin adjunct therapy in Type 1 diabetes. Diabet Med J Br Diabet Assoc. 2013;30:179–88.",{"doi":2444},{"id":2485,"text":2486,"url":2487,"identifiers":2488},"779efe7e-1eb3-4717-864e-ddb301ddebb1","UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854–65.","https:\u002F\u002Flinkinghub.elsevier.com\u002Fretrieve\u002Fpii\u002FS0140673698070378",{"doi":2489},"10.1016\u002Fs0140-6736(98)07037-8",{"id":26,"text":2491,"url":26,"identifiers":2492},"Hamilton J, Cummings E, Zdravkovic V, Finegood D, Daneman D. Metformin as an adjunct therapy in adolescents with type 1 diabetes and insulin resistance: a randomized controlled trial. Diabetes Care. 2003;26:138–43.",{},{"id":2440,"text":2494,"url":2442,"identifiers":2495},"Särnblad S, Kroon M, Aman J. Metformin as additional therapy in adolescents with poorly controlled type 1 diabetes: randomised placebo-controlled trial with aspects on insulin sensitivity. Eur J Endocrinol Eur Fed Endocr Soc. 2003;149:323–9.",{"doi":2444},{"id":2440,"text":2497,"url":2442,"identifiers":2498},"Khan ASA, McLoughney CR, Ahmed AB. The effect of metformin on blood glucose control in overweight patients with type 1 diabetes. Diabet Med J Br Diabet Assoc. 2006;23:1079–84.",{"doi":2444},{"id":2440,"text":2500,"url":2442,"identifiers":2501},"Meyer L, Bohme P, Delbachian I, Lehert P, Cugnardey N, Drouin P, Guerci B. The benefits of metformin therapy during continuous subcutaneous insulin infusion treatment of type 1 diabetic patients. Diabetes Care. 2002;25:2153–8.",{"doi":2444},{"id":2440,"text":2503,"url":2442,"identifiers":2504},"Jacobsen IB, Henriksen JE, Beck-Nielsen H. The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control. Basic Clin Pharmacol Toxicol. 2009;105:145–9.",{"doi":2444},{"id":2440,"text":2506,"url":2442,"identifiers":2507},"Konrad K, Datz N, Engelsberger I, Grulich-Henn J, Hoertenhuber T, Knauth B, Meissner T, Wiegand S, Woelfle J, Holl RW, et al. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria. Pediatr Diabetes. 2015;16:529–37.",{"doi":2444},{"id":26,"text":2509,"url":26,"identifiers":2510},"DeGeeter M, Williamson B. Alternative agents in type 1 diabetes in addition to insulin therapy: Metformin, alpha-Glucosidase inhibitors, Pioglitazone, GLP-1 agonists, DPP-IV inhibitors, and SGLT-2 inhibitors. J. Pharm Pract. 2016;29(2):144–59.",{},{"id":2440,"text":2512,"url":2442,"identifiers":2513},"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation. 2002;106:3143–421.",{"doi":2444},{"id":2440,"text":2515,"url":2442,"identifiers":2516},"Urakami T, Morimoto S, Owada M, Harada K. Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus. Pediatr Int Off J Jpn Pediatr Soc. 2005;47:430–3.",{"doi":2444},{"id":2440,"text":2518,"url":2442,"identifiers":2519},"Moon RJ, Bascombe, L-A, Holt RIG. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being. Diabetes Obes Metab. 2007;9:143–5.",{"doi":2444},{"id":2440,"text":2521,"url":2442,"identifiers":2522},"Burchardt P, Zawada A, Tabaczewski P, Naskręt D, Kaczmarek J, Marcinkaniec J, Wierusz-Wysocka B, Wysocki H. Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized low‑density lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study. Pol Arch Med. Wewnętrznej. 2013;123:526–32.",{"doi":2444},{"id":2440,"text":2524,"url":2442,"identifiers":2525},"Lund SS, Tarnow L, Astrup AS, Hovind P, Jacobsen PK, Alibegovic AC, Parving I, Pietraszek L, Frandsen M, Rossing P, et al. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes. Diabetes Obes Metab. 2009;11:966–77.",{"doi":2444},{"id":26,"text":2527,"url":26,"identifiers":2528},"Schwab KO, Doerfer J, Hecker W, Grulich-Henn J, Wiemann D, Kordonouri O, Beyer P, Holl RW, DPV Initiative of the German Working Group for Pediatric Diabetology. Spectrum and prevalence of atherogenic risk factors in 27,358 children, adolescents, and young adults with type 1 diabetes: cross-sectional data from the German diabetes documentation and quality management system (DPV). Diabetes Care. 2006;29:218–25.",{},{"id":2530,"createTime":2531,"updateTime":2532,"relativeEntities":2533,"slug":2534,"properties":2535,"entityType":779,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":2550,"translateLanguages":26,"viewCount":36,"primaryUrl":2551,"fullTextUrl":26,"authors":2552,"publicationType":858,"publisherRelationship":2631,"citationCount":142,"citationInfo":2660,"publishDate":2662,"publishYear":2663,"citationAnalyzeStatus":1143,"lastCitationAnalyze":2532,"indexDatabases":26,"openAccess":26,"references":2664,"isForceReanalyzing":996},"207aefed-15f6-4a02-b705-58a2f710a263","2024-04-13T09:15:49.274+00:00","2024-04-13T18:50:32.915+00:00",[],"Glucagon-like-peptide-analogues-for-type-2-diabetes-mellitus-systematic-review-and-meta-analysis",{"mag":2536,"keywords":2538,"pmc":2539,"openalex":2541,"abstract":2543,"title":2544,"pm":2546,"doi":2548},{"VOID":2537},"2138897693",{},{"VOID":2540},"3017518",{"VOID":2542},"W2138897693",{},{"EN":2545},"Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis",{"VOID":2547},"21143938",{"VOID":2549},"10.1186\u002F1472-6823-10-20",[102],"https:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002F1472-6823-10-20",[2553,2571,2585,2601,2617],{"id":2554,"sortIndex":114,"researcher":26,"roles":2555,"affiliations":2556,"properties":2566},"f05025e3-6b75-46e0-b79e-07649801b449",[],[2557],{"id":26,"sortIndex":36,"affiliation":2558,"properties":26},{"id":2559,"createTime":2560,"updateTime":2560,"relativeEntities":2561,"slug":2562,"properties":2563,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"91f80c36-f53a-4a90-8d1b-0bc7eeb37c2c","2024-04-13T09:15:49.284+00:00",[],"Section-of-Population-Health-Medical-School-Buildings-Foresterhill-University-of-Aberdeen-Aberdeen-AB25-2ZD",{"title":2564},{"EN":2565},"Section of Population Health, Medical School Buildings, Foresterhill, University of Aberdeen, Aberdeen, AB25 2ZD",{"openalex":2567,"title":2569},{"VOID":2568},"A5076405762",{"EN":2570},"Christine Clar",{"id":2572,"sortIndex":36,"researcher":26,"roles":2573,"affiliations":2574,"properties":2580},"f533fa15-c0c2-4a3b-8ac0-1ca2ad5eb8f3",[],[2575],{"id":26,"sortIndex":36,"affiliation":2576,"properties":26},{"id":2559,"createTime":2560,"updateTime":2560,"relativeEntities":2577,"slug":2562,"properties":2578,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2579},{"EN":2565},{"openalex":2581,"title":2583},{"VOID":2582},"A5011208350",{"EN":2584},"D Shyangdan",{"id":2586,"sortIndex":59,"researcher":26,"roles":2587,"affiliations":2588,"properties":2594},"b693752a-ad8f-4086-aa1d-3fcd30f5490f",[],[2589],{"id":26,"sortIndex":36,"affiliation":2590,"properties":26},{"id":2559,"createTime":2560,"updateTime":2560,"relativeEntities":2591,"slug":2562,"properties":2592,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2593},{"EN":2565},{"openalex":2595,"orcid":2597,"title":2599},{"VOID":2596},"A5059164576",{"VOID":2598},"https:\u002F\u002Forcid.org\u002F0000-0002-4965-6655",{"EN":2600},"Pawana Sharma",{"id":2602,"sortIndex":111,"researcher":26,"roles":2603,"affiliations":2604,"properties":2610},"2448f712-624a-4509-a5b3-373a5d7f8e87",[],[2605],{"id":26,"sortIndex":36,"affiliation":2606,"properties":26},{"id":2559,"createTime":2560,"updateTime":2560,"relativeEntities":2607,"slug":2562,"properties":2608,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2609},{"EN":2565},{"openalex":2611,"orcid":2613,"title":2615},{"VOID":2612},"A5068981280",{"VOID":2614},"https:\u002F\u002Forcid.org\u002F0000-0003-0934-4961",{"EN":2616},"Norman Waugh",{"id":2618,"sortIndex":115,"researcher":26,"roles":2619,"affiliations":2620,"properties":2626},"5ae7f896-78e7-4c3d-b668-009fed9f65d4",[],[2621],{"id":26,"sortIndex":36,"affiliation":2622,"properties":26},{"id":2559,"createTime":2560,"updateTime":2560,"relativeEntities":2623,"slug":2562,"properties":2624,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":2625},{"EN":2565},{"openalex":2627,"title":2629},{"VOID":2628},"A5058932170",{"EN":2630},"Pamela Royle",{"url":26,"publisher":2632,"properties":26},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":2633,"slug":663,"properties":2634,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":2638,"manageAffiliations":2639,"indexDatabases":2640,"url":26,"thumbnailPath":26,"statistic":2655,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":2635,"title":2636,"url":2637},{"VOID":666},{"EN":668},{"VOID":670},[],[],[2641,2648],{"id":730,"indexDatabase":2642,"url":745,"indexYears":26,"academicFieldIds":2647,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":2643,"label":2644,"description":2645,"key":741,"publicationTags":2646,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":2649,"url":723,"indexYears":724,"academicFieldIds":2654,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":2650,"label":2651,"description":2652,"key":720,"publicationTags":2653,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":2656,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":2657,"totalCitation":36,"totalCitationByYear":2658,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":2659,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"total":142,"publishYear":26,"statisticByYear":2661},{"2012":103,"2013":336,"2014":50,"2015":158,"2016":103,"2017":114,"2018":114,"2019":115,"2020":115,"2021":115,"2022":114,"2023":115},"2010-12-01",2010,[2665,2669,2673,2676,2680,2684,2688,2692,2696,2700,2704,2708,2712,2716,2720,2724,2728,2732,2736,2740,2744,2748,2751,2755,2759,2763,2767,2771,2775,2779,2783,2787,2791,2795,2799,2803,2807,2810,2814,2818,2822,2826,2830,2834,2838,2842,2845,2849,2852,2855,2858,2862,2865,2868,2871,2874,2878,2882,2886,2890,2894,2897,2901,2905,2908,2912,2916],{"id":26,"text":2666,"url":26,"identifiers":2667},"Turner R, Cull C, Holman R: United Kingdom prospective diabetes study 17: A 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Annals of Internal Medicine. 1996, 124: 136-145.",{"doi":2668},"10.7326\u002F0003-4819-124-1_Part_2-199601011-00011",{"id":26,"text":2670,"url":26,"identifiers":2671},"Stratton IM, Adler AI, Neil HAW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR, UK Prospective Diabetes Study Grp: Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. British Medical Journal. 2000, 321: 405-412. 10.1136\u002Fbmj.321.7258.405.",{"doi":2672},"10.1136\u002Fbmj.321.7258.405",{"id":26,"text":2674,"url":26,"identifiers":2675},"Type 2 diabetes: the management of type 2 diabetes. NICE clinical guideline 87. [ http:\u002F\u002Fwww.nice.org.uk\u002Fcg87 ]",{},{"id":26,"text":2677,"url":26,"identifiers":2678},"UKPDS16: U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes. 1995, 44: 1249-1258. 10.2337\u002Fdiabetes.44.11.1249.",{"doi":2679},"10.2337\u002Fdiab.44.11.1249",{"id":26,"text":2681,"url":26,"identifiers":2682},"Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, Zinman B: Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009, 32: 193-203. 10.2337\u002Fdc08-9025.",{"doi":2683},"10.2337\u002Fdc08-9025",{"id":26,"text":2685,"url":26,"identifiers":2686},"Hayward RA, Manning WG, Kaplan SH, Wagner EH, Greenfield S: Starting insulin therapy in patients with type 2 diabetes - Effectiveness, complications, and resource utilization. Jama-Journal of the American Medical Association. 1997, 278: 1663-1669. 10.1001\u002Fjama.278.20.1663.",{"doi":2687},"10.1001\u002Fjama.1997.03550200039029",{"id":26,"text":2689,"url":26,"identifiers":2690},"Baggio LL, Huang QL, Brown TJ, Drucker DJ: A recombinant human glucagon-like peptide (GLP)-1-albumin protein (Albugon) mimics peptidergic activation of GLP-1 receptor-dependent pathways coupled with satiety, gastrointestinal motility, and glucose homeostasis. Diabetes. 2004, 53: 2492-2500. 10.2337\u002Fdiabetes.53.9.2492.",{"doi":2691},"10.2337\u002Fdiabetes.53.9.2492",{"id":26,"text":2693,"url":26,"identifiers":2694},"Nauck MA, Kleine N, Orskov C, Holst JJ, Willms B, Creutzfeldt W: Normalization of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide-1 (7-36 Amide) in Type-2 (Non-Insulin-Dependent) Diabetic-Patients. Diabetologia. 1993, 36: 741-744. 10.1007\u002FBF00401145.",{"doi":2695},"10.1007\u002FBF00401145",{"id":26,"text":2697,"url":26,"identifiers":2698},"Amori RE, Lau J, Pittas AG: Efficacy and safety of incretin therapy in type 2 diabetes - Systematic review and meta-analysis. Jama-Journal of the American Medical Association. 2007, 298: 194-206. 10.1001\u002Fjama.298.2.194.",{"doi":2699},"10.1001\u002Fjama.298.2.194",{"id":26,"text":2701,"url":26,"identifiers":2702},"Barnett AH: New treatments in type 2 diabetes: a focus on the incretin-based therapies. Clinical Endocrinology. 2009, 70: 343-353. 10.1111\u002Fj.1365-2265.2008.03396.x.",{"doi":2703},"10.1111\u002Fj.1365-2265.2008.03396.x",{"id":26,"text":2705,"url":26,"identifiers":2706},"Monami M, Marchionni N, Mannucci E: Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials. European Journal of Endocrinology. 2009, 160: 909-917. 10.1530\u002FEJE-09-0101.",{"doi":2707},"10.1530\u002FEJE-09-0101",{"id":26,"text":2709,"url":26,"identifiers":2710},"Norris SL, Lee N, Thakurta S, Chan BKS: Exenatide efficacy and safety: a systematic review. Diabetic Medicine. 2009, 26: 837-846. 10.1111\u002Fj.1464-5491.2009.02790.x.",{"doi":2711},"10.1111\u002Fj.1464-5491.2009.02790.x",{"id":26,"text":2713,"url":26,"identifiers":2714},"Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes. 1999, 48: 2270-2276. 10.2337\u002Fdiabetes.48.12.2270.",{"doi":2715},"10.2337\u002Fdiabetes.48.12.2270",{"id":26,"text":2717,"url":26,"identifiers":2718},"Farilla L, Bulotta A, Hirshberg B, Calzi SL, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R: Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology. 2003, 144: 5149-5158. 10.1210\u002Fen.2003-0323.",{"doi":2719},"10.1210\u002Fen.2003-0323",{"id":26,"text":2721,"url":26,"identifiers":2722},"Li YZ, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ: Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. Journal of Biological Chemistry. 2003, 278: 471-478. 10.1074\u002Fjbc.M209423200.",{"doi":2723},"10.1074\u002Fjbc.M209423200",{"id":26,"text":2725,"url":26,"identifiers":2726},"Kobayashi M, Yamazaki K, Hirao K, Oishi M, Kanatsuka A, Yamauchi M, Takagi H, Kawai K: The status of diabetes control and antidiabetic drug therapy in Japan--a cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1). Diabetes Res Clin Pract. 2006, 73: 198-204. 10.1016\u002Fj.diabres.2006.01.013.",{"doi":2727},"10.1016\u002Fj.diabres.2006.01.013",{"id":26,"text":2729,"url":26,"identifiers":2730},"Neville SE, Boye KS, Montgomery WS, Iwamoto K, Okamura M, Hayes RP: Diabetes in Japan: a review of disease burden and approaches to treatment. Diabetes Metab Res Rev. 2009, 25: 705-716. 10.1002\u002Fdmrr.1012.",{"doi":2731},"10.1002\u002Fdmrr.1012",{"id":26,"text":2733,"url":26,"identifiers":2734},"Kaku K, Rasmussen MF, Clauson P, Seino Y: Improved glycaemic control with minimal hypoglycaemia and no weight change with the once-daily human glucagon-like peptide-1 analogue liraglutide as add-on to sulphonylurea in Japanese patients with type 2 diabetes. Diabetes Obes Metab. 2010, 12: 341-347. 10.1111\u002Fj.1463-1326.2009.01194.x.",{"doi":2735},"10.1111\u002Fj.1463-1326.2009.01194.x",{"id":26,"text":2737,"url":26,"identifiers":2738},"Higgins J, Altman DG: Assessing Risk of Bias in Included Studies. Cochrane Handbook for Systematic Reviews of Interventions. 2008, 187-241. full_text.",{"doi":2739},"10.1002\u002F9780470712184.ch8",{"id":26,"text":2741,"url":26,"identifiers":2742},"Kadowaki T, Namba M, Yamamura A, Sowa H, Wolka AM, Brodows RG: Exenatide Exhibits Dose-Dependent Effects on Glycemic Control over 12 Weeks in Japanese Patients with Suboptimally Controlled Type 2 Diabetes. Endocrine Journal. 2009, 56: 415-424. 10.1507\u002Fendocrj.K08E-296.",{"doi":2743},"10.1507\u002Fendocrj.K08E-296",{"id":26,"text":2745,"url":26,"identifiers":2746},"Kendall DM, Riddle MC, Rosenstock J, Zhuang DL, Kim DD, Fineman MS, Baron AD: Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea. Diabetes Care. 2005, 28: 1083-1091. 10.2337\u002Fdiacare.28.5.1083.",{"doi":2747},"10.2337\u002Fdiacare.28.5.1083",{"id":26,"text":2749,"url":26,"identifiers":2750},"DeFronzo RA, Triplitt C, Qu Y, Lewis MS, Maggs D, Glass LC: Effects Of Exenatide Plus Rosiglitazone On Beta Cell Function And Insulin Sensitivity In Subjects With Type 2 Diabetes On Metformin. Diabetes Care. 2010",{},{"id":26,"text":2752,"url":26,"identifiers":2753},"Rosenstock J, Reusch J, Bush M, Yang F, Stewart M: Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing. Diabetes Care. 2009, 32: 1880-1886. 10.2337\u002Fdc09-0366.",{"doi":2754},"10.2337\u002Fdc09-0366",{"id":26,"text":2756,"url":26,"identifiers":2757},"Nauck MA, Ratner RE, Kapitza C, Berria R, Boldrin M, Balena R: Treatment with the human once-weekly glucagon-like peptide-1 analog taspoglutide in combination with metformin improves glycemic control and lowers body weight in patients with type 2 diabetes inadequately controlled with metformin alone: a double-blind placebo-controlled study. Diabetes Care. 2009, 32: 1237-1243. 10.2337\u002Fdc08-1961.",{"doi":2758},"10.2337\u002Fdc08-1961",{"id":26,"text":2760,"url":26,"identifiers":2761},"Ratner R, Nauck M, Kapitza C, Asnaghi V, Boldrin M, Balena R: Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled study. Diabet Med. 2010, 27: 556-562. 10.1111\u002Fj.1464-5491.2010.02990.x.",{"doi":2762},"10.1111\u002Fj.1464-5491.2010.02990.x",{"id":26,"text":2764,"url":26,"identifiers":2765},"Gill A, Hoogwerf BJ, Burger J, Bruce S, MacConell L, Yan P, Braun D, Giaconia J, Malone J: Effect of exenatide on heart rate and blood pressure in subjects with type 2 diabetes mellitus: a double-blind, placebo-controlled, randomized pilot study. Cardiovasc Diabetol. 2010, 9: 6-10.1186\u002F1475-2840-9-6.",{"doi":2766},"10.1186\u002F1475-2840-9-6",{"id":26,"text":2768,"url":26,"identifiers":2769},"Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN: Exenatide versus glibenclamide in patients with diabetes. Diabetes Technol Ther. 2010, 12: 233-240. 10.1089\u002Fdia.2009.0141.",{"doi":2770},"10.1089\u002Fdia.2009.0141",{"id":26,"text":2772,"url":26,"identifiers":2773},"Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V, NovoLog Mix-vs-Exenatide Study Grp: Efficacy and safety of biphasic insulin aspart 70\u002F30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea. Current Medical Research and Opinion. 2009, 25: 65-75. 10.1185\u002F03007990802597951.",{"doi":2774},"10.1185\u002F03007990802597951",{"id":26,"text":2776,"url":26,"identifiers":2777},"Bunck MC, Diamant M, Corner A, Eliasson B, Malloy JL, Shaginian RM, Deng W, Kendall DM, Taskinen MR, Smith U: One-year Treatment With Exenatide Improves beta-Cell Function, Compared With Insulin Glargine, in Metformin-Treated Type 2 Diabetic Patients A randomized, controlled trial. Diabetes Care. 2009, 32: 762-768. 10.2337\u002Fdc08-1797.",{"doi":2778},"10.2337\u002Fdc08-1797",{"id":26,"text":2780,"url":26,"identifiers":2781},"Davies MJ, Donnelly R, Barnett AH, Jones S, Nicolay C, Kilcoyne A: Exenatide compared with long-acting insulin to achieve glycaemic control with minimal weight gain in patients with type 2 diabetes: results of the Helping Evaluate Exenatide in patients with diabetes compared with Long-Acting insulin (HEELA) study. Diabetes Obesity & Metabolism. 2009, 11: 1153-1162.",{"doi":2782},"10.1111\u002Fj.1463-1326.2009.01154.x",{"id":26,"text":2784,"url":26,"identifiers":2785},"Davis SN, Johns D, Maggs D, Xu H, Northrup JH, Brodows RG: Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents. Diabetes Care. 2007, 30: 2767-2772. 10.2337\u002Fdc06-2532.",{"doi":2786},"10.2337\u002Fdc06-2532",{"id":26,"text":2788,"url":26,"identifiers":2789},"Heine RJ, Van Gaal LF, Johns D, Mihm MJ, Widel MH, Brodows RG, Gwaa SG: Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes - A randomized trial. Annals of Internal Medicine. 2005, 143: 559-569.",{"doi":2790},"10.7326\u002F0003-4819-143-8-200510180-00006",{"id":26,"text":2792,"url":26,"identifiers":2793},"Nauck MA, Duran S, Kim D, Johns D, Northrup J, Festa A, Brodows R, Trautmann M: A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia. 2007, 50: 259-267. 10.1007\u002Fs00125-006-0510-2.",{"doi":2794},"10.1007\u002Fs00125-006-0510-2",{"id":26,"text":2796,"url":26,"identifiers":2797},"Diamant M, Van GL, Stranks S, Northrup J, Cao D, Taylor K, Trautmann M: Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial. Lancet. 2010, 375: 2234-2243. 10.1016\u002FS0140-6736(10)60406-0.",{"doi":2798},"10.1016\u002FS0140-6736(10)60406-0",{"id":26,"text":2800,"url":26,"identifiers":2801},"Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, Zdravkovic M, Ravn GM, Simo R, Liraglutide Effect AD: Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial. Diabetologia. 2009, 52: 2046-2055. 10.1007\u002Fs00125-009-1472-y.",{"doi":2802},"10.1007\u002Fs00125-009-1472-y",{"id":26,"text":2804,"url":26,"identifiers":2805},"Nauck M, Frid A, Hermansen K, Shah NS, Tankova T, Mitha IH, Zdravkovic M, During M, Matthews DR, Study G: Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes The LEAD (Liraglutide Effect and Action in Diabetes)-2 study. Diabetes Care. 2009, 32: 84-90. 10.2337\u002Fdc08-1355.",{"doi":2806},"10.2337\u002Fdc08-1355",{"id":26,"text":2808,"url":26,"identifiers":2809},"Bergenstal RM, Wysham C, MacConell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE: Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial. Lancet. 2010",{},{"id":26,"text":2811,"url":26,"identifiers":2812},"Pratley RE, Nauck M, Bailey T, Montanya E, Cuddihy R, Filetti S, Thomsen AB, Sondergaard RE, Davies M: Liraglutide versus sitagliptin for patients with type 2 diabetes who did not have adequate glycaemic control with metformin: a 26-week, randomised, parallel-group, open-label trial. Lancet. 2010, 375: 1447-1456. 10.1016\u002FS0140-6736(10)60307-8.",{"doi":2813},"10.1016\u002FS0140-6736(10)60307-8",{"id":26,"text":2815,"url":26,"identifiers":2816},"Marre M, Shaw J, Brandle M, Bebakar WMW, Kamaruddin NA, Strand J, Zdravkovic M, Le Thi TD, Colagiuri S, Su SG: Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabetic Medicine. 2009, 26: 268-278. 10.1111\u002Fj.1464-5491.2009.02666.x.",{"doi":2817},"10.1111\u002Fj.1464-5491.2009.02666.x",{"id":26,"text":2819,"url":26,"identifiers":2820},"Buse JB, Rosenstock J, Sesti G, Schmidt WE, Montanya E, Brett JH, Zychma M, Blonde L, Study G: Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet. 2009, 374: 39-47. 10.1016\u002FS0140-6736(09)60659-0.",{"doi":2821},"10.1016\u002FS0140-6736(09)60659-0",{"id":26,"text":2823,"url":26,"identifiers":2824},"Drucker DJ, Buse JB, Taylor K, Kendall DM, Trautmann M, Zhuang DL, Porter L, Study G: Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. Lancet. 2008, 372: 1240-1250. 10.1016\u002FS0140-6736(08)61206-4.",{"doi":2825},"10.1016\u002FS0140-6736(08)61206-4",{"id":26,"text":2827,"url":26,"identifiers":2828},"DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD: Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care. 2005, 28: 1092-1100. 10.2337\u002Fdiacare.28.5.1092.",{"doi":2829},"10.2337\u002Fdiacare.28.5.1092",{"id":26,"text":2831,"url":26,"identifiers":2832},"Apovian CM, Bergenstal RM, Cuddihy RM, Qu Y, Lenox S, Lewis MS, Glass LC: Effects of exenatide combined with lifestyle modification in patients with type 2 diabetes. Am J Med. 2010, 123: 468-17. 10.1016\u002Fj.amjmed.2009.11.019.",{"doi":2833},"10.1016\u002Fj.amjmed.2009.11.019",{"id":26,"text":2835,"url":26,"identifiers":2836},"Zinman B, Gerich J, Buse JB, Lewin A, Schwartz S, Raskin P, Hale PM, Zdravkovic M, Blonde L, Study I: Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD). Diabetes Care. 2009, 32: 1224-1230. 10.2337\u002Fdc08-2124.",{"doi":2837},"10.2337\u002Fdc08-2124",{"id":26,"text":2839,"url":26,"identifiers":2840},"Gao Y, Yoon KH, Chuang LM, Mohan V, Ning G, Shah S, Jang HC, Wu TJ, Johns D, Northrup J: Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylurea. Diabetes Research and Clinical Practice. 2009, 83: 69-76. 10.1016\u002Fj.diabres.2008.09.037.",{"doi":2841},"10.1016\u002Fj.diabres.2008.09.037",{"id":26,"text":2843,"url":26,"identifiers":2844},"Kendall D, Nielsen L, Han J, Brodows R, Bhole D: Metabolic improvement associated with temporal pattern of weight loss in exenatide-treated patients with type 2 diabetes. Diabetologia. 2008, 51: 886-",{},{"id":26,"text":2846,"url":26,"identifiers":2847},"Loh J, Clement SC: Efficacy of exenatide therapy over two years in a \"Real World\" setting. Diabetes. 2008, 57: A32-",{"doi":2848},"10.2337\u002Fdb07-1199",{"id":26,"text":2850,"url":26,"identifiers":2851},"Guideline for managment of postmeal glucose. [ http:\u002F\u002Fwww.idf.org\u002Fwebdata\u002Fdocs\u002FGuideline_PMG_final.pdf ]",{},{"id":26,"text":2853,"url":26,"identifiers":2854},"Guide to the methods of technology appraisal. [ http:\u002F\u002Fwww.nice.org.uk\u002Faboutnice\u002Fhowwework\u002Fdevnicetech\u002Ftechnologyappraisalprocessguides\u002Fguidetothemethodsoftechnologyappraisal.jsp ]",{},{"id":26,"text":2856,"url":26,"identifiers":2857},"Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S: Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation. Health Technology Assessment. 2010,",{},{"id":26,"text":2859,"url":26,"identifiers":2860},"Sheffield CA, Kane MP, Busch RS, Bakst G, Abelseth JM, Hamilton RA: Safety and efficacy of exenatide in combination with insulin in patients with type 2 diabetes mellitus. Endocr Pract. 2008, 14: 285-292.",{"doi":2861},"10.4158\u002FEP.14.3.285",{"id":26,"text":2863,"url":26,"identifiers":2864},"Information for Healthcare Professionals: Exenatide (marketed as Byetta). [ http:\u002F\u002Fwww.fda.gov\u002FDrugs\u002FDrugSafety\u002FPostmarketDrugSafetyInformationforPatientsandProviders\u002Fucm124713.htm ]",{},{"id":26,"text":2866,"url":26,"identifiers":2867},"Byetta Safety Update for Healthcare Professionals. [ http:\u002F\u002Fwww.fda.gov\u002FDrugs\u002FDrugSafety\u002FPostmarketDrugSafetyInformationforPatientsandProviders\u002FDrugSafetyInformationforHeathcareProfessionals\u002Fucm190406.htm ]",{},{"id":26,"text":2869,"url":26,"identifiers":2870},"Information for Healthcare Professionals: Reports of Altered Kidney Function in patients using Exenatide (Marketed as Byetta). [ http:\u002F\u002Fwww.fda.gov\u002FDrugs\u002FDrugSafety\u002FPostmarketDrugSafetyInformationforPatientsandProviders\u002FDrugSafetyInformationforHeathcareProfessionals\u002Fucm188656.htm ]",{},{"id":26,"text":2872,"url":26,"identifiers":2873},"Assessment report for Victoza (liraglutide). [ http:\u002F\u002Fwww.ema.europa.eu\u002Fema\u002Findex.jsp?curl=pages\u002Fmedicines\u002Fhuman\u002Fmedicines\u002F001026\u002Fhuman_med_001137.jsp%26murl=menus\u002Fmedicines\u002Fmedicines.jsp%26mid=WC0b01ac058001d125# ]",{},{"id":26,"text":2875,"url":26,"identifiers":2876},"Butler PC, Matveyenko AV, Dry S, Bhushan A, Elashoff R: Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?. Diabetologia. 2010, 53: 1-6. 10.1007\u002Fs00125-009-1591-5.",{"doi":2877},"10.1007\u002Fs00125-009-1591-5",{"id":26,"text":2879,"url":26,"identifiers":2880},"Schernthaner G, Barnett AH, Betteridge DJ, Carmena R, Ceriello A, Charbonnel B, Hanefeld M, Lehmann R, Malecki MT, Nesto R: Is the ADA\u002FEASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysis. Diabetologia. 2010, 53: 1258-1269. 10.1007\u002Fs00125-010-1702-3.",{"doi":2881},"10.1007\u002Fs00125-010-1702-3",{"id":26,"text":2883,"url":26,"identifiers":2884},"Fewtrell MS, Kennedy K, Singhal A, Martin RM, Ness A, Hadders-Algra M, Koletzko B, Lucas A: How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?. Arch Dis Child. 2008, 93: 458-461. 10.1136\u002Fadc.2007.127316.",{"doi":2885},"10.1136\u002Fadc.2007.127316",{"id":26,"text":2887,"url":26,"identifiers":2888},"Schulz KF, Grimes DA: Sample size slippages in randomised trials: exclusions and the lost and wayward. Lancet. 2002, 359: 781-785. 10.1016\u002FS0140-6736(02)07882-0.",{"doi":2889},"10.1016\u002FS0140-6736(02)07882-0",{"id":26,"text":2891,"url":26,"identifiers":2892},"Fonseca V, Rosenstock J, Patwardhan R, Salzman A: Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial. JAMA. 2000, 283: 1695-1702. 10.1001\u002Fjama.283.13.1695.",{"doi":2893},"10.1001\u002Fjama.283.13.1695",{"id":26,"text":2895,"url":26,"identifiers":2896},"Bunck MC, Corner A, Eliasson B, Heine RJ, Shaginian RM, Taskinen MR, Smith U, Yki-Jarvinen H, Diamant M: Three-Year Exenatide Therapy, Followed by a 4-Week Off-Drug Period, Had a Sustainable Effect on ß-Cell Disposition Index in Metformin Treated Patients with Type 2 Diabetes. 70th Scientific Session of the American Diabetes Association, June 25 - 29, Orlando, Florida. 2010",{},{"id":26,"text":2898,"url":26,"identifiers":2899},"Vilsboll T: The effects of glucagon-like peptide-1 on the beta cell. Diabetes, Obesity & Metabolism. 2009, 11 (Suppl-8):",{"doi":2900},"10.1111\u002Fj.1463-1326.2009.01073.x",{"id":26,"text":2902,"url":26,"identifiers":2903},"Holman RR, Farmer AJ, Davies MJ, Levy JC, Darbyshire JL, Keenan JF, Paul SK: Three-year efficacy of complex insulin regimens in type 2 diabetes. N Engl J Med. 2009, 361: 1736-1747. 10.1056\u002FNEJMoa0905479.",{"doi":2904},"10.1056\u002FNEJMoa0905479",{"id":26,"text":2906,"url":26,"identifiers":2907},"Diabetes - liraglutide: appraisal consultation 2 document. [ http:\u002F\u002Fwww.nice.org.uk\u002Fguidance\u002Findex.jsp?action=article%26o=49173 ]",{},{"id":26,"text":2909,"url":26,"identifiers":2910},"Klonoff DC, Buse JB, Nielsen LL, Guan X, Bowlus CL, Holcombe JH, Wintle ME, Maggs DG: Exenatide effects on diabetes, obesity, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes treated for at least 3 years. Curr Med Res Opin. 2008, 24: 275-286.",{"doi":2911},"10.1185\u002F030079908X253870",{"id":26,"text":2913,"url":26,"identifiers":2914},"Yki-Jarvinen H, Ryysy L, Nikkila K, Tulokas T, Vanamo R, Heikkila M: Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1999, 130: 389-396.",{"doi":2915},"10.7326\u002F0003-4819-130-5-199903020-00002",{"id":26,"text":2917,"url":26,"identifiers":2918},"Zinman B, Hoogwerf BJ, Garcia SD, Milton DR, Giaconia JM, Kim DD, Trautmann ME, Brodows RG: The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes - A randomized trial. Annals of Internal Medicine. 2007, 146: 477-485.",{"doi":2919},"10.7326\u002F0003-4819-146-7-200704030-00003",{"id":2921,"createTime":2922,"updateTime":2923,"relativeEntities":2924,"slug":2925,"properties":2926,"entityType":779,"verifyStatus":25,"verifyTime":2923,"verifyNote":1307,"syncStatus":28,"languages":2941,"translateLanguages":26,"viewCount":36,"primaryUrl":2942,"fullTextUrl":26,"authors":2943,"publicationType":858,"publisherRelationship":3140,"citationCount":568,"citationInfo":3169,"publishDate":3171,"publishYear":3172,"citationAnalyzeStatus":1143,"lastCitationAnalyze":3173,"indexDatabases":26,"openAccess":26,"references":3174,"isForceReanalyzing":996},"0b2166bd-47a7-4f00-9019-1b57bb5b3cdf","2024-04-11T18:10:41.626+00:00","2024-12-26T18:58:11.541+00:00",[],"Subclinical-and-clinical-hypothyroidism-and-non-alcoholic-fatty-liver-disease-a-cross-sectional-study-of-a-random-population-sample-aged-18-to-65-years",{"mag":2927,"keywords":2929,"pmc":2930,"openalex":2932,"abstract":2934,"title":2935,"pm":2937,"doi":2939},{"VOID":2928},"1828686092",{},{"VOID":2931},"4536732",{"VOID":2933},"W1828686092",{},{"EN":2936},"Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years",{"VOID":2938},"26276551",{"VOID":2940},"10.1186\u002Fs12902-015-0030-5",[102],"http:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002Fs12902-015-0030-5",[2944,2962,2979,2996,3012,3032,3046,3060,3091,3112,3126],{"id":2945,"sortIndex":50,"researcher":26,"roles":2946,"affiliations":2947,"properties":2957},"29369fc2-8676-43fe-ad6e-994535b79de6",[],[2948],{"id":26,"sortIndex":36,"affiliation":2949,"properties":26},{"id":2950,"createTime":2951,"updateTime":2951,"relativeEntities":2952,"slug":2953,"properties":2954,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"8eaca5c3-9367-489b-a6f0-594213f2dd96","2024-04-11T18:10:41.731+00:00",[],"Louis-Stokes-Cleveland-Department-of-Veterans-Affairs-Medical-Center-10701-East-Boulevard-Cleveland-USA",{"title":2955},{"EN":2956},"Louis Stokes Cleveland Department of Veterans Affairs Medical Center, 10701 East Boulevard, Cleveland, USA",{"openalex":2958,"title":2960},{"VOID":2959},"A5091866011",{"EN":2961},"Richard Mason",{"id":2963,"sortIndex":116,"researcher":26,"roles":2964,"affiliations":2965,"properties":2974},"97286211-dd77-4cd1-94d6-d4e8b8cfd3bf",[],[2966],{"id":26,"sortIndex":36,"affiliation":2967,"properties":26},{"id":2968,"createTime":2969,"updateTime":2969,"relativeEntities":2970,"slug":26,"properties":2971,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d88ab8eb-ee35-41bb-88fd-54ba68e0ae4b","2024-01-24T17:55:45.657+00:00",[],{"title":2972},{"VI":2973},"Department of Diagnostic and Interventional Radiology, University Medical Center Ulm, Ulm, Germany",{"openalex":2975,"title":2977},{"VOID":2976},"A5049262061",{"EN":2978},"Tilmann Graeter",{"id":2980,"sortIndex":111,"researcher":26,"roles":2981,"affiliations":2982,"properties":2991},"ec526af5-1dbd-4329-ba37-37fd8bf97cad",[],[2983],{"id":26,"sortIndex":36,"affiliation":2984,"properties":26},{"id":2985,"createTime":2986,"updateTime":2986,"relativeEntities":2987,"slug":26,"properties":2988,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"c96a6e77-0b2f-4c3d-a815-ffc13a4b91fe","2024-02-22T20:09:17.578+00:00",[],{"title":2989},{"VI":2990},"Department of Internal Medicine I, Center for Internal Medicine, University Medical Center Ulm, Ulm, Germany",{"openalex":2992,"title":2994},{"VOID":2993},"A5029192385",{"EN":2995},"Mark Martin Haenle",{"id":2997,"sortIndex":52,"researcher":26,"roles":2998,"affiliations":2999,"properties":3005},"5ed74f0e-1ae8-481a-8c54-3b5e64da49ce",[],[3000],{"id":26,"sortIndex":36,"affiliation":3001,"properties":26},{"id":2985,"createTime":2986,"updateTime":2986,"relativeEntities":3002,"slug":26,"properties":3003,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3004},{"VI":2990},{"openalex":3006,"orcid":3008,"title":3010},{"VOID":3007},"A5086070214",{"VOID":3009},"https:\u002F\u002Forcid.org\u002F0000-0002-9727-3843",{"EN":3011},"Wolfgang Kratzer",{"id":3013,"sortIndex":114,"researcher":26,"roles":3014,"affiliations":3015,"properties":3025},"c23c930d-efff-42c5-984b-eaa54bcf6949",[],[3016],{"id":26,"sortIndex":36,"affiliation":3017,"properties":26},{"id":3018,"createTime":3019,"updateTime":3019,"relativeEntities":3020,"slug":3021,"properties":3022,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"d6e0100a-fef9-4722-a92d-d26d3a9055c2","2024-04-11T18:10:41.659+00:00",[],"Dept-of-Pediatrics-and-Adolescent-Medicine-University-Medical-Center-Ulm-Ulm-Germany-",{"title":3023},{"EN":3024},"Dept. of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany.",{"openalex":3026,"orcid":3028,"title":3030},{"VOID":3027},"A5003025213",{"VOID":3029},"https:\u002F\u002Forcid.org\u002F0000-0003-0302-6161",{"EN":3031},"Christian Denzer",{"id":3033,"sortIndex":162,"researcher":26,"roles":3034,"affiliations":3035,"properties":3041},"48d758b8-10b1-4a82-952e-c425f7ac835e",[],[3036],{"id":26,"sortIndex":36,"affiliation":3037,"properties":26},{"id":2985,"createTime":2986,"updateTime":2986,"relativeEntities":3038,"slug":26,"properties":3039,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3040},{"VI":2990},{"openalex":3042,"title":3044},{"VOID":3043},"A5053825728",{"EN":3045},"Suemeyra Oeztuerk",{"id":3047,"sortIndex":115,"researcher":26,"roles":3048,"affiliations":3049,"properties":3055},"ae294fc6-4b3f-471a-ab7c-f43e94364301",[],[3050],{"id":26,"sortIndex":36,"affiliation":3051,"properties":26},{"id":2985,"createTime":2986,"updateTime":2986,"relativeEntities":3052,"slug":26,"properties":3053,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3054},{"VI":2990},{"openalex":3056,"title":3058},{"VOID":3057},"A5075596249",{"EN":3059},"Daniela Holzner",{"id":3061,"sortIndex":158,"researcher":26,"roles":3062,"affiliations":3063,"properties":3084},"fd38ba57-709b-4920-9352-d5d62f626a2e",[],[3064,3074],{"id":26,"sortIndex":36,"affiliation":3065,"properties":26},{"id":3066,"createTime":3067,"updateTime":3068,"relativeEntities":3069,"slug":3070,"properties":3071,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"1918fa53-d935-4b8d-9843-10a13a06dcb3","2024-02-06T13:09:22.622+00:00","2025-02-09T11:20:28.760+00:00",[],"Lee-Kong-Chian-School-of-Medicine-Nanyang-Technological-University-Singapore-Singapore",{"title":3072},{"VI":3073},"Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore",{"id":26,"sortIndex":36,"affiliation":3075,"properties":26},{"id":3076,"createTime":3077,"updateTime":3078,"relativeEntities":3079,"slug":3080,"properties":3081,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"17f02db6-b61b-4d58-960d-ff641b637df8","2023-11-27T20:46:54.559+00:00","2025-01-25T14:28:34.704+00:00",[],"Imperial-College-London-London-UK",{"title":3082},{"VI":3083},"Imperial College London, London, UK",{"openalex":3085,"orcid":3087,"title":3089},{"VOID":3086},"A5001086144",{"VOID":3088},"https:\u002F\u002Forcid.org\u002F0000-0002-2706-7710",{"EN":3090},"Bernhard O. Boehm",{"id":3092,"sortIndex":135,"researcher":26,"roles":3093,"affiliations":3094,"properties":3105},"78a32296-1b03-4880-8967-ba8c0a09e994",[],[3095],{"id":26,"sortIndex":36,"affiliation":3096,"properties":26},{"id":3097,"createTime":3098,"updateTime":3099,"relativeEntities":3100,"slug":3101,"properties":3102,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"62e439a6-05f7-4776-8a57-8dad1ce5a6e3","2024-01-12T01:00:13.148+00:00","2024-09-18T15:53:58.593+00:00",[],"Deutsches-Herzzentrum-M%C3%BCnchen-Technische-Universit%C3%A4t-M%C3%BCnchen-Munich-Germany",{"title":3103},{"VI":3104},"Deutsches Herzzentrum München, Technische Universität München, Munich, Germany",{"openalex":3106,"orcid":3108,"title":3110},{"VOID":3107},"A5028480812",{"VOID":3109},"https:\u002F\u002Forcid.org\u002F0000-0002-2064-9603",{"EN":3111},"Wolfgang Köenig",{"id":3113,"sortIndex":36,"researcher":26,"roles":3114,"affiliations":3115,"properties":3121},"c2bcecfb-2a21-44a9-aa07-ab90763268e9",[],[3116],{"id":26,"sortIndex":36,"affiliation":3117,"properties":26},{"id":2985,"createTime":2986,"updateTime":2986,"relativeEntities":3118,"slug":26,"properties":3119,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3120},{"VI":2990},{"openalex":3122,"title":3124},{"VOID":3123},"A5008827298",{"EN":3125},"Ulla Ludwig",{"id":3127,"sortIndex":59,"researcher":26,"roles":3128,"affiliations":3129,"properties":3135},"fb443ec1-7091-4fe7-8fde-53c6fca14e44",[],[3130],{"id":26,"sortIndex":36,"affiliation":3131,"properties":26},{"id":2985,"createTime":2986,"updateTime":2986,"relativeEntities":3132,"slug":26,"properties":3133,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3134},{"VI":2990},{"openalex":3136,"title":3138},{"VOID":3137},"A5083637531",{"EN":3139},"Artur Greinert",{"url":26,"publisher":3141,"properties":26},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3142,"slug":663,"properties":3143,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3147,"manageAffiliations":3148,"indexDatabases":3149,"url":26,"thumbnailPath":26,"statistic":3164,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":3144,"title":3145,"url":3146},{"VOID":666},{"EN":668},{"VOID":670},[],[],[3150,3157],{"id":730,"indexDatabase":3151,"url":745,"indexYears":26,"academicFieldIds":3156,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":3152,"label":3153,"description":3154,"key":741,"publicationTags":3155,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":3158,"url":723,"indexYears":724,"academicFieldIds":3163,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":3159,"label":3160,"description":3161,"key":720,"publicationTags":3162,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":3165,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":3166,"totalCitation":36,"totalCitationByYear":3167,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":3168,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"total":568,"publishYear":26,"statisticByYear":3170},{"2016":59,"2017":111,"2018":116,"2019":116,"2020":116,"2021":103,"2022":162,"2023":103,"2024":59},"2015-12-01",2015,"2024-04-11T21:26:14.128+00:00",[3175,3179,3183,3187,3191,3195,3199,3203,3207,3211,3215,3219,3223,3227,3231,3235,3239,3243,3247,3251,3255,3259,3263,3267,3270,3274,3278,3282,3286,3290,3294,3298,3302,3306,3310,3314],{"id":26,"text":3176,"url":26,"identifiers":3177},"Musso G, Gambino R, Cassader M. Non-alcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev. 2010;11:430–45.",{"doi":3178},"10.1111\u002Fj.1467-789X.2009.00657.x",{"id":26,"text":3180,"url":26,"identifiers":3181},"Oh HJ, Kim TH, Sohn YW, Kim YS, Oh YR, Cho EY, et al. Association of serum alanine aminotransferase and gamma-glutamyltransferase levels within the reference range with metabolic syndrome and nonalcoholic fatty liver disease. Korean J Hepatol. 2011;17:27–36.",{"doi":3182},"10.3350\u002Fkjhep.2011.17.1.27",{"id":26,"text":3184,"url":26,"identifiers":3185},"Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51:1820–32.",{"doi":3186},"10.1002\u002Fhep.23594",{"id":26,"text":3188,"url":26,"identifiers":3189},"Vuppalanchi R, Chalasani N. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management. Hepatology. 2009;49:306–17.",{"doi":3190},"10.1002\u002Fhep.22603",{"id":26,"text":3192,"url":26,"identifiers":3193},"Frith J, Day CP, Henderson E, Burt AD, Newton JL. Non-alcoholic fatty liver disease in older people. Gerontology. 2009;55:607–13.",{"doi":3194},"10.1159\u002F000235677",{"id":26,"text":3196,"url":26,"identifiers":3197},"Xu C, Xu L, Yu C, Miao M, Li Y. Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese. Clin Endocrinol (Oxf). 2011;75:240–6.",{"doi":3198},"10.1111\u002Fj.1365-2265.2011.04016.x",{"id":26,"text":3200,"url":26,"identifiers":3201},"Zelber-Sagi S, Nitzan-Kaluski D, Halpern Z, Oren R. Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures. Liver Int. 2006;26:856–63.",{"doi":3202},"10.1111\u002Fj.1478-3231.2006.01311.x",{"id":26,"text":3204,"url":26,"identifiers":3205},"Anstee QM, McPherson S, Day CP. How big a problem is non-alcoholic fatty liver disease? BMJ. 2011;343:d3897.",{"doi":3206},"10.1136\u002Fbmj.d3897",{"id":26,"text":3208,"url":26,"identifiers":3209},"Bookman ID, Pham J, Guindi M, Heathcote EJ. Distinguishing nonalcoholic steatohepatitis from fatty liver: serum-free fatty acids, insulin resistance, and serum lipoproteins. Liver Int. 2006;26:566–71.",{"doi":3210},"10.1111\u002Fj.1478-3231.2006.01256.x",{"id":26,"text":3212,"url":26,"identifiers":3213},"Papandreou D, Rousso I, Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clin Nutr. 2007;26:409–15.",{"doi":3214},"10.1016\u002Fj.clnu.2007.02.002",{"id":26,"text":3216,"url":26,"identifiers":3217},"Angulo P. Non-alcoholic fatty liver disease. N Engl J Med. 2002;346:1221–31.",{"doi":3218},"10.1056\u002FNEJMra011775",{"id":26,"text":3220,"url":26,"identifiers":3221},"Kotronen A, Yki-Järvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:27–38.",{"doi":3222},"10.1161\u002FATVBAHA.107.147538",{"id":26,"text":3224,"url":26,"identifiers":3225},"Chung GE, Kim D, Kim W, Yim JY, Park MJ, Kim YJ, et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. J Hepatol. 2012;57:150–6.",{"doi":3226},"10.1016\u002Fj.jhep.2012.02.027",{"id":26,"text":3228,"url":26,"identifiers":3229},"Liangpunsakul S, Chalasani N. Is hypothyroidism a risk factor for non-alcoholic steatohepatitis? J Clin Gastroenterol. 2003;37:340–3.",{"doi":3230},"10.1097\u002F00004836-200310000-00014",{"id":26,"text":3232,"url":26,"identifiers":3233},"Pagadala MR, Zein CO, Dasarathy S, Yerian LM, Lopez R, McCullough AJ. Prevalence of hypothyroidism in nonalcoholic fatty liver disease. Dig Dis Sci. 2012;57:528–34.",{"doi":3234},"10.1007\u002Fs10620-011-2006-2",{"id":26,"text":3236,"url":26,"identifiers":3237},"Xu L, Ma H, Miao M, Li Y. Impact of subclinical hypothyroidism on the development of non-alcoholic fatty liver disease: A prospective case–control study. J Hepato. 2012;57:1153–4.",{"doi":3238},"10.1016\u002Fj.jhep.2012.05.025",{"id":26,"text":3240,"url":26,"identifiers":3241},"Loria P, Carulli L, Bertolotti M, Lonardo A. Endocrine and liver interaction: the role of endocrine pathways in NASH. Nat Rev Gastroenterol Hepatol. 2009;6:236–47.",{"doi":3242},"10.1038\u002Fnrgastro.2009.33",{"id":26,"text":3244,"url":26,"identifiers":3245},"Ineck BA, Ng TM. Effects of subclinical hypothyroidism and its treatment on serum lipids. Ann Pharmacother. 2003;37:725–30.",{"doi":3246},"10.1345\u002Faph.1C376",{"id":26,"text":3248,"url":26,"identifiers":3249},"Haenle MM, Brockmann SO, Kron M, Bertling U, Mason RA, Steinbach G, et al. Overweight, physical activity, tobacco and alcohol consumption in a cross-sectional random sample of German adults. BMC Public Health. 2006;6:233.",{"doi":3250},"10.1186\u002F1471-2458-6-233",{"id":26,"text":3252,"url":26,"identifiers":3253},"Expert Panel on Detection. Evaluation, and treatment of high blood cholesterol in adults: executive summary of the third report of the national cholesterol education program (NCEP) (2001) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001;285:2486–97.",{"doi":3254},"10.1001\u002Fjama.285.19.2486",{"id":26,"text":3256,"url":26,"identifiers":3257},"Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed). 1986;292:13–5.",{"doi":3258},"10.1136\u002Fbmj.292.6512.13",{"id":26,"text":3260,"url":26,"identifiers":3261},"Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2003;102:2708–15.",{"doi":3262},"10.1111\u002Fj.1572-0241.2007.01526.x",{"id":26,"text":3264,"url":26,"identifiers":3265},"Charatcharoenwitthaya P, Lindor KD. Role of radiologic modalities in the management of non-alcoholic steatohepatitis. Clin Liver. 2007;11:37–54.",{"doi":3266},"10.1016\u002Fj.cld.2007.02.014",{"id":26,"text":3268,"url":26,"identifiers":3269},"Eshraghian A, Dabbaghmanesh MH, Eshraghian H, Fattahi MR, Omrani GR. Nonalcoholic fatty liver disease in a cluster of Iranian population: thyroid status and metabolic risk factors. Arch Iran Med. 2013;16:584–9.",{},{"id":26,"text":3271,"url":26,"identifiers":3272},"Mazo DF, Lima VM, Stefano JT, Rabelo F, Faintuch J, Oliveira CP. Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease. Arq Gastroenterol. 2011;48:186–9.",{"doi":3273},"10.1590\u002FS0004-28032011000300006",{"id":26,"text":3275,"url":26,"identifiers":3276},"Gardner CJ, Richardson P, Wong C, Polavarapu N, Kemp GJ, Cuthbertson DJ. Hypothyroidism in a patient with non-alcoholic fatty liver disease. BMJ. 2011;342:c7199.",{"doi":3277},"10.1136\u002Fbmj.c7199",{"id":26,"text":3279,"url":26,"identifiers":3280},"Zhang Y, Chang Y, Ryu S, Cho J, Lee WY, Rhee EJ, et al. Thyroid hormones and mortality risk in euthyroid individuals: the Kangbuk Samsung health study. J Clin Endocrinol Metab. 2014;99:2467–76.",{"doi":3281},"10.1210\u002Fjc.2013-3832",{"id":26,"text":3283,"url":26,"identifiers":3284},"Carulli L, Ballestri S, Lonardo A, Lami F, Violi E, Losi L, et al. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? Intern Emerg Med. 2013;8:297–305.",{"doi":3285},"10.1007\u002Fs11739-011-0609-4",{"id":26,"text":3287,"url":26,"identifiers":3288},"Moustafa AH, Ali EM, Mohamed TM, Abdou HI. Oxidative stress and thyroid hormones in patients with liver diseases. Eur J Intern Med. 2009;20:703–8.",{"doi":3289},"10.1016\u002Fj.ejim.2009.08.003",{"id":26,"text":3291,"url":26,"identifiers":3292},"Silveira MG1, Mendes FD, Diehl NN, Enders FT, Lindor KD. Thyroid dysfunction in primary biliary cirrhosis, primary sclerosing cholangitis and non-alcoholic fatty liver disease. Liver Int. 2009;29:1094–100.",{"doi":3293},"10.1111\u002Fj.1478-3231.2009.02003.x",{"id":26,"text":3295,"url":26,"identifiers":3296},"Ittermann T, Haring R, Wallaschofski H, Baumeister SE, Nauck M, Dörr M, et al. Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid. 2012;22:568–74.",{"doi":3297},"10.1089\u002Fthy.2011.0279",{"id":26,"text":3299,"url":26,"identifiers":3300},"Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas. 2009;62:301–5.",{"doi":3301},"10.1016\u002Fj.maturitas.2009.01.007",{"id":26,"text":3303,"url":26,"identifiers":3304},"Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92:491–6.",{"doi":3305},"10.1210\u002Fjc.2006-1718",{"id":26,"text":3307,"url":26,"identifiers":3308},"Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, et al. TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol. 2010;163:273–8.",{"doi":3309},"10.1530\u002FEJE-10-0312",{"id":26,"text":3311,"url":26,"identifiers":3312},"Liu C, Scherbaum WA, Schott M, Schinner S. Subclinical hypothyroidism and the prevalence of the metabolic syndrome. Horm Metab Res. 2011;43:417–21.",{"doi":3313},"10.1055\u002Fs-0031-1275719",{"id":26,"text":3315,"url":26,"identifiers":3316},"Tagami T, Kimura H, Ohtani S, Tanaka T, Tanaka T, Hata S, et al. PHPH study group: multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemia. Endocr J. 2011;58:449–57.",{"doi":3317},"10.1507\u002Fendocrj.K11E-012",{"id":3319,"createTime":3320,"updateTime":3321,"relativeEntities":3322,"slug":3323,"properties":3324,"entityType":779,"verifyStatus":25,"verifyTime":3321,"verifyNote":1307,"syncStatus":28,"languages":3339,"translateLanguages":26,"viewCount":36,"primaryUrl":3340,"fullTextUrl":26,"authors":3341,"publicationType":858,"publisherRelationship":3448,"citationCount":250,"citationInfo":3481,"publishDate":2662,"publishYear":2663,"citationAnalyzeStatus":28,"lastCitationAnalyze":26,"indexDatabases":26,"openAccess":26,"references":3483,"isForceReanalyzing":996},"276d4e00-03dc-4465-9875-931116420709","2024-04-17T23:59:39.492+00:00","2025-01-09T19:38:40.224+00:00",[],"Thyroid-function-derangement-and-childhood-obesity-an-Italian-experience",{"mag":3325,"keywords":3327,"pmc":3328,"openalex":3330,"abstract":3332,"title":3333,"pm":3335,"doi":3337},{"VOID":3326},"2145466670",{},{"VOID":3329},"2874556",{"VOID":3331},"W2145466670",{},{"EN":3334},"Thyroid function derangement and childhood obesity: an Italian experience",{"VOID":3336},"20441588",{"VOID":3338},"10.1186\u002F1472-6823-10-8",[102],"https:\u002F\u002Fbmcendocrdisord.biomedcentral.com\u002Farticles\u002F10.1186\u002F1472-6823-10-8",[3342,3363,3378,3395,3410,3431],{"id":3343,"sortIndex":36,"researcher":26,"roles":3344,"affiliations":3345,"properties":3356},"bfa753a7-8df5-4bb3-898d-7eb8edf393df",[],[3346],{"id":3347,"sortIndex":36,"affiliation":3348,"properties":26},"45c6f4d1-1199-4f0e-9cea-1293c84f9527",{"id":3349,"createTime":3350,"updateTime":3350,"relativeEntities":3351,"slug":3352,"properties":3353,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"37a006fd-b76f-4bad-a0a3-a2c2b78c0907","2024-04-17T23:59:39.510+00:00",[],"Department-of-Pediatrics-F-Fede-Seconda-Universit%C3%A0-degli-Studi-di-Napoli-Via-Luigi-De-Crecchio-2-80138-Napoli-Italy",{"title":3354},{"EN":3355},"Department of Pediatrics \"F. Fede\", Seconda Università degli Studi di Napoli, Via Luigi De Crecchio 2, 80138, Napoli, Italy",{"openalex":3357,"orcid":3359,"title":3361},{"VOID":3358},"A5068852387",{"VOID":3360},"https:\u002F\u002Forcid.org\u002F0000-0002-6343-4768",{"EN":3362},"Anna Grandone",{"id":3364,"sortIndex":114,"researcher":26,"roles":3365,"affiliations":3366,"properties":3373},"3d5f8c26-83f0-4a99-8058-561674b1a5b3",[],[3367],{"id":3368,"sortIndex":36,"affiliation":3369,"properties":26},"a7a62844-4aab-45e0-aa37-7c83583fdbd6",{"id":3349,"createTime":3350,"updateTime":3350,"relativeEntities":3370,"slug":3352,"properties":3371,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3372},{"EN":3355},{"openalex":3374,"title":3376},{"VOID":3375},"A5010559373",{"EN":3377},"Filomena Coppola",{"id":3379,"sortIndex":115,"researcher":26,"roles":3380,"affiliations":3381,"properties":3388},"4a055784-a1e9-4dd2-af2a-33b97036c6cc",[],[3382],{"id":3383,"sortIndex":36,"affiliation":3384,"properties":26},"c38565b5-78df-4b9a-bbe0-6313ac5151a4",{"id":3349,"createTime":3350,"updateTime":3350,"relativeEntities":3385,"slug":3352,"properties":3386,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3387},{"EN":3355},{"openalex":3389,"orcid":3391,"title":3393},{"VOID":3390},"A5058065651",{"VOID":3392},"https:\u002F\u002Forcid.org\u002F0000-0001-6437-4173",{"EN":3394},"Nicola Santoro",{"id":3396,"sortIndex":111,"researcher":26,"roles":3397,"affiliations":3398,"properties":3405},"0c68c83a-6a4a-4ee2-b2d8-f8034b578afa",[],[3399],{"id":3400,"sortIndex":36,"affiliation":3401,"properties":26},"588f91b0-f807-43f3-a378-4eb202c869c6",{"id":3349,"createTime":3350,"updateTime":3350,"relativeEntities":3402,"slug":3352,"properties":3403,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3404},{"EN":3355},{"openalex":3406,"title":3408},{"VOID":3407},"A5001726700",{"EN":3409},"Laura Perrone",{"id":3411,"sortIndex":59,"researcher":26,"roles":3412,"affiliations":3413,"properties":3424},"09cef8a3-3fb9-4fc7-8154-f03a10451381",[],[3414],{"id":3415,"sortIndex":36,"affiliation":3416,"properties":26},"28339185-1c2b-4454-b945-006f7e89c6ca",{"id":3417,"createTime":3418,"updateTime":3418,"relativeEntities":3419,"slug":3420,"properties":3421,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},"5d450ca3-6d30-4108-b8a9-965b431dc03c","2024-04-17T23:59:39.552+00:00",[],"Division-of-Cardiology-Seconda-Universit%C3%A0-degli-Studi-di-Napoli-A-O-Monaldi-Via-L-Bianchi-80131-Napoli-Italy",{"title":3422},{"EN":3423},"Division of Cardiology, Seconda Università degli Studi di Napoli -A.O.Monaldi, Via L.Bianchi, 80131, Napoli, Italy",{"openalex":3425,"orcid":3427,"title":3429},{"VOID":3426},"A5000200390",{"VOID":3428},"https:\u002F\u002Forcid.org\u002F0000-0002-5018-830X",{"EN":3430},"Paolo Calabrò",{"id":3432,"sortIndex":162,"researcher":26,"roles":3433,"affiliations":3434,"properties":3441},"794a9540-221a-4dfa-b807-1c7c25d1b38f",[],[3435],{"id":3436,"sortIndex":36,"affiliation":3437,"properties":26},"5ea05f05-fab4-4919-b15f-7788339e8a73",{"id":3349,"createTime":3350,"updateTime":3350,"relativeEntities":3438,"slug":3352,"properties":3439,"entityType":98,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36},[],{"title":3440},{"EN":3355},{"openalex":3442,"orcid":3444,"title":3446},{"VOID":3443},"A5075103514",{"VOID":3445},"https:\u002F\u002Forcid.org\u002F0000-0002-9410-5393",{"EN":3447},"Emanuele Miraglia del Giudice",{"url":26,"publisher":3449,"properties":3477},{"id":659,"createTime":660,"updateTime":661,"relativeEntities":3450,"slug":663,"properties":3451,"entityType":24,"verifyStatus":28,"verifyTime":26,"verifyNote":26,"syncStatus":28,"languages":26,"translateLanguages":26,"viewCount":36,"subjectFields":3455,"manageAffiliations":3456,"indexDatabases":3457,"url":26,"thumbnailPath":26,"statistic":3472,"gsStatistic":26,"type":175,"analyzePriority":26},[],{"issn":3452,"title":3453,"url":3454},{"VOID":666},{"EN":668},{"VOID":670},[],[],[3458,3465],{"id":730,"indexDatabase":3459,"url":745,"indexYears":26,"academicFieldIds":3464,"indexDatabaseRanking":26},{"id":732,"createTime":733,"updateTime":734,"relativeEntities":3460,"label":3461,"description":3462,"key":741,"publicationTags":3463,"standard":26},[],{"EN":737,"VI":737},{"VI":739,"EN":740},[743,744],[747],{"id":710,"indexDatabase":3466,"url":723,"indexYears":724,"academicFieldIds":3471,"indexDatabaseRanking":728},{"id":712,"createTime":713,"updateTime":714,"relativeEntities":3467,"label":3468,"description":3469,"key":720,"publicationTags":3470,"standard":26},[],{"EN":717,"VI":717},{"EN":717,"VI":719},[722],[726,727],{"impactFactor":36,"impactFactorByYear":3473,"i10Index":36,"i10IndexLast5Year":36,"totalPublication":750,"totalPublicationByYear":3474,"totalCitation":36,"totalCitationByYear":3475,"totalCitationPerPublication":36,"totalCitationPerPublicationByYear":3476,"hindexLast5Year":36,"hindex":36},{},{"2001":115,"2002":114,"2003":115,"2004":115,"2005":158,"2006":59,"2007":59,"2008":116,"2009":158,"2010":52,"2011":103,"2012":242,"2013":287,"2014":283,"2015":168,"2016":257,"2017":168,"2018":284,"2019":623,"2020":533,"2021":633,"2022":352,"2023":752,"2024":241},{},{},{"volume":3478,"issue":3480},{"VOID":3479},"10",{"VOID":892},{"total":250,"publishYear":26,"statisticByYear":3482},{"2012":135,"2013":53,"2014":114,"2015":135,"2016":135,"2017":158,"2018":162,"2019":162,"2020":59,"2021":59,"2022":59,"2023":114,"2024":114},[3484,3488,3492,3496,3499,3503,3507,3511,3514,3518,3521,3525,3529,3533,3537,3541,3545,3548,3552,3556,3560,3564,3568,3572,3576,3580,3584,3588,3592,3596,3600,3604,3608],{"id":26,"text":3485,"url":26,"identifiers":3486},"Sokol RJ: The chronic disease of childhood obesity: the sleeping giant has awakened. J Pediatr. 2000, 136: 711-13. 10.1067\u002Fmpd.2000.107787.",{"doi":3487},"10.1067\u002Fmpd.2000.107787",{"id":26,"text":3489,"url":26,"identifiers":3490},"Nathan BM, Moran A: Metabolic complications of obesity in childhood and adolescence: more than just diabetes. Curr Opin Endocrinol Diabetes Obes. 2008, 15: 21-29.",{"doi":3491},"10.1097\u002FMED.0b013e3282f43d19",{"id":26,"text":3493,"url":26,"identifiers":3494},"Stichel H, l'Allemand D, Gruters A: Thyroid function and obesity in children and adolescents. Horm Res. 2000, 54: 14-19. 10.1159\u002F000063431.",{"doi":3495},"10.1159\u002F000063431",{"id":26,"text":3497,"url":26,"identifiers":3498},"Bhowmick SK, Dasari G, Levens KL, Rettig KR: The prevalence of elevated serum thyroid-stimulating hormone in childhood\u002Fadolescent obesity and of autoimmune thyroid disease in a subgroup. J Natl Assoc. 2007, 99: 773-776.",{},{"id":26,"text":3500,"url":26,"identifiers":3501},"Reinehr T, de Sousa S, Andler W: Hyperthyrotropinemia In obese children is reversible after weight loss and is not related to lipids. J Clin Endocrinol Metab. 2006, 91: 3088-3091. 10.1210\u002Fjc.2006-0095.",{"doi":3502},"10.1210\u002Fjc.2006-0095",{"id":26,"text":3504,"url":26,"identifiers":3505},"Reinher T, Andler W: Thyroid hormones before and after weight loss in obesity. Arch Dis Child. 2002, 87: 320-323. 10.1136\u002Fadc.87.4.320.",{"doi":3506},"10.1136\u002Fadc.87.4.320",{"id":26,"text":3508,"url":26,"identifiers":3509},"Shalitin S, Yackobovitch-Gavan M, Philip M: Prevalence of thyroid dysfunction in obese children and adolescents before and after weight reduction and its relation to other metabolic paramenters. Horm Res. 2009, 71: 155-161. 10.1159\u002F000197872.",{"doi":3510},"10.1159\u002F000197872",{"id":26,"text":3512,"url":26,"identifiers":3513},"Reinher T: Obesity and thyroid function. Mol Cell Endocrinol. 2009,",{},{"id":26,"text":3515,"url":26,"identifiers":3516},"Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L: Italian crosssectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest. 2006, 29: 581-93.",{"doi":3517},"10.1007\u002FBF03344156",{"id":26,"text":3519,"url":26,"identifiers":3520},"Cole TJ: The LMS method for constructing normalized growth standards. Eur J Clin Nutr. 1990, 44: 45-60.",{},{"id":26,"text":3522,"url":26,"identifiers":3523},"Zannolli R, Morgese G: Waist percentiles: a simple test for atherogenic disease?. Acta Paediatr. 1996, 85: 1368-9. 10.1111\u002Fj.1651-2227.1996.tb13928.x.",{"doi":3524},"10.1111\u002Fj.1651-2227.1996.tb13928.x",{"id":26,"text":3526,"url":26,"identifiers":3527},"National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and A: The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004, 114: 555-76. 10.1542\u002Fpeds.114.2.S2.555.",{"doi":3528},"10.1542\u002Fpeds.114.2.S2.555",{"id":26,"text":3530,"url":26,"identifiers":3531},"Tanner JM, Whitehouse RH: Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976, 51: 170-9. 10.1136\u002Fadc.51.3.170.",{"doi":3532},"10.1136\u002Fadc.51.3.170",{"id":26,"text":3534,"url":26,"identifiers":3535},"Matthews DR, Hosler JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985, 28: 412-419. 10.1007\u002FBF00280883.",{"doi":3536},"10.1007\u002FBF00280883",{"id":26,"text":3538,"url":26,"identifiers":3539},"Reinehr T, Andler W: Changes in the atherogenic risk factor profile according to degree of weight loss. Arch Dis Child. 2004, 89: 419-422. 10.1136\u002Fadc.2003.028803.",{"doi":3540},"10.1136\u002Fadc.2003.028803",{"id":26,"text":3542,"url":26,"identifiers":3543},"Eliakim A, Barzilai M, Walach B, Nemet D: Should we treat elevated thyroid stimulating hormone levels in obese children and adolescents?. Int J Pediatr Obes. 2006, 1: 217-221. 10.1080\u002F17477160600805006.",{"doi":3544},"10.1080\u002F17477160600805006",{"id":26,"text":3546,"url":26,"identifiers":3547},"Reinehr T, Andler W: Thyroid hormones before and after weight loss in obesity. Arch Dis Child. 2002, 87: 320-10.1136\u002Fadc.87.4.320.",{"doi":3506},{"id":26,"text":3549,"url":26,"identifiers":3550},"Cetinkaya E, Aslan AT, Vidinlisan S, Ocal G: Height improvement by L-thyroxine treatment in subclinical hypothyroidism. Pediatr Int. 2003, 45: 534-10.1046\u002Fj.1442-200X.2003.01786.x.",{"doi":3551},"10.1046\u002Fj.1442-200X.2003.01786.x",{"id":26,"text":3553,"url":26,"identifiers":3554},"Wu T, Flowers JW, Tudiver F, Wilson JL, Punyasavatsut N: Subclinical thyroid disorders and cognitive performance among adolescents in the United states. BMC Pediatr. 2006, 6: 12-10.1186\u002F1471-2431-6-12.",{"doi":3555},"10.1186\u002F1471-2431-6-12",{"id":26,"text":3557,"url":26,"identifiers":3558},"Kapelari K, Kirchlechner C, Högler W, Schweitzer K, Virgolini I, Moncayo R: Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study. BMC Endocrine Disorders. 2008, 8: 15-10.1186\u002F1472-6823-8-15.",{"doi":3559},"10.1186\u002F1472-6823-8-15",{"id":26,"text":3561,"url":26,"identifiers":3562},"Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH: Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr. 1975, 86: 675-10.1016\u002FS0022-3476(75)80350-7.",{"doi":3563},"10.1016\u002FS0022-3476(75)80350-7",{"id":26,"text":3565,"url":26,"identifiers":3566},"Ortiga-Carvalho TM, Oliveira KJ, Soares BA, Pazos-Moura CC: The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies. J Endocrinol. 2002, 174: 121-125. 10.1677\u002Fjoe.0.1740121.",{"doi":3567},"10.1677\u002Fjoe.0.1740121",{"id":26,"text":3569,"url":26,"identifiers":3570},"Mantzoros CS, Ozata M, Negrao AB, Suchard MA, Ziotopoulou M, Caglayan S: Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab. 2001, 86: 3284-91. 10.1210\u002Fjc.86.7.3284.",{"doi":3571},"10.1210\u002Fjcem.86.7.7644",{"id":26,"text":3573,"url":26,"identifiers":3574},"Reinehr T, Isa A, de Sousa G, Dieffenbach R, Andler W: Thyroid hormones and their relation to weight status. Horm Res. 2008, 70: 51-57. 10.1159\u002F000129678.",{"doi":3575},"10.1159\u002F000129678",{"id":26,"text":3577,"url":26,"identifiers":3578},"Sreenan S, Cairo JF, Refetoff S: Thyroid dysfunction is not associated with alteration in serum leptin levels. Thyroid. 1997, 7: 407-409. 10.1089\u002Fthy.1997.7.407.",{"doi":3579},"10.1089\u002Fthy.1997.7.407",{"id":26,"text":3581,"url":26,"identifiers":3582},"Mihaly E, Fekete C, Tatro C, Liposits Z, Stopa EG, Lechan RM: Hypophysiotropic thyrotropin-releasing hormone-synthesizing neurons in the human hypothalamus are innervated by neuropeptide Y, agouti-related protein, and alpha-melanocyte-stimulating hormone. J clin Endocrinol Metab. 2000, 85: 2596-2603. 10.1210\u002Fjc.85.7.2596.",{"doi":3583},"10.1210\u002Fjc.85.7.2596",{"id":26,"text":3585,"url":26,"identifiers":3586},"Syed MA, Thompson MP, Pachucki J, Burmeister LA: The effect of thyroid hormone on size of fat depots accounts for most of the changes in leptin mRNA and serum levels in the rat. Thyroid. 1999, 9: 503-12. 10.1089\u002Fthy.1999.9.503.",{"doi":3587},"10.1089\u002Fthy.1999.9.503",{"id":26,"text":3589,"url":26,"identifiers":3590},"Araujo RL, Andrade BM, da Silva ML, Ferreira AC, Carvalho DP: D2 deiodinase activity at pituitary level, which controls the feedback of T3 on TSH. Am J Physiol Endocrinol Metab. 2009, 296: E1157-63. 10.1152\u002Fajpendo.90869.2008.",{"doi":3591},"10.1152\u002Fajpendo.90869.2008",{"id":26,"text":3593,"url":26,"identifiers":3594},"Rodondi N, Aujesky D, Vittinghoff E, Cornuz J, Bauer DC: Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. Am J Med. 2006, 119: 541-51. 10.1016\u002Fj.amjmed.2005.09.028.",{"doi":3595},"10.1016\u002Fj.amjmed.2005.09.028",{"id":26,"text":3597,"url":26,"identifiers":3598},"Hueston WJ, King DE, Geesey ME: Serum biomarkers for cardiovascular inflammation in subclinical hypothyroidism. Clin Endocrinol (Oxf). 2005, 63: 582-587. 10.1111\u002Fj.1365-2265.2005.02388.x.",{"doi":3599},"10.1111\u002Fj.1365-2265.2005.02388.x",{"id":26,"text":3601,"url":26,"identifiers":3602},"De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R: Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resi stance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol. 2007, 67: 265-269. 10.1111\u002Fj.1365-2265.2007.02874.x.",{"doi":3603},"10.1111\u002Fj.1365-2265.2007.02874.x",{"id":26,"text":3605,"url":26,"identifiers":3606},"Kiortis DN, Durack I, Turpin G: Effects of a low-calorie diet on resting metabolic rate and serum triiodothyroxine levels in obese children. Eur J Pediatr. 1999, 158: 446-450. 10.1007\u002Fs004310051117.",{"doi":3607},"10.1007\u002Fs004310051117",{"id":26,"text":3609,"url":26,"identifiers":3610},"Niedziela M: Subclinical hypothyroidism: dilemmas in the treatment of children. J Endocrinol Invest. 2007, 30: 529-531.",{"doi":3611},"10.1007\u002FBF03346340"]